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Abstract
Up-and-Down and the Percentile-Finding Problem
Assaf Peretz Oron
Chair of the Supervisory Committee:
Associate Professor Peter D. Hoff
Statistics
Up-and-Down (U&D), a popular sequential design for estimating threshold percentiles in binary
experiments, has not been a major subject of statistical research since the 1960’s. U&D application
practices have stagnated, and significant gaps in understanding its properties persist. The first
part of my work aims to fill critical gaps in U&D theory. All U&D variants studied generate
Markov chains of treatments. New results concerning stationary distribution properties are proven.
A commonly used U&D variant known as “fixed forced-choice staircase” or “k-in-a-row” (KR),
is proven to have a single-mode stationary distribution – contradicting recent remarks about it in
literature. Moreover, KR is shown to be the best-performing design in terms of convergence rate and
estimation precision, compared with other designs targeting the same percentiles. A second focus of
this study is nonparametric U&D estimation. An improvement to isotonic regression called “centered
isotonic regression” (CIR), and a new averaging estimator called “auto-detect” are introduced and
their properties studied. Interval estimation solutions are also developed for both estimators.
Bayesian percentile-finding designs, most notably the continual reassessment method (CRM)
developed for Phase I clinical trials, are also studied. CRM is believed to converge to exclusive
allocation to a single optimal level, but to date, this belief had not been substantiated by extensive
proofs. Here I add several proofs, expanding the understanding of when CRM might converge. In
general, CRM convergence depends upon random run-time conditions – meaning that convergence
is not always assured. Small-sample behavior is studied as well. It is shown that CRM is quite
sensitive to outlier sub-sequences of thresholds, resulting in highly variable small-sample behavior
between runs under identical conditions. Nonparametric CRM variants exhibit a similar sensitivity.
Ideas to combine the advantages of U&D and Bayesian designs are examined. A new approach is
developed, using a hybrid framework, that evaluates the evidence for overriding the U&D allocation
with a Bayesian one. This new design, called “Bayesian Up-and-Down” (BUD), is shown numeri-
cally to be more robust than CRM, and moderately outperforms either CRM or U&D in terms of
estimation.
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1Chapter 1
PREFACE AND INTRODUCTION
21.1 Preface
In many binary-response experiments, researchers are not interested in finding the entire
treatment-response curve, but only a single representative value, which can be described via
a percentile of the underlying threshold distribution F . This percentile can represent (for
example) the sensory threshold, the LD50 of a toxic substance, or the maximum-tolerated-
dose (MTD) of a medication. Such experiments are typically limited to a sample of several
dozen trials or even less, and with little prior knowledge about the form of F . An additional,
rather common constraint is that treatment levels are limited to a fixed, discrete, finitely-
spaced set.
Statisticians have been developing designs to answer this type of challenge for at least two
generations. Yet, interestingly, if an applied researcher were to seek statistical consulting
on this problem, he or she would receive wildly differing recommendations, depending upon
which field they work in or which statistician happened to be the consultant. Moreover, an
applied statistician wishing to consult a client on this issue would discover, upon a cursory
literature search, that any clear, well-tested and practical guidelines (if they exist) are
drowning in a sea of contradictory “best practices” recommendations, antiquated references,
unverified claims and controversy. In short: until quite recently, there was no up-
to-date, standard reference for this problem.1
These are not hypothetical statements; this is exactly what happened to me in late 2003,
when I was enlisted to help Dr. M. J. Souter design an anesthesiology percentile-finding
experiment (Oron, 2004; Bhananker et al., 2007). My search for solid and reliable solutions
has evolved into the dissertation you are reading. After this tortuous journey, I find it
important to repeat in this introduction a well-known truism, which is somehow forgotten
in this field’s prevalent patterns of debate. Here it is, in the form of a disclaimer:
Constrained by the binary response, a small sample size, an unknown response
threshold distribution and a discrete treatment set, the quality of information
the experiment can provide is limited. Failed experiments (however one
chooses to define ”failure”) are far from unlikely. The degree of confidence
expressed by many statisticians promoting this or that method is exaggerated.2
Keeping this perspective in mind, there is quite enough room for theoretical insight and
1Apparently, I am not the only person to have noticed this. Chevret (2006) is a recent attempt to fill
the gap. Pace and Stylianou (2007)’s review is an attempt to update the anesthesiology community with
recent statistical developments relevant to their needs.
2Fisher (2007), in a recent Anesthesiology editorial, voiced similar concerns regarding the use of ‘Up-and-
Down’ methods.
3methodological developments. The next section will expand and clarify these statements.
1.2 Introduction
1.2.1 Conceptual Framework
As the opening paragraph explains, we are looking for a treatment value x that will gen-
erate positive response with probability p. We assume that this probability is monotone
increasing in x. Furthermore, we assume that the response is deterministically triggered
via an underlying population (sub)distribution of response thresholds F (t), with a density
f(t).3 We aim to estimate Qp ≡ F−1(p), known as the target percentile, or simply the
target.
An excellent, perhaps ideal experiment, would be to directly sample the thresholds them-
selves, {Tn} ∼ f . If this is possible, then without knowledge of F a good target estimate
would be T(np), the sample np-th order statistic (or 100p-th percentile). For large n, T(np)
is approximately normal with asymptotic variance
V ar
[
T(np)
] ≈ p(1− p)
nf2(Qp)
. (1.1)
This can be perceived as a rough precision benchmark for the percentile-finding problem.
Our conditions, however, are far from ideal. Rather than the thresholds themselves, we
observe binary responses that can be interpreted as censored current-status informa-
tion: at a given trial indexed i with treatment xi, we know that ti ≤ xi if the response
was ‘yes’ and ti > xi if it was ‘no’. If we pool all our treatments to the same value x0, we
can estimate F (x0) with variance F (x0) [1− F (x0)] /n. This is not a very impressive feat;
for example, unless F (x0) is close to 0 or 1, we need n ≈ 100 to get a 95% CI of ±0.1 for
Fˆ (x0). And the best we can achieve this way, is knowing whether Qp > x0, Qp < x0, or
(if we are lucky) Qp ≈ x0. It is no wonder that in the related problem of binary-response
opinion polls (which are analogous to estimating F at a single specified x0), the minimal
acceptable sample size is several hundred.
If we try to cover a larger range of treatments by splitting the sample equally between m
levels (l1 . . . lm), we will obtain m even less precise point estimates, with many observations
taken quite far from Qp – indicating a waste of resources. The MLE with no knowledge of
F ’s shape is not much more than an interpolation between these rather blunt point estimates
3This last assumption is often wrong, especially in psychophysical experiments to find the sensory thresh-
old of a single subject. In that field, it is common to apply fixes such as added parameters for the false
positive and false negative rates. However, the simplifying assumption allows us to treat x and t as one
and the same, and focus on the core features of the problem.
4(this is examined more closely in Chapter 3). Taking the range-covering approach further,
if we could let x vary randomly and continuously, the nonparametric MLE of F for current-
status data converges – both globally and locally – only at an n1/3 rate (Kim and Pollard,
1990; Groenenboom and Wellner, 1992).
In short, the problem’s properties imply that our prospects for solidly successful target
estimation are not very promising.
A way out of this quagmire would be some “intelligent” sequential scheme, that would
lead us to collect most of our information in the vicinity of Qp – even though before our first
trial we have little knowledge where that target might be – and then allow for reasonably
useful estimation.4 Again, as hinted previously, statisticians and others have suggested
many such schemes, but the most widely used methods fall almost exclusively into one
of two groups. These are Markovian or Up-and-Down (U&D) designs, and Bayesian
schemes.
I shall revisit this generic sampling perspective occasionally throughout the dissertation.5
Typically, these will also be the only places where the response threshold distribution might
be referred to as F (t). Otherwise, because of the threshold-triggering assumption spelled
out above, I will refer to the threshold CDF as F (x): an (indirect) function of treatments.
1.2.2 Some Definitions and Constraints
Before we proceed further, it may be a good idea to define the two design approaches. The
following definition is broad enough to include all methods discussed in the thesis, and is in
the spirit of Storer (2001); Potter (2002) and Ivanova and Flournoy (2006).
Definition 1 (i) An ‘Up-and-Down’ (U&D) or algorithm-based design is any percentile-
finding, binary-response sequential experimental design with treatments and responses {xn}, {yn},
respectively; with fixed, discrete treatment levels {lm} and sequential treatment allocation
rules, which are functions of {xn}, {yn} and possibly also φ, a set of fixed parameters.
(ii) A Bayesian or model-based scheme is as in (i) above, but the allocation rules
are functions of {xn}, {yn}, φ, and a statistical model G ({xn}, {yn} | φ, θ), where θ is a set
of data-estimable parameters.
As Definition 1 indicates, the dissertation will only deal with designs constrained to a
fixed discrete set {lm}. This excludes methods such as stochastic approximation and its
4Observing (1.1), the concentration of observations around target is tantamount to artificially increasing
f(Qp) – with a linear effect on estimation error.
5See Sections 2.2.1,3.2.1,4.2.5, 4.3.1 and 5.3.1. To complete this bird’s-eye view of the dissertation, I also
suggest Section 3.6 – which summarizes my U&D-related findings in the form of practical recommendations
– and the conclusions.
5descendants (Robbins and Monro, 1951; Lai, 2003). Additionally, we will usually assume
that {lm} is evenly spaced (whether on the original or on a transformed scale), with level
spacing s.6 Other simplifying assumptions are that the underlying threshold CDF F is
continuous strictly increasing, that it has a density f , and that thresholds in the experiment’s
trials are i.i.d. draws from f .
These assumptions will save a great deal of burdensome notation, and should help us
focus on essential design and estimation properties rather than on terminology.7
1.2.3 Audience and Scope
Percentile-finding is an application encountered in many research fields. However, two fields
have dominated the design debate. In one of them (psychophysics or sensory studies), it
is because the field’s most routine experiment - determination of sensory thresholds - is
modeled as a percentile-finding problem. Proper treatment of the sheer wealth and breadth
of percentile-finding designs used in psychophysics may take several books. Fortunately, the
constraints outlined above already filter out a large part of these designs.
The second field (Phase I clinical trials) is dominant not so much because of its preva-
lence, or because of the wealth of designs. In fact, the vast majority of Phase I trials still
appear to use conservative protocols, which most statisticians (myself included) view as out-
dated. The ‘Phase I’ application has dominated debate mostly because of the large amount
of resources and statistical attention commanded by clinical trials in general.
The typical practical constraints in these two fields are very different. In psychophysics,
most experimental runs are carried out on a single subject. Sample size and trial cost are
usually not a problem, and in principle the treatment can vary continuously (though most
designs prefer to stick to a discrete set). The sensory threshold itself is also defined quite
flexibly: anything from the median to the 80th percentile may be commonly encountered.
By contrast, Phase I trials are limited to small sample size (< 40), and are usually carried
out in cohorts of 3 patients. The target is typically between the 20th and 33rd percentile,
and due to toxicity concerns it is preferably approached from below.
In between, the “vanilla” engineering and scientific applications are usually median-
targeting, size-constrained, and for lack of statistical attention have continued to plough
along with 1940’s to 1960’s methodology. The three application types are summarized in
Table 1.1.
6In some cases we will assume {lm} is finite and in others not, depending upon context. Usually the
difference between the two cases is more notational than substantial.
7Most results discussed here can be easily extended to cases when one suspects F to behave otherwise,
or wishes to run the experiment on an unevenly spaced {lm}.
6Table 1.1: Side-by-side comparison of the properties of three most prominent types of
percentile-finding applications mentioned in the text.
Application Psychophysics Phase I General Engi-
neering
Target Median or above 20th to 33rd Per-
centile
Median
Cohort Size 1 2 – 6 1
Major Constraints Simplicity, re-
sponse fa-
tigue/reliability
Toxicity, medical
ethics, volunteers,
duration
Simplicity, cost, du-
ration, toxicity (in
some cases)
Currently Popular
Designs
A large variety, in-
cluding U&D and
Bayesian designs
‘3+3’ protocol,
with Bayesian de-
signs increasingly
popular
U&D
My approach has been to steer clear of complete commitment to a single field’s specific
needs. The rationale is that this is precisely a statistical researcher’s role: to look at the
generic problem, examine and formulate solutions to it - solutions useful for all applications.
From these generic solutions, it should not be difficult to tailor specific applications. All
that being said, given the medical motivation that introduced me to the problem, the terms
and concerns encountered in medical literature are more prevalent in this thesis than those
of other fields.
1.2.4 Thesis Layout
The thesis focuses on the most veteran family of U&D designs, which includes the original
1940’s method (Dixon and Mood, 1948). Chapter 2 tackles the designs themselves, while
Chapter 3 is devoted to estimation. In recent decades, Bayesian model-based designs known
under acronyms such as QUEST and CRM (Watson and Pelli, 1983; O’Quigley et al., 1990)
have quickly eclipsed U&D in the number of statisticians studying them (though not in
their prevalence of use). These designs are discussed in Chapter 4. There have been some
attempts to combine the two approaches, and I have devoted quite a bit of energy to
this as well. Combined approaches are discussed in Chapter 5, which is followed by the
conclusions. To minimize confusion between the thesis terminology and that of
other publications, I will refer to the algorithm-based design family simply as
U&D, and to the model-based family as CRM or “Bayesian”.
7Rather than precede the thesis body with a long and tedious introduction to all these
subjects, I have opted to start each chapter with an introductory section, which reviews the
current state of knowledge on that chapter’s topic. Such sections are followed by sections
with theoretical results, and then sections with new methodological developments. In Chap-
ter 3, the dissertation’s largest chapter, there is also a separate section presenting numerical
results 8, a section reporting and analyzing the results of the motivating anesthesiology
experiment, which has been recently completed (Bhananker et al., 2007) – and finally, a
section summarizing Chapters 2-3 with a list of practical recommendations. At the end of
Chapters 2, 3 and 4 the reader can find glossaries for these chapters.
1.2.5 The Role of Simulation
In fall 2003, while still on the anesthesiology consulting job, team leader Nancy Temkin
suggested that I use computer simulation to see how different U&D designs pan out. I
proceeded to do so, unwittingly following in the footsteps of Wetherill, who in the 1960’s
traveled across the ocean to make use of computing resources not available at the time
in Great Britain (Wetherill, 1963; Wetherill et al., 1966). This was such a novelty back in
England, that the mere use of simulations became a major gossip topic during the customary
Royal Society discussion appearing in Wetherill (1963). Ever since then, for better or worse,
simulation has played a central role in evaluating percentile-finding designs and estimators.
Sometimes this approach is taken to the extreme: recently, O’Quigley and Zohar (2006) in
their mini-review of CRM claimed that numerical simulation should be the main approach
in studying and evaluating designs for the small-sample percentile-finding problem.
I could not disagree more.
At their best, simulations can perform a role analogous to that of lab experiments –
proving or disproving a theory, demonstrating a theoretical result, and revealing novel pat-
terns that inspire further theoretical research. Much of the painstaking work carried out
by Garc´ıa-Perez and colleagues over a decade, examining percentile-finding designs in psy-
chophysics, belongs to this category (Garc`ıa-Perez, 1998; Alcala`-Quintana and Garc`ıa-Perez,
2004; Garc`ıa-Perez and Alcala`-Quintana, 2005).
Not at their best, simulations can be a lazy man’s escape from doing theory, producing
individual trees that are then mistaken for a forest. A classic example is Wetherill’s “re-
versal” estimator (see Chapter 3), chosen in a large part because of favorable simulation
outcomes (Wetherill et al., 1966). As Section 3.2 will show, in general this estimator is in
fact inferior.
8In other chapters, numerical results are embedded within the sections.
8At their worst, simulations can be abused to further irrelevant agendas. Here the classic
example is the rise of Bayesian designs for Phase I trials. Researchers have used simulations
to “prove” this approach’s advantage over others, most notably U&D (O’Quigley and Chevret,
1991; Babb et al., 1998). Immediately upon presenting the first such simulation study, the
authors openly called upon regulatory authorities to discontinue use of U&D (O’Quigley and Chevret,
1991). While this call was not heeded, such simulations and the confidence with which they
were presented have doubtlessly played a role in shutting most of the statistical world off to
U&D. But in both cases the comparisons have been “rigged” in several ways against U&D
(see section 4.1 for details). More neutral comparisons (Garc`ıa-Perez and Alcala`-Quintana,
2005) have yielded an almost diametrically opposite conclusion. I hope this thesis would
help explain why.
During my work on this problem, I have spent thousands of human and CPU hours
on simulation. I tried to keep simulations “at their best” as defined above. Many times I
have found myself to be lazy, discovering that 2 months of simulations have saved me... 10
minutes of theory. I have been quite wary, and hopefully have succeeded, in keeping myself
from abusing simulations, as happened in the cases mentioned above.
As the thesis materialized, I have tended to base more and more of my results on theory
and not on simulation. This has been a mostly successful endeavor. Simulation in this thesis
is confined mainly to illustrating the pros and cons of different designs and point estimators
under different scenarios, or for such essential technical tasks as evaluating the coverage of
interval estimators. There are one or two exceptions, where the numerical pattern strongly
suggests a theoretical result, but my quest for that result has been incomplete (U&D con-
vergence comparison in Section 2.2, smoothed isotonic regression in Chapter 3). Here I have
to cling to the well-worn, job-security cliche´: hopefully future work will find that proof.
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THE UP-AND-DOWN DESIGN AND SOME VARIANTS
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2.1 Description and Current Knowledge
2.1.1 Basic Terminology
Let X be some experimental treatment with a binary response Y (X) ∼ Bernoulli (F (X)).
We assume F is continuous and strictly increasing. Researchers look for Qp ≡ F−1(p),
the 100p-th percentile (or p-th quantile) of F . Treatments are administered sequentially:
both treatments and responses are indexed xi, yi, i = 1 . . . n. Following trial i, the next
treatment xi+1 is determined by some subset of all previous treatments and responses
{x1 . . . xi, y1 . . . yi}, and by the specific method’s transition rules. In U&D methods, exper-
imental treatments are restricted to a fixed set of levels lu, u = 1, . . . m, with level spacing
s.1 The subsequent discussion focuses on targets at or below the median, but all results can
be trivially translated to targets above the median.
2.1.2 History
The up-and-down (U&D) sequential method was developed in the 1940’s (Dixon and Mood,
1948; von Bekesy, 1947; Anderson et al., 1946). It is designed to estimate the median thresh-
old, under constraints of moderate sample size and a discrete set of treatment levels. It is
still in use today in its original applications - finding the median sensitivity of explosives to
shock loading (Chao and Fuh, 2003) and estimating sensory thresholds (Treutwein, 1995;
Garc`ıa-Perez, 1998). It can also be found in a wide array of applied research fields - includ-
ing fatigue testing in metallurgy and material science (Lagoda and Sonsino, 2004), testing
of dental restorative materials (Scherrer et al., 2003), breakdown voltage estimation in elec-
trical engineering (Komori and Hirose, 2000), animal toxicity response (Sunderam et al.,
2004), and anesthesiology (Capogna et al., 2001; Drover et al., 2004). In numerous appli-
cations, U&D is considered a standard method (JSME, 1981; ASTM, 1991; OECD, 1998;
NIEHS, 2001). Note on terminology: the term “up-and-down” used to refer only to the
median-finding design, but hereafter I shall use it in its more recent interpretation - any
percentile-finding design that can be seen as an extension of the original method. That
original method will be called ‘simple up-and-down’ (SU&D).
Methodological research during U&D’s early years (Brownlee et al., 1953; Derman, 1957;
Wetherill, 1963; Dixon, 1965; Wetherill et al., 1966; Tsutakawa, 1967b) generated accepted
practices for design and estimation. The first proper identification of the U&D treatment
sequence as a Markov chain is credited to Tsutakawa (1967a,b). Paradoxically, just as this
discovery was made, and as U&D was proliferating into more and more fields, statistical
1However, since F is continuous, we shall sometimes refer to x as a continuous variable when studying
properties of F .
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interest in the method had begun to dwindle. From the mid-1970’s until the late 1980’s,
very few U&D theoretical or methodological studies were published. This gap has probably
contributed to the rather uneven pattern of usage observed today. Different fields adhere
to different practices, whose rationale has often been lost in the mists of time.
Sample size is a case in point. Dixon and Mood (1948) originally recommended a sample
size of n ≈ 40 for median estimation. Shortly afterwards, there was a trend to tailor the
method for smaller and smaller sample sizes, n < 10 (Brownlee et al., 1953; Dixon, 1965).
Nowadays, some military industries still use n ≈ 40 for median-sensitivity estimation (H.
Dror, personal communication, 2006). Some groups in anesthesiology use a fixed sample
size of 30 for ED50 estimation (Capogna et al., 2001; Camorcia et al., 2004). In the same
field, Paul and Fisher (2001) report that many anesthesiologists use the fourth reversal as
a stopping rule – roughly equivalent to a dozen treatments (reversals will be defined later
in this section). Meanwhile, many researchers in anesthesiology and elsewhere use n < 10
for the same goal (Lichtman, 1998; Sunderam et al., 2004; Drover et al., 2004).
Since around 1990, methodological interest in U&D has been gradually picking up again.
Practitioners in fields using U&D have expressed increased interest and skepticism about the
method, leading to extensive studies – typically numerical – and to ad-hoc improvement
suggestions (Garc`ıa-Perez, 1998; Zhang and Kececioglu, 1998; Braam and van der Zwaag,
1998; Lin et al., 2001; Paul and Fisher, 2001; Pollak et al., 2006). Several statistical teams
have entered the fray as well, mostly in the context of Phase I clinical trials, which target
the 20th to 33rd percentiles (Storer, 1989). This recent research has yielded results that
incorporate advances in the study of Markov chains (Durham and Flournoy, 1994, 1995;
Durham et al., 1995; Gezmu, 1996; Giovagnoli and Pintacuda, 1998; Ivanova et al., 2003;
Bortot and Giovagnoli, 2005; Gezmu and Flournoy, 2006) and in estimation (Komori and Hirose,
2000; Chao and Fuh, 2001; Stylianou and Flournoy, 2002; Stylianou et al., 2003). Much of
this progress is summarized by Ivanova and Flournoy (2006) and Pace and Stylianou (2007).
All the same, some of the U&D’s basic properties are still seldom discussed.
But perhaps before everything else, the simple question of which U&D variant to choose
for a given application, especially for non-median targets, has not been properly addressed.
Since the 1950’s researchers have creatively proposed many dozens of non-median U&D
variants (e.g., Wetherill et al. (1966); Storer (1989); Durham et al. (1995); Garc`ıa-Perez
(1998); Ivanova et al. (2003); Bortot and Giovagnoli (2005)). Yet, only a handful of articles
actually compare different U&D methods’ performance, and usually only via limited-scope
simulations.2 There are also many innovative non-U&D sequential designs to achieve the
2The only exception that comes to mind is (Bortot and Giovagnoli, 2005), who prove that BCD is optimal
among first-order Markovian methods. But applied researchers do not care about a method’s Markov-
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same goal (O’Quigley et al., 1990; Rosenberger and Grill, 1997), and one may legitimately
question whether U&D is the best platform. But a comparison of U&D with other ap-
proaches means little, if the U&D design and estimation methods used are clearly inferior
to other available U&D methods, of which the researchers were not aware.
Another interesting aspect of the historical gap in U&D research is the method’s per-
ceived nature. U&D was originally tied to a parametric assumption: the thresholds were
assumed to be normally distributed (Dixon and Mood, 1948; Dixon, 1965). Nowadays U&D
is almost universally seen as a nonparametric design. There has been little theoretical explo-
ration into the ramifications of this change in perception, regarding design and estimation
as actually practiced in the field.
2.1.3 Transition Probabilities, Balance Equations and Stationary Formulae
The original, median-targeting simple up-and-down (SU&D) starts at an arbitrary level, and
then moves up or down 1 level, following ‘no’ or ‘yes’ responses, respectively. This makes
SU&D a lattice random walk, with ‘up’ and ‘down’ transition probabilities pu = 1 − F (lu)
and qu = F (lu), respectively.
3 Assuming F (lu) ∈ (0, 1) ∀u, there is a stationary distribution
(Tsutakawa, 1967b; Durham and Flournoy, 1995), obeying:
πupu = πu+1qu+1, u = 1 . . .m− 1
γu ≡ piu+1piu =
pu
qu+1
= 1−F (lu)F (lu+1) =
1−F (x)
F (x+s)
, (2.1)
with straightforward normalization to determine π1. The symbol γu, hereafter termed “the
stationary distribution profile”, is monotone decreasing in u. Therefore, the stationary
distribution has a single mode, including the possibility that the mode is on a boundary
(Durham and Flournoy, 1995). The U&D treatment sequence is known as a random walk
with a central tendency (see e.g., Hughes, 1995, Ch. 3.4). Durham and Flournoy (1994)
prove that the stationary mode is at most one spacing interval away from the median.
This is the place to note that U&D’s basic properties, such as a single mode near target,
are retained even under an infinite (unbounded) set of treatment levels. Since the profiles
{γm} are monotone decreasing, with reference to the frequency at the mode the stationary
frequencies form a sequence that decreases in a faster-than-geometric rate to either direction.
Therefore, the overall sum of frequencies is a convergent series, even if carried to infinity,
and π always exists with a mode near target. Hence, distinguishing between a bounded set
chain order; they would like to know which method is best for estimating a given percentile, under certain
practical constraints.
3On the boundaries, trivial “reflecting” conditions are imposed; this type of boundary conditions is
assumed throughout the text, but explicit boundary details are omitted for brevity.
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of treatments indexed 1 . . . m, and an unbounded one indexed u,−∞ < u < ∞ presents
only a minor technical challenge and not a conceptual difference. Furthermore, as will be
seen in Chapter 3, in some sense the unbounded-design version of U&D is the “pure” one.
Derman (1957) suggested modifying U&D via randomization in order to target non-
median percentiles. However, the method now known as ‘biased-coin’ design (BCD)
was developed independently by Durham and Flournoy (1994, 1995). It is similar to SU&D,
except that after a ‘no’ response the next treatment is determined using a random draw:
with probability Γ/(1−Γ) we go up one level, otherwise the level is unchanged (Γ ∈ (0, 0.5]).
Now ru, the probability of remaining at the same level for another trial, can be nonzero.
The resulting transition probability rule as a function of F is
pu = [1− F (lu)] Γ1−Γ , u = 1 . . . m− 1;
ru = [1− F (lu)] 1−2Γ1−Γ , u = 2 . . . m− 1;
qu = F (lu), u = 2 . . . m
. (2.2)
The stationary distribution obeys (Durham and Flournoy, 1995)
γu =
1− F (lu)
F (lu+1)
Γ
1− Γ . (2.3)
Again, the walk has a central tendency and a single mode; it was shown (Durham and Flournoy,
1994) that the stationary mode is at most one spacing interval away from QΓ, which is the
method’s designated target.
Another non-median U&D method is known as “forced-choice fixed staircase” or ‘k-
in-a-row’ (KR) (Wetherill et al., 1966; Gezmu, 1996).4 Here there is no random draw;
instead, we must observe exactly k consecutive ‘no’s at a given level before moving up (the
‘down’ rule remains as in SU&D). For k = 1, KR reduces to SU&D. Even though KR is
by far the most widely used non-median U&D method and is arguably easier to administer
than BCD (requiring no random draw), its Markov chain properties are more complex and
have rarely been studied. KR’s transition probability matrix and stationary distribution
were described by Gezmu in her unpublished dissertation (Gezmu, 1996). In numerical
runs, KR has repeatedly exhibited advantages over similar-targeted BCD designs (see also
Storer, 1989; Ivanova et al., 2003). However, Gezmu and her collaborators have come to
doubt the method’s theoretical properties, most notably the existence of a single stationary
4In fairness, I should have used the term ‘staircase’ to refer to this method, since this is how most of
its users (in psychophysics) know it. However, ‘k-in-a-row’ is shorter and more descriptive. Moreover,
rigorously speaking, all 3 U&D ‘flavors’ discussed here answer the definition ‘forced-choice fixed staircase’
(as contrasted with ‘adaptive staircase’, in which the ‘up’ and ‘down’ steps have different level spacing;
see e.g. Garc`ıa-Perez (1998)).
14
mode (Ivanova and Flournoy, 2006). This and other properties will be explored in the next
section.
One aspect of KR that has been known since its inception (Wetherill et al., 1966) is its
target: it is the solution to the equation 5
[1− F (Qp)]k = 1− [1− F (Qp)]k
p ≡ F (Qp) = 1−
(
1
2
)1/k . (2.4)
Unlike BCD, KR can target only a discrete set of percentiles; for k = 2, 3, 4, these are
approximately Q0.293, Q0.206 and Q0.159, respectively.
6
SU&D, BCD (Γ = 0.206) and KR (k = 3) are illustrated in Fig. 2.1 - where all
three were run numerically on the same set of 40 thresholds. As the figure shows, how
closely an individual experiment’s chain tracks around Qp depends upon F ’s properties
(the distribution used for Fig. 2.1 is relatively shallow), and also upon the “luck of the
draw”: for example, between trials 15 and 31, low thresholds were frequently encountered,
and therefore the SU&D and KR chains remained mostly below target. For the BCD
chain this was compounded by ‘unlucky’ randomization draws: between trials 21 and 37,
treatment escalations took 5, 6 and 5 successive ‘no’s, respectively, while the conditional
escalation probability per trial (given a ‘no’ response) was in fact a little over 1/4. Note also
that the n + 1-th treatment is determined by n-th outcome, a property used for averaging
estimators (see Chapter 3).
In group ‘up-and-down’ (GU&D) (Tsutakawa, 1967b) instead of a single trial, at
each stage a cohort of k simultaneous independent trials with the same treatment is per-
formed. Probabilistically, GU&D does not use a binary-outcome trial, but rather the bi-
nomial outcome YG(x) ∼ Binomial (k, F (x)), the number of ‘yes’ responses observed in the
cohort. GU&D transition rules stipulate a move up if YG ≤ a, a move down if YG ≥ b,
and staying at the same level otherwise (obviously, 0 ≤ a < b ≤ k). As k increases, the
increasing number of possible combinations of a and b provides a large variety of targets
(there are k(k+ 1)/2 possible designs with cohort size k). Generic stationary formulae and
other key properties of GU&D are detailed by Gezmu and Flournoy (2006). More recently,
Ivanova et al. (2007) prove that GU&D’s mode lies at most 1 spacing unit away from target.
Here we focus mostly on the GU&D subset with a = 0, b = 1 (hereafter: GU&D(k,0,1)),
5Paradoxically, Wetherill et al. (1966) derived KR’s target in an erroneous way: they calculated the target
of a GU&D method to be presented below, and attributed it to KR.
6In sensory studies the method is inverted: one ‘no’ response triggers an ‘up’ move, while k consecutive
‘yes’ responses are required for a ‘down’ move. Hence the targets are Q0.707, Q0.794, Q0.841, etc.
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Figure 2.1: Sample numerical runs of SU&D (top), BCD (center) and KR (bottom) experiments.
The latter two were designed to have the same target (Γ = 0.2063, k = 3). Targets are indicated by
horizontal dashed lines. ‘Yes’ and ‘no’ responses are indicated by ‘x’ and ‘o’ marks, respectively. The
design had 10 levels, and thresholds were drawn from a Weibull distribution with shape parameter
at 2, F = 0.7 at the top level and 0 one spacing interval below the bottom level.
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whose transition probabilities are equal to those of SU&D performed on a transformed CDF
H(x) ≡ 1− [1− F (x)]k (2.5)
(and with each single ‘transformed trial’ representing a cohort of k actual trials). GU&D(k,0,1)
targets are identical to those of KR with the same k, thus enabling direct comparison be-
tween the three U&D variants described here.
Another interesting GU&D design family is GU&D(k,a,k−a), which targets the median
(SU&D itself can be re-defined as GU&D(1,0,1) and therefore belongs to this family too).
Gezmu and Flournoy (2006) found numerically that for a fixed cohort size k, convergence
accelerates with increasing a, but the stationary distribution’s mode becomes more shallow
(see also comment in Ivanova et al., 2007). Finally, as Storer (1989), Ivanova and Flournoy
(2006) and Ivanova (2006) note, the commonly used phase I cancer trial ‘3+3’ method can
be modeled as an initial GU&D(3,0,2) stage, changing into a size 6 cohort design before
stopping. The convergence of GU&D(3,0,2) will be examined in the next section. That
design’s target is Q0.347.
2.1.4 The Convergence-Stationarity Tradeoff, Reversals and ‘Down-shift’ Schemes
In his seminal work, Wetherill (1963) noticed that U&D designs face an inherent tradeoff.
Choosing a large spacing reduces the expected number of trials until the chain first reaches
target, and hence speeds convergence. On the other hand, a smaller spacing generates a
tighter distribution around target, once it is reached. The most obvious solution is to begin
with a large spacing, then reduce it at some point (most conveniently by a factor of 2).7 I
shall refer to these spacing-reduction designs as “down-shift” schemes. The question is,
what would be a good point to make the shift, if such a point exists.
This is where the notion of “reversal” comes into play. A reversal is a point in the
experiment, where the response is different from the previous, i.e. a reversal at i means
that yi 6= yi−1. For SU&D, reversals are where the treatment chain reverses direction, hence
the name. For the U&D variants described above, that is not necessarily the case; however,
the term “reversal” has been used for them under the same definition. Brownlee et al.
(1953) were the first to suggest discarding all data up to the first reversal, using ‘common
sense’ arguments. Wetherill (1963) suggested “down-shifting” at the first reversal, an idea
that has recurred in different forms since then. Interestingly, “down-shift” schemes triggered
by the first reversal have been prominent in recent attempts to integrate U&D into model-
7This can be seen as a crude attempt to utilize some of the advantages of stochastic approximation
(Robbins and Monro, 1951), under the constraint of discrete levels. It can also be viewed as a simplified
version of simulated annealing (V. Minin, personal communication, 2007).
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based Phase I designs (Storer, 1989, 2001; Potter, 2002). In some fields, reversals are also
used as a stopping rule, with the experiment length specified in reversals instead of trials
(Garc`ıa-Perez, 1998; Paul and Fisher, 2001).
The benefit of using the first reversal as a down-shift point has not been verified theoret-
ically. Numerically, both Garc`ıa-Perez (1998) and this author (Oron, 2005) have concluded
that down-shift schemes are not a guarantee for performance improvement. More generally,
the theoretical properties of reversals have not been studied since Wetherill (1963).
2.1.5 Other Up-and-Down Descendants
Beyond the straightforward modifications described above, U&D has spawned a wide vari-
ety of related designs over the years. Wetherill (1963) was the first to lay out a catalogue of
such designs. In psychophysics, a popular family of related designs mandates a different step
size for ‘up’ and ‘down’ transitions (Garc`ıa-Perez, 1998; Garc`ıa-Perez and Alcala`-Quintana,
2005). If the step size ratio is irrational, the range of levels becomes continuous. Another
related family is that of Polya` urn schemes (Rosenberger and Grill, 1997). Here the transi-
tion probabilities vary as a function of prior responses, according to a predefined algorithm.
That family has been less extensively studied.
Given the significant gaps in knowledge about the simpler Markov-chain U&D designs,
these non-Markovian U&D descendants are outside the scope of my dissertation.
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Figure 2.2: Illustration of U&D reversals (marked in circles), using the same numerical runs from
Fig. 2.1. SU&D reversals (top) can be identified visually as direction changes. For the other two
designs, reversals occur at the beginning and end of each uninterrupted descent (of course, for the
mirror-image versions of these designs targeting above-median percentiles, reversals would occur
around ascents rather than descents).
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2.2 Theoretical Study
2.2.1 Conceptual Prelude
The U&D design family achieves a remarkable feat: it converts censored, binary-response
(and therefore indirect) threshold sampling – a rather unfriendly turf for percentile estima-
tion – back into direct sampling from a quantitative distribution on the threshold/treatment
scale. This distribution is π, the stationary distribution of treatments. Even better, π ap-
pears to be centered near Qp. These properties are even more remarkable, considering that
the method was developed not from a deep understanding of Markov chains, but rather
using ad-hoc intuitive innovation.
The properties of π suggest a very natural estimator for Qp: the empirical mean. How
well such an estimator performs, depends on how quickly we can assume to be sampling
from π, and on how well π is centered around target. These will be some of the topics
discussed below. But first, for lack of a standard reference, some foundational definitions of
basic concepts are needed – as well as a careful study of KR’s properties.
Notational comment: from here on, I will use Fu as a shorthand for F (lu).
2.2.2 Definition of Target and Mode
The concept of U&D target has been somewhat ill-defined in research. Most (e.g. Gezmu and Flournoy,
2006) are content with a general intuitive notion, similar to that of the method’s origina-
tors. Giovagnoli and Pintacuda (1998) attempted a more rigorous approach; however, they
end up defining target only for a narrow (and somewhat contrived) subset of U&D designs,
which does not cover KR or GU&D. I have found the following definition useful, broad and
rigorous, and in the spirit of the original idea:
Definition 2 Consider an ‘Up-and-Down’ design with a stationary distribution π, and with
(marginal) stationary ‘up’ transition probabilities p(x)|pi continuous monotone decreasing in
x, and ‘down’ probabilities q(x)|pi continuous monotone increasing in x, respectively. The
design’s target Qp is defined as the x value such that
p(x)|pi = q(x)|pi . (2.6)
Ivanova et al. (2007), in a concurrent paper, have suggested a similar definition for
GU&D’s target. In words, the target is the x value from which marginal stationary ‘up’
and ‘down’ probabilities would be equal, had a design level been placed exactly there.
It is straightforward to see that this definition does recover SU&D’s and BCD’s targets
as the median and QΓ, respectively. It is also equivalent to the definition appearing in
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Giovagnoli and Pintacuda (1998) on the subset discussed there. The reason for including
the terms “stationary” and “marginal” in the definition will become clear below.
This is also a good occasion for defining the notion of a single mode. The definition is
followed by a useful result about the mode’s location w.r.t Qp.
Definition 3 Let π be an U&D (marginal) stationary distribution. Then π will be said to
have a single mode, if the set of indices M = {u : πu > πv ∀v < u and πu > πv′ ∀v
′
> u
}
has either a single member or two members with adjacent indices u, u+ 1.
Lemma 1 If a U&D (marginal) stationary distribution’s profile γu(x) is continuous and
strictly monotone decreasing in x, then
(i) The distribution has a single mode.
(ii) If there exist two adjacent levels lu∗ , lu∗+1, such that Qp ∈ [lu∗ , lu∗+1], then the mode
is either at lu∗ or at lu∗+1.
Proof (i) If γ1 ≤ 1 or γm−1 ≥ 1, then the mode is obviously on the lower or upper boundary,
respectively. In the remaining (and more interesting) case, there has to be some u∗ such
that γu∗−1 ≥ 1 ≥ γu∗ , with equality holding for at most one of the relationships. By the
definitions of γ and of the mode, the mode is at lu∗ , possibly with either lu∗−1 or lu∗+1 (but
not both). Due to monotonicity, this mode is unique.
(ii) Note that the following inequality always holds for any u (except on the lower
boundary – a case that can be omitted here w.l.o.g.), under the specified conditions:
γu−1 >
pu
qu
> γu. (2.7)
Therefore, for all x ≤ Qp−s, γ(x) > 1 and for all x ≥ Qp, γ(x) < 1. Recalling (i), this means
that the mode lu∗ has to maintain lu∗ ∈ [Qp − s,Qp + s]. Together with γ’s monotonicity,
this forces the mode to be within s of Qp. 
2.2.3 Basic Properties of ‘K-in-a-row’
We now return to the ‘k-in-a-row’ design (KR). Unlike SU&D, BCD and GU&D, KR does
not generate a first-order random walk. A KR run can be described as a k-th order random
walk with two sets of transition rules, only one of which applies at each trial depending on
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the string of k most recent treatments (Gezmu, 1996):
xi = lu, but ∃j, i− k < j < i s.t. xj 6= lu :

pu = 0
ru = 1− Fu, u = 2 . . .m
qu = Fu, u = 2 . . .m
xi = xi−1 . . . = xi−k+1 = lu :

pu = 1− Fu, u = 1 . . .m− 1
ru = 0, u = 1 . . .m− 1
qu = Fu, u = 2 . . .m
,
However, this description does not explicitly acknowledge the counting of k ‘no’ responses
before an up transition. For this and other purposes, it is more useful to view KR as
generating a Markov chain whose treatments {xn} are paired with a sequence of internal
states {wn}. Each internal state can take one of k possible values τ = 0 . . . k − 1, for a
total of mk states (cf. e.g. Weiss, 1994, Ch.6). Under this internal-state formulation the
transition rules become
pu,τ = 0, u = 1 . . .m, τ < k − 1
ru,τ = 1− Fu, u = 2 . . .m, τ < k − 1
qu,τ = Fu, u = 2 . . .m, τ < k − 1
pu,τ = 1− Fu, u = 1 . . .m− 1, τ = k − 1
ru,τ = 0, u = 1 . . .m− 1, τ = k − 1
qu,τ = Fu, u = 2 . . . , τ = k − 1m{
xi+1 = xi ⇒ wi+1 = wi + 1
xi+1 6= xi ⇒ wi+1 = 0
. (2.8)
Note that the terms pu, qu, ru still pertain to transition between physical treatment levels,
and not between internal states. A few more notes on the internal-state formulation:
• The wi are uniquely determined by the xi; hence, after the experiment is over it
suffices to record {xn}, and then {wn} can be reconstructed.
• In the same vein, a subject receiving a given treatment xi is oblivious to wi, which
has no practical effect upon trial i itself.
• For this reason and also for comparison purposes, we ultimately focus uponmarginal
probabilities and distributions, i.e. values summed over all internal states. The
marginal stationary frequency of level u will be denoted πu ≡
∑
τ πu,τ .
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Theorem 1 (i) KR’s marginal stationary distribution profile {γu} is given by
γu =
Fu [1− Fu]k
Fu+1
{
1− [1− Fu]k
} (2.9)
(ii) Let the stationary marginal ‘up’ probability of a KR design be the weighted average
pu|pi = (
∑
τ πu,τpu,τ ) πu. Then
pu|pi =
Fu[1− Fu]k
1− [1− Fu]k (2.10)
.
(iii) KR’s marginal stationary distribution has a single mode, which is at most 1 spacing
unit away from Qp under the conditions specified in Lemma 1 (ii).
Proof (i) Taking the internal-state approach, the balance equations between adjacent treat-
ment levels may be written as
πu,k−1[1− Fu] = πu+1Fu+1. (2.11)
Now, transitions between internal states of the same treatment level are possible only for
single upward increments, each with probability 1− Fu. Therefore, to maintain balance at
stationarity, the internal state frequencies must obey πu,τ+1 = [1 − Fu]πu,τ , τ = 0 . . . k − 2
- a diminishing geometric sequence. This enables us to calculate relative internal-state
frequencies, and specifically the upper state:
πu,k−1
πu
= πu,0[1− Fu]k−1
/{
πu,0
{
1− [1− Fu]k
}
Fu
}
=
[1− Fu]k−1Fu
{1− [1− Fu]k} . (2.12)
Plugging back into (2.11), we obtain (2.9).
(ii) This result is immediate from (2.9).
(iii) Differentiating pu|pi w.r.t to F shows that it is monotone decreasing as F increases
(a more detailed derivation can be found in Appendix A). Since F itself is monotone in-
creasing in x, and since qu|pi = Fu is monotone increasing in x, γ(x) is monotone decreasing.
Therefore, by Lemma 1, there is a single stationary mode at most 1 spacing unit away from
target. 
A somewhat different proof for result (i) appears in Gezmu (1996).
Under stationarity, the frequencies of internal states within each treatment level form
a decreasing geometric sequence. This means that the base (w = 0) internal state is the
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most common. Intuitively, this is due to the fact that each level transition (whether up or
down) resets the internal state to zero. It may be of interest to look at the distribution of
these first visits - i.e., the stationary distribution of a KR chain for which each sojourn at
a treatment level is collapsed to a single trial corresponding to the base internal state.
Corollary 1 Consider a subset of any KR experimental chain, composed only of base-state
trials, i.e. {xi : wi = 0}. The stationary profile of this subset is
γu,0 =
[1− Fu]k
1− [1− Fu+1]k , (2.13)
That is, a profile identical to that of a GU&D(k,0,1) design with the same k.
Proof Using the geometric-series formula as in (2.12),
γu,0 =
πu+1,0
πu,0
=
πu+1
πu
Fu+1
{
1− [1− Fu]k
}
Fu {1− [1− Fu+1]k} .
Plugging in γu leads to most terms canceling out, yielding (2.13). 
Conceptually, we can explain this surprising identity: after deleting all trials with wi > 0,
one is left with an SU&D-like (or GU&D(k,0,1)-like) chain, in the sense that it never remains
at the same level. Now, from a given level’s base state, the probability of the next transition
being an ’up’ one is [1−Fu]k, and the move must be down otherwise - yielding exactly the
transition probabilities of GU&D(k,0,1) (see (2.5)). This result will prove rather useful later
on.
2.2.4 Location of the Stationary Mode
We have established that for all U&D variants discussed here, the stationary mode is one
of the two levels closest to target. It turns out we can do even better.
Theorem 2 (i) SU&D stationary mode is located at the level whose F value is closest to
0.5.
(ii) GU&D(k,0,1) stationary mode is located at the level whose H value (with H(x) defined
in (2.5)) is closest to 0.5.
(iii) GU&D(k,a,k−a) stationary mode is located at the level whose F value is closest to
0.5.
Proof (i) Let Qp ∈ [lu∗ , lu∗+1] w.l.o.g. Then we can write Fu∗ = 0.5 − ∆p1, Fu∗+1 =
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0.5 + ∆p2, with ∆p1,∆p2 ≥ 0. Now
γu∗ =
pu∗
qu∗+1
=
0.5 + ∆p1
0.5 + ∆p2
. (2.14)
Therefore, γu∗ > 1 if and only if ∆p1 > ∆p2, with equality only if the two are equal. Since
the mode is at one of these two levels, our proof is complete. 
(ii) This part follows immediately from (i) and from the definition of H(x).
(iii) First, note that for the binomial cohort-outcome r.v. YG defined in the previous
section, Pr (YG ≤ a|F = 0.5 −∆) = Pr (YG ≥ k − a|F = 0.5 + ∆). Moreover, both sides of
the equation are monotone increasing in ∆. Now using the same ∆p1,∆p2 notation of part
(i),
γu∗ =
Pr (YG ≤ a|F = 0.5−∆1)
Pr (YG ≥ k − a|F = 0.5 + ∆2) . (2.15)
Again, γu∗ > 1 if and only if ∆p1 > ∆p2, with equality only if the two are equal. 
For median-finding U&D, the stationary mode is the closest to target on the response
scale. For GU&D(k,0,1), this is true on the transformed scale of H(x). Since F = 1 − (1 −
H)1/k is convex in H, on the original response scale the transformed midpoint lies closer to
Fu∗ , the lower of the two levels. This means that the “attraction basin” of the upper level
is larger, and therefore if the target lies midway between levels on the F scale, the mode
would revert upward to lu∗+1. However, this asymmetry is relatively small: to first order in
∆p1,∆p2, the two “attraction basins” are equal in size.
If one wishes to measure closest treatment on the x scale, exact results depend upon the
form of F (x). However, to first order in s, it is straightforward to show that the treatment
midpoint is the boundary between the two “attraction basins” for all designs covered by
Theorem 2.
The mode location of the two remaining non-median designs is less symmetric.
Theorem 3 (i) For BCD designs, and using the same terminology as in Theorem 2, the
stationary mode would revert to lu∗ unless Fu∗+1 is closer to p by a factor greater than
(1− p)/p.
(ii) For KR designs, the stationary mode would revert to lu∗ if .
(p−∆p1) (1− p+∆p1)k < (p+∆p2)
[
1− (1− p+∆p1)k
]
, (2.16)
and vice versa.
Proof (i) This follows directly from substituting pu∗ , qu∗+1 from (2.2) in the formula for
γu∗ .
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(ii) This follows directly from substituting the analogous KR formulae found in the
previous subsection. 
The KR formula is again more complicated; analysis to first order in ∆p1,∆p2 yields
the approximation
∆p1
∆p2
<
1− p
(2k + 1)p − 1 (2.17)
for the mode to revert to lu∗ . For k = 2, 3 this yields approximately 1.52, 1.79, respectively,
for the ∆p1/∆p2 ratio at the “basin boundary”. The analogous factors for BCD are 2.41,
3.85, respectively. So both designs tend to create a mode below target more often than
above it – a tendency opposite that of GU&D(k,0,1) – but KR’s tendency is quite a bit
milder than BCD’s. This explains the numerical observations of Gezmu (1996), who noted
that KR is ‘better centered’ on target than same-target BCD (see e.g. Fig. 2.3). As above,
on the treatment scale these same ratios can be used as approximations to first order in s.
2.2.5 More Stationary Properties
Peakedness of non-median-target designs
Due to limitations related to the unknown location of target relative to the fixed design
levels, the notion of ‘peakedness’ is not easily converted to more familiar terminology used
to describe dispersion (e.g. precision or variance), but it carries a similar meaning within
the U&D context. The more ‘peaked’ a stationary U&D distribution is around its mode, the
closer the method is to the ideal design, and percentile estimation precision will generally
improve. Here is a rigorous definition of ‘peakedness’, following Giovagnoli and Pintacuda
(1998).
Definition 4 (i) For two ‘Up-and-Down’ designs, ”all other things being equal” will
mean that both target the same percentile, the threshold distribution F is the same, the
treatment levels {lu} are the same and the initial conditions are the same.
(ii) (Giovagnoli and Pintacuda, 1998) Let designs 1 and 2 be two U&D designs. Then,
all other things being equal, if γ
(1)
u ≥ γ(2)u for lu ≤ Qp while γ(1)u ≤ γ(2)u for lu ≥ Qp
(i.e., design 1’s stationary distribution profile is steeper), then design 1 and its stationary
distribution are called more ‘peaked’.
Thus, for example, to compare KR and BCD we need to examine
γKRu
γBCDu
=
Fu (1− Fu)k−1
1− (1− Fu)k
1− p
p
. (2.18)
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Theorem 4 For any k > 1, all other things being equal, KR designs are more ‘peaked’ than
BCD designs.
Proof On target, the ratio in (2.18) is exactly 1. Therefore, it suffices to show that (2.18)
is monotone decreasing in F . Careful differentiation yields this result. 
Proposition 1 For KR and GU&D(k,0,1) with the same k, neither design can be said to be
more ‘peaked’ than the other.
Proof The ratio analogous to (2.18) is
γKRu
γ
GUD(k,0,1)
u
=
Fu
[
1− (1− Fu+1)k
]
Fu+1
[
1− (1− Fu)k
] ≤ 1.
The inequality results from the concavity of 1 − (1− F ))k in F . GU&D(k,0,1)’s stationary
distribution profile is steeper to the left of the peak, while KR’s is steeper to the right of
the peak. 
Fig. 2.3 provides a numerical example of ‘peakedness’. The differences between methods
do not appear to be dramatic. On the other hand, if the spacing is too coarse (e.g. m = 5 on
the left) the stationary peak is very broad and the method’s stationary properties offer only
a modest improvement over standard, non-sequential treatment-response designs. As the
spacing becomes finer (e.g. m = 10 on the right), a sharp peak forms: under stationarity,
all 3 methods allocate 50−55% of treatments to the two levels closest to target. Thus, finer
spacing dramatically reduces the chance for treatments allocated too far from target. In
the scenario illustrated in Fig. 1, with m = 10, Prpi(x ≥ 0.7) (x = 0.7 roughly corresponds
to the 60th percentile here) is 0.02 to 0.03 depending upon method, while with m = 5
the analogous probabilities are 0.12 to 0.14. The figure also shows (for m = 10) BCD and
KR’s tendency to have the mode below target, and GU&D(k,0,1)’s opposite tendency. Here
∆p1 = 0.061 and ∆p2 = 0.042, so KR’s “basin boundary” falls just above target on the F
scale, while BCD’s and GU&D(k,0,1)’s boundaries are at a larger distance above and below
target, respectively.
Peakedness of median-target GU&D designs
Another result related to GU&D ‘peakedness’ was numerically observed by Gezmu and Flournoy
(2006): for median-targeting GU&D(k,a,k−a) (k > 2), the stationary distribution appeared
more peaked with decreasing a. Here is a general proof.
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Figure 2.3: Stationary distributions for KR (’k’ marks and solid lines), BCD (’b’ marks
and dotted lines) and GU&D (’g’ marks and dashed lines) - all targeting Q0.293, marked
with a vertical line. F is Weibull with shape parameter 1.5, and scale normalized so that
F (1) = 0.8. Shown are a coarser design with m = 5 (left) and a finer design with m = 10
(right). Also plotted is a standard non-sequential treatment allocation of 1/(m − 1) to
interior levels and 1/2(m − 1) to boundary levels (’s’ marks and thick lines). The vertical
axes are normalized to account for the factor 2 difference in m, so that the area under the
curves is similar in both plots.
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Theorem 5 For GU&D(k,a,k−a) designs (k > 2), and all other things being equal, ‘peaked-
ness’ increases with decreasing a.
Proof Consider design 1 with a and design 2 with a
′
, such that a < a
′
. Since the transition
probabilities are ‘drawn’ from the same binomial model, they can be represented thus:
p
′
u = pu + δpu, q
′
u = qu + δqu, where δpu ≡ Pr(a < YG ≤ a
′ | Fu), δqu ≡ Pr(k − a′ ≤ YG <
k − a | Fu). The ‘peakedness’ ratio is then
pu
qu+1
q
′
u+1
p
′
u
=
(qu+1 + δqu+1)pu
(pu + δpu)qu+1
=
1 + Pr(k−a
′
≤YG<k−a|Fu+1)
Pr(YG≥k−a|Fu+1)
1 + Pr(a<YG≤a
′ |Fu)
Pr(YG≤a|Fu)
. (2.19)
If Fu + Fu+1 = 1 (meaning that the target is exactly midway between the two levels if
distance is measured on the response scale), the ratio is exactly 1. Focusing on the fraction
on the right-hand-side, the ratio in the numerator is decreasing with F while the one in the
denominator is increasing. Therefore, the ratio would be < 1 with both levels below target
and vice versa, and thus by definition design 1 is more ‘peaked’. 
2.2.6 Convergence Rates
For U&D methods, the term “convergence rate” can be interpreted in a number of ways. In
view of theoretical results about the stationary mode, one may be interested in the conver-
gence of the probability that the empirical mode is the stationary mode, or more generally
in the convergence of empirical frequencies to their stationary values. On the other hand,
in view of the prevalence of averaging-based estimators, there is practical interest in the
convergence of the empirical mean to the stationary mean. Fortunately, the three methods
discussed here generate simple Markov chains with finite state spaces, and therefore all con-
vergence rate comparisons should yield equivalent results. Here we focus on the empirical
mean, which is the simplest, most intuitive, and carries a direct practical significance for
most applications.
As Gezmu and Flournoy (2006) note, for finite-state Markov chains the exact treatment
distribution after i trials can be calculated, given knowledge of initial conditions and of P ,
the design’s transition probability matrix (tpm):
ρ(i)† = ρ(1)†P i−1, (2.20)
where ρ(1) is an initial probability vector over the levels, † is the transpose operator and
P i−1 is P raised to the i−1-th power. As n→∞, ρ(n) → π, regardless of ρ(1). Convergence
rates can be estimated using the tpm. The tpm’s of the three Markovian methods discussed
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here are stochastic and irreducible. Hence, the real parts of their eigenvalues are bounded
between −1 and 1, and are usually labeled in decreasing order: 1 = λ0 ≥ Re(λ1) ≥ . . . ≥
Re(λm−1) ≥ −1. If the tpm is also reversible, that is πiPij = πjPji ∀i, j, then the eigenvalues
are all real. In that case, it can be shown that the total variation distance between ρ(n) and
π converges to zero with a rate (Diaconis and Stroock, 1991)
‖Pnρ(1) − π‖2var ∝
{∑
u
∣∣∣ρ(n+1)u − πu∣∣∣
}2
≤ cλ2n# , (2.21)
where c is a constant and λ# ≡ max (λ1, | λm−1 |). Thus, the rate of convergence is governed
by the second-largest eigenvalue. For finite-state Markov chains, it is straightforward to
show that the empirical mean would converge at half the rate of the total variation distance.
Unfortunately, comparing the 3 methods cannot be trivially reduced to an eigenvalue
problem: KR tpm’s (listing all internal sub-states as separate states) aremk×mk irreversible
matrices (Gezmu, 1996). On the other hand, all sub-states of the same external KR level
actually represent the same experimental treatment. Therefore, a possible fix is to compare
convergence by observing KR’s k× k reversible matrix of marginal transition probabilities,
using (2.10). This is analogous to assuming that in KR experiments internal-state balance
is achieved much faster than external-level balance.
One relationship can be directly proven without resorting to eigenvalues.
Proposition 2 Consider a KR and a GU&D(k,0,1) design with the same k. Then, all other
things being equal, the KR design converges faster to its stationary distribution.
Proof Recall Corollary 1 and the discussion following it, and observe the zero-state-only
KR subchain. Its transition probabilities are identical to those of GU&D(k,0,1). However,
while the latter must carry out a cohort of k trials for each transition, the KR subchain
may take anywhere from 1 to k trials – on the average, less than k. Therefore, it would
require less trials to achieve the same probabilistic convergence. 
In order to investigate convergence rates more closely, an “all other things being equal”
numerical time-progression was performed, as in (2.20).8 A summary of results for conver-
gence ‘upwards’ from l1 and some targets appears in Table 2.1 (’downward’ convergence
8Two sets of initial conditions were examined: beginning at l1 (similar to typical Phase I conditions)
or at lm, over a variety of right-skewed, left-skewed and symmetric threshold distributions, 3 values of s
and k = 1, 2, 3 for BCD, KR and GU&D (k,0,1); a second comparison was performed between BCD and
GU&D (3,0,2). Table 2.1 shows a subset of the data. The adjectives ‘tight’ and ‘disperse’ for the logistic
and log-normal scenarios indicate smaller or larger scale parameters, respectively. Convergence rates were
estimated via an exponential fit on the difference between the mean at time i and the stationary mean. All
calculations – here and in the rest of the dissertation – were performed in R (R Development Core Team,
2005).
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Table 2.1: Comparative summary of convergence calculations for several design scenarios
and targets. Shown are the number of trials needed to achieve 99% convergence of the
ensemble mean of xi to the stationary mean, beginning with the entire probability mass on
l1 at trial 1. Numbers were rounded up to the nearest integer, except for GU&D, for which
they were rounded up to the nearest multiple of k.
“Trials to 99% Convergence”
Distribution
Weibull (Shape Parameter) Logistic Log-Normal
1 (Exp.) 1.5 3.5 5 ‘Tight’ ‘Disperse’ ‘Tight’ ‘Disperse’
m = 5
SU&D 12 9 6 10 7 9 6 9
BCD, Γ = 0.293 19 17 15 17 14 17 13 16
KR, k = 2 17 14 10 10 10 14 8 13
GU&D (2,0,1) 20 16 12 10 12 16 12 16
BCD, Γ = 0.347 18 15 12 12 12 15 10 14
GU&D (3,0,2) 36 27 15 15 15 24 15 24
m = 10
SU&D 34 26 14 12 13 22 14 26
BCD, Γ = 0.293 44 38 30 31 28 39 23 33
KR, k = 2 39 32 21 21 20 32 17 27
GU&D (2,0,1) 46 36 24 22 22 36 20 32
BCD, Γ = 0.347 44 35 24 23 22 34 19 31
GU&D (3,0,2) 81 57 33 30 33 54 27 51
was faster in most scenarios, but the overall pattern was not substantially different; data
omitted here). Shown are the number of trials needed for the ensemble mean of the xi’s
to converge 99% of the way from l1 to the stationary mean. These numbers can be seen
as a practical cutoff, beyond which the treatment chain is ‘as good as’ a sample from π, at
least for averaging purposes (one reason for choosing 99% is because halving the numbers
on Table 2.1 conveniently yields the number of trials needed to converge a more lenient 90%
of the way).
Some observations from Table 2.1:
1. SU&D converges faster than any non-median method examined. This is intuitively
expected, since SU&D requires a only single trial before transition in either direction.
2. For a given target response rate p, convergence rates are most strongly affected by a
combination of distribution properties and spacing - specifically, by the difference in
F values between adjacent levels around target. For example, the “shallowest” CDF
(exponential thresholds and m = 10) causes the slowest convergence, and vice versa.
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3. Among the three non-median methods, KR is solidly ahead, while BCD is slowest.
Based on these and other numerical runs not shown here, one could expect BCD to
take around 20 − 40% more trials than same-target KR to reach the same degree of
convergence. The performance gap increases with k.
4. The number of trials to 99% convergence can be quite substantial when compared with
the design limitations of applications such as Phase I clinical trials. Moreover, the
Markovian method most closely resembling the ‘3+3’ design (GU&D(3,0,2)) converges
very slowly - even slower than BCD. It takes GU&D(3,0,2) 50− 90% more trials than
KR (k = 2) to achieve the same degree of convergence, even though the former’s target
is closer to the median. Furthermore, recall that these are ensemble averages and not
single-run statistics.
Table 2.1’s convergence rate estimates are in rough agreement with eigenvalue predictions for
BCD and GU&D (data not shown). KR rates show an agreement with the ‘marginalized’
tpm eigenvalue, indicating that indeed it is the between-level convergence that is rate-
limiting.
Note that in agreement with Proposition 2, KR converges faster than GU&D(k,0,1). Fur-
thermore, same-targeted BCD is the slowest-converging. This has been observed universally,
over a much wider range of scenarios than is reported here. I have yet to find a rigorous
proof why. Can a heuristic explanation be found?
The KR-BCD convergence gap recalls the observation by Gezmu and Flournoy (2006)
that for median-targeting GU&D with fixed k, convergence speeds up with increasing a. In
both cases, the (marginal) pu, qu of the faster method are always as large or larger than
those of the slower method – and in such a way that the |pu − qu| difference is also larger.
This means that both the “probability flux” in each direction, and the net flux in direction
of target, are larger for the faster method. This is formalized in the conjecture below.
Conjecture 1 Consider two U&D designs: design 1 with p, q, r and design 2 with p′, q′, r′,
and all other things being equal. If pu ≥ p′u, qu ≥ q′u for all levels, and | pu − qu+1 |≥|
p
′
u − q
′
u+1 | when lu, lu+1 are both below or above target, then design 1 converges faster.
Note the similarity to and difference from the ‘peakedness’ definition, Definition 4. Here
and there we compare up and down probabilities between adjacent levels. However, ‘peaked-
ness’ is related to the probability ratio, while the convergence conjecture is related to the
probability difference (or ‘flux’). In the median-targeting GU&D case, increasing a in-
creases the difference while making the ratio smaller; therefore for this design family one
faces a tradeoff between fast convergence and sharp stationary distribution. On the other
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hand, KR maintains both a greater ratio and a larger difference between up and down
probabilities, compared with BCD – so it has a performance edge on both aspects.
2.2.7 Bias of Early Reversals
First Reversal
From this chapter’s theoretical analysis, it is now clear that the number of trials to the first
reversal is a random variable. Of practical interest is the location of first reversal, denoted
xR1 , conditional upon starting point x1. Those who use the first reversal as a cutoff or
transition point, implicitly assume that this location is close to target. Let us examine this
for GU&D(k,0,1) and KR. For both of them, assuming a start from the lowest level l1, the
distribution will be
Pr (xR1 = lu | x1 = l1) =
[
1− (1− Fu)k
] u−1∏
v=1
(1− Fv)k. (2.22)
This distribution is reminiscent of a generalized geometric r.v., with the reversal defined
as ‘success’, and with monotonically decreasing ‘failure’ (i.e., passage) probabilities at each
trial. If s is sufficiently small w.r.t. the slope of F , then in the vicinity of Qp the ‘up’
passage probability is approximately 0.5. This means that conditional upon reaching lu∗ ,
the level immediately below Qp, before the first reversal, the expected additional number
of levels traversed is less than 1 - landing us very close to target. However, the expected
location of xR1 is a weighted average of this and of the expectation conditional upon not
reaching lu∗ :
E [xR1 = lu | x1 = l1] = E [xR1 = lu | x1 = l1, xR1 ≥ lu∗ ]Pr (xR1 ≥ lu∗ | x1 = l1)
+E [xR1 = lu | x1 = l1, xR1 < lu∗ ]Pr (xR1 < lu∗ | x1 = l1) .
(2.23)
Therefore, under typical design scenarios, if Qp > l3, xR1 should be expected to be well
below target. Now, suppose x1 = lu, with l1 < lu < lu∗ . Then (2.23) still holds, but now
the second term includes the possibility that the chain’s first move would be downward. So
again, if x1 is 2 or more levels below target, E [xR1 ] should also be below target. The same
conclusions hold for BCD since eventual transition probability without a reversal is also 0.5
on target, and is monotone decreasing with increasing x. On the other hand, if x1 is close
to target, the first reversal will be approximately ‘right on’.
If the experiment begins at the top level lm, for SU&D the outcome will be similar
to that when starting from bottom. For the non-median methods, downward transition
probabilities will become 0.5 at the median - long before reaching target. Therefore, if x1 is
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at or above the median, the upward bias of xR1 should be even greater than the downward
bias when starting below target.
This asymmetry suggests that perhaps the interpretation of reversal for non-median-
target designs may be wrong. Perhaps, instead of “a point where a change in response is
observed” we should define reversal as a point where a change in chain direction is observed,
i.e. a move up when the last move was down (ignoring trials that mandate no change). For
SU&D the two definitions are equivalent. It is easy to see that for non-median-target
designs the second definition causes a symmetry in behavior, as far as first reversal bias
is concerned. However, a closer look reveals that direction changes are more likely than
reversals to occur far from target (to either side; more about this on Section 3.2). All in
all, the potential benefit from this changed definition is not clear, and is outweighed by the
added complication. Hence it is more useful to understand the properties of reversals as
they are currently defined, and plan our design accordingly.
To sum it up, the location of xR1 is in general biased towards x1, and is not guaranteed
to be close to target unless x1 itself is close.
Subsequent Reversals
So we have just learned that unless x1 is very close to target, the point of first reversal xR1
is likely to be on the same side of target as x1 (though closer on the average). Since xR2
is between x1 and xR1 , the second reversal is an even worse choice for cutoff or transition.
However, the expected net movement away from target between first and second reversals,
is obviously smaller than the expected gain between starting point and first reversal (since
probabilities for moving away from target are smaller than for moving towards it). This
makes the third reversal an interesting cutoff-point candidate. The next potential can-
didate is naturally the fifth reversal. Choosing a cutoff point beyond the fifth reversal may
be too late for many sample-size restricted applications.
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Glossary for Chapters 1-2
Glossary is alphabetically ordered, starting with acronyms, then mathematical symbols
(Roman letters first, Greek following). There are additional glossaries for Ch. 3 and Ch.4-
5, but this one is the most extensive.
Note: in order to keep the glossary manageable and informative, I chose to omit some
symbols which make a one-time appearance somewhere in the text, if they have no general
significance.
BCD: The Biased-Coin Up-and-Down design developed by Durham et al. (1995).
GU&D: The Group Up-and-Down design first developed by Tsutakawa (1967b).
KR: The “k-in-a-row” Up-and-Down design, first developed by Wetherill et al. (1966);
Markov-chain properties first described properly by Gezmu (1996). The name KR
is taken from Ivanova et al. (2003); I use it because it better distinguishes KR from
other U&D variants.
SU&D: The original median-targeting Up-and-Down design described by Dixon and Mood
(1948).
U&D: Up-and-Down. In this thesis, I use the name U&D to refer to the family of
designs that generate Markov chains whose stationary distribution is centered on the
target percentile. Includes (though not limited to) BCD, GU&D, KR and SU&D.
a, b: The lower and upper transition criteria parameters in group U&D designs. If ≤ a
‘yes’ responses are observed in the k-sized cohort, a move ‘up’ is mandated, and if ≥ b
are observed a move ‘down’ is mandated.
F : The CDF of thresholds; throughout the thesis, assumed to be strictly increasing
and to have a density.
f : The threshold density; first derivative of F .
Fu: The value of F at treatment level lu.
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H : A transformed CDF of thresholds for a certain family of GU&D designs (see text
for details). The concept of “transformed CDF” was first offered in this context by
Wetherill et al. (1966), where it was used erroneously for KR-type designs.
i: Used for indexing trials and responses.
k: The number of consecutive ‘yes’ (’no’) responses needed for a move ‘up’ (’down’)
in below-(above-)median KR designs; the cohort size in group U&D designs.
lu: Treatment level, indexed u.
m: The number of treatment levels (if finite)
N : Ensemble size (i.e., number of individual runs) used in simulations.
n: Sample size of a single experiment.
p: The target response rate.
P : The transition probability matrix (tpm) of an U&D design.
pu, qu, ru (indexed): The U&D ‘up’, ‘down’ and ‘stay the same’ probabilities, respec-
tively, at level lu.
Qp: The p-th quantile (or 100p-th percentile) of F . Qp, with p specifically the target
response rate, is the experiment’s target.
Rj : Index denoting the location (between 1 and n) of the j-th reversal point.
s: The spacing between adjacent treatment levels (assuming levels are evenly spaced).
T : The response-threshold r.v. Viewing a binary-response experiment as thresholds
being triggered by the treatments, underlies the entire statistical approach to the
percentile-finding problem. Individual thresholds are then assumed to come from
some (generally unknown) distribution with a density f .
t: Actual values that T takes.
u, v, u
′
, v
′
: Used for indexing treatment levels.
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wi: The internal state at trial i in a KR experiment, so that the current state of the
experiment is fully described by the pair (xi, wi). w can take integer values from 0 to
k − 1.
x (generic): The treatment as an independent variable (in the algebraic sense).
xi (indexed): The treatment value at trial i of an U&D design.
yi (indexed): The binary response at trial i.
YG: The cohort response variable in group U&D experiments. It is binomial rather
than binary.
Γ: The BCD “biased-coin” parameter. It is equal to p, but is retained here for ter-
minological compatibility with other publications.
γu: The “stationary profile”: the ratio between adjacent stationary frequencies, πu+1/πu.
γ(x): The “stationary profile” as an algebraic function of the independent variable x.
λu: The u-th eigenvalue of the tpm P , arranged in decreasing order.
pi: The stationary and/or limiting distribution of treatment allocations.
ρ(i): The probability distribution of treatments (across levels) at trial i.
τ : Used for indexing internal states in KR designs.
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Chapter 3
NONPARAMETRIC UP-AND-DOWN ESTIMATION
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3.1 Existing Estimators and Current Knowledge
Nearly all U&D target estimators can be divided into two groups: averaging estimators,
making direct use of the treatment chain {xn} only; and response-based estimators,
making use of both treatments and responses. This chapter will discuss each type separately,
in alternating order. Only the numerical study (Section 3.4) will compare them to each
other. As the chapter’s title indicates, the focus is solely on nonparametric estimators.
3.1.1 Averaging Estimators
History and Basic Description
Early U&D estimators were modified averages of the treatment chain, with the modification
coefficients based on normal theory (Dixon and Mood, 1948; Brownlee et al., 1953; Dixon,
1965). Tsutakawa (1967b) studied the properties of an average of all trials beginning with
x2, and found a nonparametric expression for its variance (see further below). However, the
U&D estimator of choice in most fields is reversal averaging, introduced by Wetherill and
aptly named w¯ (Wetherill et al., 1966).1 The estimator w¯ is a somewhat modified arithmetic
average of x at reversal points {xRj} (reversals were defined in Section 2.1):
w¯ =
∑
j xRj + xRj−1
2nR
, (3.1)
where nR is the number of reversals. A straightforward reversal average is known as wˆ,
introduced by Choi (1971). Estimators belonging to the w¯ or wˆ type (i.e., some average of
treatments at reversals only, beginning from a certain cutoff point) appear to be the most
commonly used U&D estimators in median-finding applications across most relevant fields,
and in psychophysics experiments using KR. From here on I will refer to this estimator
family as wˆ.2 As Choi (1971) pointed out, for SU&D w¯ is identical to the simpler wˆ when
nR is even, and differs from it by ±s/2nR when nR is odd. For KR and other non-median
methods, this is not the case, but the two are still very closely related.
Considering its prevalent use, wˆ has received very scant theoretical attention in its 40
years of existence. In the 1980’s, Kershaw (1985, 1987) looked at stationary properties,
especially variance, and concluded that wˆ is in fact inferior to Dixon and Mood’s original
1Interestingly, Wetherill’s reasoning for favoring reversals over all treatments was less theoretical than
numerical: this estimator performed somewhat better in simulation.
2It should be noted that according to Pace and Stylianou (2007)’s recent meta-analysis of 16 U&D anes-
thesiology experiments published in 2000-2006, half the studies still used Dixon and Mood (1948)’s original
estimator, with wˆ only second in popularity.
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estimator. Kershaw’s conclusions were largely ignored, and wˆ continues to be the most
popular U&D estimator. More recently, Paul and Fisher (2001) conducted a numerical
study of wˆ in the context of anesthesiology experiments. They concluded that 6 or more
reversals are needed for reliable estimation, contrary to a prevalent practice by some groups
in that field that use only 4.
Dixon (1965) claimed without proof, that SU&D’s empirical mean (apparently under
stationarity) is unbiased if F has a symmetric density. Garc`ıa-Perez (1998) simulated sta-
tionary SU&D and KR runs (using the last 9000 reversals from runs having 10000 reversals
each), finding that for KR wˆ is biased towards the median (a bias that is of course zero for
SU&D).
Finally, the empirical mode can be seen as related to averaging estimators. Markov-
chain studies (Durham et al., 1995; Giovagnoli and Pintacuda, 1998) prove that the empir-
ical mode converges to the stationary mode, which is guaranteed to be one of the 2 levels
closest to target. However, we saw in Section 2.2 that the stationary mode may end up
being only the second-closest level to target, especially for BCD and KR designs. Addition-
ally, the mode is restricted to be at a treatment level, while averages can vary on a finer
scale and hence are more precise. It is therefore not surprising that numerical studies find
this estimator performs poorly (Durham et al., 1997; Stylianou and Flournoy, 2002; Oron,
2005). The empirical mode will not be discussed further.
Mitigating The Starting-Point Effect
Perhaps the most obvious problem with averaging estimators is starting-point bias. The
first treatment x1 is completely arbitrary (even if determined with good judgment). Then,
somewhere during the experiment, the chain begins meandering around target. But at
what point does the chain become “good enough” to include in an averaging estimator?
Since during U&D’s formative years it was not understood to generate a Markov chain,
solution approaches had developed gradually and intuitively. Brownlee et al. (1953) recom-
mended discarding x1 (they were also the first to note that xn+1 is uniquely determined
by the experiment, and incorporated it into the estimate instead). Dixon (1965) and then
Wetherill et al. (1966) recommended starting from the first reversal. Much more recently,
Garc`ıa-Perez (1998), based on extensive KR simulations, recommended starting from the
2nd or 3rd reversal. In practice, most researchers use all reversals for wˆ, but some discard
the first 1− 4.3
3Garc`ıa-Perez (1998) tabulates a meta-analysis of KR vision research experiments published in the mid-
1990’s. The vast majority of the 82 studies used some form of reversal averaging. Out of 60 reversal-
averaging studies for which information was available about initial-sequence removal, 32 removed no
reversals, 14 removed the first 1-2 reversals, 12 removed 3 or more reversals, and 2 used some other
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In the previous chapter, we have seen that in general the first reversal point is quite
likely to occur while the starting-point bias is still substantial. We will revisit this issue,
and novel ways to tackle it, later on.
Mitigating The Boundary Effect
When the treatment set is finite and Qp lies too close to a design boundary, averaging esti-
mators will display a strong bias away from that boundary (this point will be explained in
more detail in the next section). Garc`ıa-Perez (1998) offers an interesting fix for this prob-
lem, dubbed “layover boundary conditions”: one continues the experimental bookkeeping
(for averaging purposes) as if there was no boundary. However, in case levels beyond the
boundary are indicated, the boundary treatment is administered. For example, if lm = 1,
s = 0.1 and the transition rules indicate an upward move, the next treatment will be
recorded as 1.1 but administered at 1. Afterwards, the chain will have to move back down
“through” 1 before reaching 0.9.
Layover boundary conditions are equivalent to assuming that F remains constant outside
the design boundaries. The treatment chain becomes infinite-state, but since transition
probabilities beyond the true boundaries are equal to those at the boundaries, the stationary
frequencies of the ‘phantom’ levels constitute a diminishing geometric sequence, and so π
still exists. This issue, too, will be inspected more closely later on.
3.1.2 Response Based Estimation: Isotonic Regression
Response-based averages use {Fˆm}, the empirical binomial point estimates of F at design
points, created by tabulating the responses:
Fˆu ≡
∑n
i=1 yi1 [xi = lu]∑n
i=1 1 [xi = lu]
. (3.2)
Probit and logit regression are occasionally enocountered in U&D applications (Storer, 1993;
Camorcia et al., 2004). Being parametric, they exhibit the usual pros and cons, with their
quality depending mostly on whether the model family provides a fair approximation of F .
Parametric U&D estimators will not be discussed here.
A nonparametric response-based estimator - isotonic regression, which is in fact the
NPMLE - was recently introduced to U&D in the Phase I context, and has been recom-
mended by the NIH (Stylianou and Flournoy, 2002; Stylianou et al., 2003; NIEHS, 2001).
This innovation has yet to reach all other fields using U&D; and perhaps for the better, since
criterion.
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it was not directly compared with wˆ which it aims to replace. This comparison appears
further below in the numerical study.
Isotonic regression (IR) is a well-known nonparametric solution for a variety of sta-
tistical problems (Barlow et al., 1972; Robertson et al., 1988). IR can be produced via
a couple of lengthy-named algorithms (pool-adjacent-violators-algorithm, or PAVA; least-
convex-minorant), but in fixed treatment-response design context it boils down to a set of
binomial point estimates: the original point estimate Fˆu wherever there is no monotonicity
violation, and an estimate pooled from the responses at adjacent levels in case of a violation.
The procedure is described in Algorithm 1 below.
Algorithm 1 Pool-Adjacent-Violators Algorithm (PAVA), Adapted for Treatment-
Response Designs
procedure PAVA({zm}, {nm})
while H ≡ {u : 1 ≤ u < m, zu > zu+1} 6= ∅ do
i← min(H)
M ← 1
while zi > zi+M do
zi = . . . = zi+M ← zi:i+M ≡
∑i+M
u=i n˜uzu, where n˜u ≡ nu/
(∑i+M
j=i nj
)
M ←M + 1
end while
end while
Return {zm}.
end procedure
PAVA replaces any subsequence of {Fˆm} it deems “violating” by a sequence that is a
repetition of a single value (which in the case of treatment-responses designs is simply the
overall proportion of ‘yes’ responses over the subsequence). This means that the IR estimate
of F is constant over any interval of x values covered by a violating subsequence. In intervals
between non-violating design points, IR provides no unique estimate. Since in order to find
the percentile one has to perform an inverse estimation, we need a (forward) estimate of F
over the entire range. In treatment-response applications this problem is commonly solved
by linear interpolation (e.g. Dilleen et al., 2003; Stylianou and Flournoy, 2002).4.
The operation of IR on treatment-response data is illustrated in Table 3.1 and Fig. 3.1.
Shown are two simulated runs, in each of which there was a single violating pair. Assuming
4apparently, in some fields people still believe that a straight line is the simplest way to connect two
points. So statisticians have their work cut out for them :)
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Table 3.1: Summary tables illustrating how IR works in practice on treatment-response
data. Data are taken from two simulated GU&D(2,0,1) experiments with the same threshold
distribution and n = 32. Yes/no summaries from sequences of violating points are pooled
together to a single point estimate, which is then used for all original points in the sequence.
Treatment Raw Input IR Output Raw Input IR Output
Yes No Fˆ Yes No Fˆ Yes No Fˆ Yes No Fˆ
0.17 0 4 0.00 0 4 0.00 1 7 0.13 1 7 0.13
0.33 3 9 0.25 3 9 0.25 4 8 0.33
6 14
0.30
0.50 3 7 0.30
4 10
0.28 2 6 0.25 0.30
0.67 1 3 0.25 0.28 4 0 1.00 4 0 1.00
0.83 1 1 0.50 1 1 0.50
(Simulation Run 14) (Simulation Run 9)
the target is Q0.3, in Run 14 (LHS of both table and figure) Fˆ3 = p exactly; however, Fˆ3 >
Fˆ4. Therefore, technically we cannot determine a unique estimate via linear interpolation
between Fˆ values; and conceptually, neither Fˆ3 nor Fˆ4 can be fully “trusted” without
more information. IR resolves this by pooling the data from points 3, 4 together; the final
estimate for Q0.3 is to the right of point 4. In Run 9 (RHS) we see an (extreme, but possible
whenever p is rational) example for IR’s limitations: the flat stretch produced by the process
lies exactly at F = 0.3, and therefore IR does not provide a unique inverse estimate without
some additional convention (taking the highest/lowest/midpoint of possible estimates, etc.).
These two numerical examples will be revisited in Section 3.3.
Why is IR the NPMLE for our application? Let us examine U&D’s nonparametric
likelihood; it can be written as
L = Pr ({xn, yn}) =
∏n
i=2 Pr (xi|x1 . . . xi−1, y1 . . . yi−1) Pr (yi|x1 . . . xi, y1 . . . yi−1)
= const.×∏ni=2 Pr(yi|xi)
= const.×∏mu=1 FnuFˆuu (1− Fu)nu(1−Fˆu),
(3.3)
where the Fˆu were defined above in (3.2). The derivation uses the following properties:
• Given each treatment xi, the corresponding response yi depends on no other treatment
or response, since the underlying threshold sampling is i.i.d.;
• Given all previous treatments and responses, xi can be found either deterministically,
or (for BCD) using a separate, independent random draw which is unrelated to F .
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Figure 3.1: Graphs illustrating how IR works in practice on treatment-response data. Data
are the same as shown on Table 3.1. Raw Fˆ values are in ‘X’ marks, and the IR output
values are in circles connected by solid lines. The dashed red lines indicate the inverse-
interpolation process. Note that in Run 9 (right), the IR estimate for Q0.3 is not unique,
and could be any value in [1/3, 1/2].
Hence, the “const” appearing in the equation is either a product of functions of the
biased-coin parameter Γ (for BCD), or simply 1 (for all other designs).
The form of (3.3) is identical to a product of binomial likelihoods, except for having
different constant coefficients (the binomial likelihood has combinatorial coefficients). A
product of binomials is the nonparametric likelihood of a standard non-sequential treatment-
response experiment. Note that the nonparametric approach yields a likelihood that can be
interpreted parametrically, as having m parameters representing the true values {Fm}.
Now, since the log-likelihood takes the form
logL = const.+
m∑
u=1
nu
{
Fˆu logFu + (1− Fˆu) log [1− Fu]
}
, (3.4)
the unconstrained NPMLE is of course just {Fˆm}. Under monotonicity constraints, pro-
ceeding recursively from the first monotonicity-violating pair of Fˆ values and treating
one pair at a time, it can be easily shown that the constrained NPMLE is identical to
PAVA’s output. More detailed derivations appear in standard references (Barlow et al.,
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1972; Robertson et al., 1988).
The “flat” intervals produced by PAVA in case of a monotonicity violation in {Fˆm} ap-
pear to hurt estimation performance, both forward and inverse. I will inspect this suspicion
more closely in the next section.
3.1.3 Interval Estimation
Nonparametric U&D interval estimation has been even more seldom studied than point
estimation. However, interest in this topic as well has been picking up recently.
SD-Based Approaches
Dixon and Mood (1948)’s original averaging estimator came with a variance estimator based
on normal theory. Pollak et al. (2006), using numerical simulations of material-fatigue
SU&D testing, show that this variance estimator performs very poorly, and is strongly
dependent upon the spacing s. They suggest a 3-parameter empirical correction function
fitted to their data.
In anesthesiology, some researchers using SU&D with wˆ report confidence intervals. In
calculating standard errors, they seem to count each pair of reversals as a single independent
observation, and assume asymptotic normality of the average, hence the method’s name:
“independent paired reversals” (Capogna et al., 2001; Camorcia et al., 2004).5
Tsutakawa (1967b) pursued a Markov-chain based approach. He noted that a stationary
Markov chain can be split into subchains, identified by successive hitting times at a given
state - i.e., the points at which the treatment chain visits the state. The lengths of these
subchains, {νj}, are i.i.d. random variables, as is any algebraic functional on the treatments,
calculated separately per subchain. Tsutakawa (1967b) then goes on, basing his calculations
on Chung (1960, Ch. 1), and claims that∑
j ν
2
j (x¯j − x¯)2∑
j ν
2
j
→ V ar(x¯) (3.5)
as n → ∞. Therefore, he proposes the LHS of (3.5) as an estimator of the variance for
the empirical-mean estimator. However, from data tables in that article, as well as my own
numerical trials, it seems that the LHS approaches the limit from below, and therefore the
resulting CI’s are too optimistic.
5To be honest, up till now (summer 2007) I have yet to find a full documentation, nor a reference
for “independent paired reversals”. The observation reported here is based on “reverse engineering” of
reported estimates in anesthesiology articles using the raw data, and I am not 100% sure that it is correct.
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Another approach to averaging-estimator confidence intervals was presented by Choi
(1990). Starting from first principles, the variance of the average of n r.v.’s {V1, . . . Vn} is
V ar
[
V¯n
]
=
∑
i V ar(Vi) + 2
∑
i<j Cov(Vi, Vj)
n2
. (3.6)
Now, being part of a Markov chain, x values at reversals are clearly dependent. Assuming
that they are identically distributed and that dependence follows an AR(1) autoregressive
form, Choi (1990) obtains formulae for the s.e. of wˆ as a function of the threshold s.d. σ and
the autocorrelation coefficient ρ. Additionally assuming normally-distributed thresholds,
CI’s can be calculated. Choi (1990) found them to be overly optimistic, but better than
Dixon and Mood’s original CI’s.
Bootstrap Approaches
Recently, use of the bootstrap for U&D CI’s was explored – both for parametric estimation
(Chao and Fuh, 2001) and for for isotonic regression (Stylianou et al., 2003). The bootstrap
approach for U&D is to simulate chains of length n, with transition probabilities determined
via some estimate of F (IR or a parametric regression). In both cases, however, the boot-
strap was used not for CI’s around Qp, but for CI’s around the forward estimate of F at
the closest design level. Chao and Fuh (2001) used the ordinary bootstrap and bootstrap-t,
while Stylianou et al. (2003) used the bias-corrected bootstrap (see Davison and Hinkley,
1995, Ch. 5). Pollak et al. (2006) explored using the bootstrap combined with their empir-
ical fix to Dixon and Mood (1948)’s formula, and reported good results.
Use of Current-Status Theory
Recalling that U&D is a special case of current-status data, there is a wealth of theoretically-
derived interval estimation knowledge in that field (Banerjee and Wellner, 2005). However,
U&D appears to be too special a case: under the typical current-status assumptions, treat-
ments are random with a continuous CDF. This leads to an n1/3 rate of convergence every-
where for the NPMLE. U&D, though its treatments are random, is more akin to standard
treatment-response designs in that treatments are limited to a discrete finite grid – while
the continuity of treatments is a key assumption in most current-status CI discussions. As
a result, the point estimates {Fˆm} converge with an n1/2 rate, and the linearly-interpolated
IR used in U&D converges at the same rate - but not to F , but rather to F¯ - a linear
interpolation of F between the design points. Therefore, it appears that current-status CI
theory is not applicable to U&D interval estimation.
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3.2 Theoretical Study
3.2.1 Conceptual Prelude
We have at our disposal two nonparametric approaches to U&D estimation. The response-
based one is generic to any binary-outcome design. It does not make direct use of the
properties of π, but benefits indirectly from having more precise Fˆ estimates in the vicinity
of Qp. Averaging estimators, on the other hand, are intimately related to the peculiar
properties of U&D sampling.
Considering the stationary properties already discussed here, one can say that some
sort of empirical treatment mean is the “natural estimator” for U&D designs. I
put forward this rather strong statement, in order to re-emphasize the conversion trick that
underpins averaging estimation. U&D converts censored sampling back into direct sampling
– which, as suggested in Section 1.2.1, would be far more desirable than indirect, binary
censored sampling.
However, to utilize the potential of averaging estimators, we need to better understand
the properties of π and of random-walk sampling from it. Unfortunately, since the averaging
estimators currently in use were developed without the Markovian perspective, they do not
utilize the full estimation potential. In particular, choosing to average reversal points means
that we are not sampling from π itself, but from its “sibling”: the stationary distribution
of reversals. Much of this section will be devoted to untangling the peculiar properties of
such sampling, and to suggesting other approaches.
Meanwhile, even though isotonic regression is not “natural” in the sense discussed above,
this also means that it suffers less from U&D’s peculiarities and limitations, such as starting-
point bias or boundary effects. Therefore we expect it to be more robust, and will look at
its properties more carefully later on.
3.2.2 Estimation Properties of Treatment Means
Bias of the Stationary Mean
We have already seen that for median-targeting designs and for GU&D(k,0,1), the stationary
mode is on the closest treatment to target on the response scale - which is also the closest on
the threshold or treatment scale (to first order in s). BCD and KR tend to shift the mode
somewhat to the left of target. One could expect, therefore, that with the former variants
the stationary mean µpi would show little or no bias w.r.t. Qp, while with the latter there
would be a downward bias, or more generally, a bias away from the median.
More insight into stationary biases can be gained via a telescopic-series analysis. First,
note that in the limit of infinitely fine design (s→ 0), the stationary biases of BCD and KR,
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too, should vanish. Therefore, we may expect the bias magnitude to be related to s. In the
subsequent discussion, we assume that there are no design boundaries (i.e., the treatment
set is potentially infinite) that F is twice continuously differentiable in x, and also – for
convenience – that Qp falls exactly on (lu∗ (letting Qp land midway between design levels
is nearly as convenient).6 One can then express the stationary mean as a telescopic series
around target:
µpi ≡
∑
u
πulu = Qp + s
∑
j
j(πu∗+j − πu∗−j) (3.7)
= Qp + sπu∗
∑
j
j
u∗+j−1∏
v=u∗
γv −
u∗−1∏
v=u∗−j
γ−1v
 .
Since the stationary frequencies diminish in a faster-than-geometric rate away from Qp, the
sum is typically dominated by the first 1 − 3 summand pairs. The pairs are composed of
opposite-sign terms, which may nearly cancel out. We now carry out a detailed calculation
of the first pair for SU&D.
First, note that if F has a symmetric density, for SU&D the terms in each pair will
cancel each other exactly. So apart from design-offset biases, SU&D averaging estimation is
indeed unbiased as claimed by Dixon (1965). For asymmetric distributions, we would need
standard Taylor expansions around target:
1
Fu∗+1
=
1
Fu∗
− sfu∗
F 2u∗
+
s2
(
2f2u∗ − f
′
u∗Fu∗
)
2F 3u∗
+ . . . (3.8)
1
1− Fu∗−1 =
1
1− Fu∗ −
sfu∗
(1− Fu∗)2 +
s2
(
2f2u∗ + f
′
u∗(1− Fu∗)
)
2(1 − Fu∗)3 + . . . ,
where f is the threshold density and f
′
its derivative. Substituting this and setting Fu∗ =
0.5, the first summand pair then becomes
γu∗ − γ−1u∗−1 = 0.5
[
2− 4sfu∗ + 2s2
(
4f2u∗ − f
′
u∗
)]
+ . . . (3.9)
−0.5
[
2− 4sfu∗ + 2s2
(
f
′
u∗ + 4f
2
u∗
)]
+ . . .
≈ −2s2f ′u∗.
6Numerical runs (data not shown) seem to indicate that biases related to design offset w.r.t to target are
much smaller than the spacing-related bias discussed here.
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The first-order terms cancel out, and we are left with a bias that is second-order in s with
a sign opposite that of f ′(Q0.5) (for unimodal or monotone-decreasing threshold densities,
this means a bias in the direction of F ’s skew). It is quite straightforward to show that
all summand pairs in (3.7) for SU&D give similar negative second-order terms when thus
expanded. Therefore, it appears that SU&D’s stationary mean is a biased estimator of Q0.5
for asymmetric densities. However, this bias can be kept very small under reasonably fine
spacing.
The same analysis for BCD yields
γu∗ − γ−1u∗−1 =
Γ
Fu∗+1
− 1− Γ
1− Fu∗−1 (3.10)
≈ 2p− 1
p(1− p)sfu∗ < 0,
and for KR
γu∗ − γ−1u∗−1 = p
[
1
Fu∗+1
− 1− (1− Fu∗−1)
k
Fu∗−1 (1− Fu∗−1)k
]
(3.11)
≈ 2(k + 1)p − 1
p(1− p) sfu∗ < 0.
In both cases there is a downward (i.e., away from median) first-order bias. BCD’s bias
term is larger than same-targeted KR, by a factor of about 5/3 (the exact ratio as a function
of k is found by substituting KR’s target (2.4) for p). GU&D(k,0,1) “inherits” the properties
of SU&D, meaning that its bias is only second-order and therefore usually smaller than
that of the other two methods. For symmetric or upward-skewed threshold distributions (a
realistic assumption when dealing with positive thresholds), GU&D(k,0,1)’s bias is positive,
i.e., towards the median.
So we have seen that stationary biases are approximately first-order or second-order
in the spacing, depending upon the design. All these finds are in line with numerical
observations such as Fig. 2.3 and with the theory in Section 2.2. Numerical results indicate
that for all four variants, stationary biases are quite moderate except when using very coarse
spacing.
3.2.3 Averaging All Treatments or Only Reversals?
The simplest candidate to replace the reversal average wˆ is some average of all treat-
ments (possibly starting from a certain cutoff point); let us call this latter estimator vˆ.
Wetherill et al. (1966)’s simulations showed wˆ as having smaller MSE than vˆ, and this is
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why it was chosen. Since then, other simulations (e.g., Kershaw, 1985) have shown the
opposite. Can we make a more theoretical comparison between the two options?
Reversals as a Filter
Assuming stationarity, the frequency of reversals at each level should also become stationary.
However, the stationary distribution of reversals is not necessarily identical to π. We can
calculate it using π and the balance equations:
π(rev.)u =
[πu−1pu−1 + πuru]Fu + πu+1qu+1 (1− Fu)∑
v π
(rev.)
v
(3.12)
=
πu [(qu + ru)Fu + pu (1− Fu)]∑
v π
(rev.)
v
=
πu [pu + Fu − 2puFu]∑
v π
(rev.)
v
,
where we implicitly assumed that ‘up’ and ‘down’ transitions occur only after a ‘no’ or
a ‘yes’, respectively, and that staying at the same level (if possible) also follows a ‘no’.
Conveniently enough, the (relative) stationary reversal frequency at a given level is a linear
function of π at the same level. This means, that picking only reversals can be viewed as a
secondary, linearly filtered sampling from π.
For SU&D, (3.12) translates to
π(rev.)u ∝ πu
[
F 2u + (1− Fu)2
]
, (3.13)
where the normalizing proportionality factor has been omitted. So the filter is distorting:
levels far from the median are over-sampled compared with those near the median, by a
factor of up to 2 - which means that the stationary variance of reversals is larger than that of
the entire chain. If the threshold density is exactly symmetric, the sampling does not induce
a bias to the averaging estimator. But if it is asymmetric, the sampling induces a slight bias
in direction of the distribution’s skew – i.e., in the same direction as the stationary-mean
bias.
For BCD, π(rev.) is proportional to
π(rev.)u ∝ πu
Γ
1− Γ(1− Fu)(1− 2Fu) + Fu, (3.14)
which reduces to (3.13) under Γ = 0.5. The sampling coefficient’s minimum point, as a
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function of F , is at
F (min.) =
4Γ− 1
4Γ
. (3.15)
The minimum moves to the left of Γ as Γ decreases; it is positioned at zero for Γ = 0.25.
Thus, for most or all of F ’s range, sampling probability increases with F - meaning that
BCD reversal averaging induces a bias towards the median. Here, too, we expect π(rev.) to
have larger variance, since the filtering is more aggressive near target.
For KR we get
π(rev.)u ∝ πu
Fu
[
1− 2Fu(1− Fu)k
]
1− (1− Fu)k . (3.16)
Again, the formula reduces to (3.13) for k = 1. KR sampling has the same qualitative
properties as BCD (i.e., bias towards the median and a larger stationary variance), albeit
milder. The filtered sampling coefficient has a minimum slightly to the left of target.
Note that for BCD and KR, wˆ’s additional bias is in the opposite direction of µpi’s
stationary-mean bias. This leads to the interesting question whether the two cancel out.
First-order analysis indicates that the reversal bias may be of comparable magnitude, but
is generally smaller than the stationary-mean bias. The exact interplay between the two
would depend upon specific distribution and spacing conditions.
Variance Comparison
One way to generically describe the variance of a dependent-sample average is
σx¯ =
σpi√
neff
, (3.17)
where neff is an effective sample size, usually smaller than n. We have seen that under
stationarity, σpi for reversals is larger than for all trials. What about neff? This is a measure
of the information content in the sample about the distribution of trials (or reversals). But
reversals are a subset of the sample used for vˆ; their information content cannot be larger.
Therefore, V ar (wˆ) > V ar (vˆ).
Instead of this intuitive and not quite rigorous approach, it is also possible to obtain the
same result via a direct and more tedious approach for some of the designs.
Proposition 3 For SU&D and GU&D(k,0,1) designs, under stationarity V ar (wˆ) > V ar (vˆ).
Proof We slice the chain into subchains, each beginning with a reversal and ending right
before the next reversal. For each subchain indexed j, let aj be the subchain’s treatment
mean. A simple average of aj is equal to w¯ which is known to be equivalent to wˆ. Meanwhile,
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vˆ is an average of the aj ’s, weighted by the subchain length nj. Which one has smaller
variance?
If shorter subchains have a higher probability of being farther away from µa, the popu-
lation mean of the aj ’s (which is equal to E[wˆ]), then definitely V ar (wˆ) > V ar (vˆ), since
the latter down-weights them. Now, at a given level lu, the length of a subchain ending
with the next reversal is a generalized geometric r.v. with increasing “success” probabilities
(”success” being a reversal). However, the subchain-terminating “success” probabilities are
always larger in the direction away from Qp, which (ignoring boundary conditions) is very
close to µa. Therefore, subchains are expected to be shorter, the farther their center is from
µa, and hence V ar (wˆ) > V ar (vˆ). 
For BCD and KR, this approach encounters some difficulties. Now vˆ is not a weighted
average of aj ’s, but somewhat smaller than that average because ascent subchains are
“bottom-heavy” (recall that wˆ is biased upwards w.r.t µpi). Subchains still tend to be
shorter when they are oriented away from Qp, but because of the upward bias we are not
quite sure how close Qp is to µa. However, since the biases (of µpi w.r.t to Qp and of µa w.r.t
µpi) are opposite in sign, there is little reason to expect a different relationship between the
two variances for BCD and KR.
3.2.4 Isotonic Regression and Bias
As detailed in Section 3.1, whenever isotonic regression (IR) departs from simple linear in-
terpolation, it produces constant intervals. Besides being problematic for inverse estimation
of quantiles, since we assumed F to be continuous strictly increasing this may generate bi-
ases. Specifically, if F is as assumed, then any estimator z(t) producing a constant interval
z = c ∀t ∈ [t1, t2] is either unbiased only at a single point on [t1, t2], or is biased across
the entire interval. Common sense suggests that if IR is based on unbiased estimates {Fˆm},
then the former case is far more likely. This can in fact be proven in some specific scenarios,
such as normal errors with variance inversely proportional to the IR weights.
The proof requires two preparatory lemmas.
Lemma 2 Assume that at each treatment level lu we have a raw point estimate Fˆu, which
is normal with mean Fu and variance V0/nu, and that all point estimates are mutually
independent. Then for each sequence of points indexed u . . . u+M which are replaced by a
single value in the PAV algorithm (hereafter: a violating interval), the pooled IR estimate
is independent of the degree of the last violation in the sequence, i.e.
F˜u:u+M ⊥
(
F˜u:u+M−1 − Fˆu+M
)
, (3.18)
52
where F˜u:u+M denotes a weighted average of Fˆ values from lu through lu+M .
Proof Let Y ≡ (Y1, Y2)
′
be independent normal r.v.’s with variance
V ≡
(
V1 0
0 V2
)
.
Then Z, a linear transformation of Y , Z = AY , will be normal with variance V ar[Z] =
AVA
′
. Specifically, Z =
(
Y2 − Y1, KY1V1 + KY2V2
)′
, with K 6= 0 some constant, will have a
variance (
V1 + V2 0
0 K
2
V1
+ K
2
V2
)
.
Therefore, Z1 ⊥ Z2.
Now take a violating interval extending from lu to lu+M , and set Y1 = F˜u:u+M−1, Y2 =
Fˆu+M . Then
V ar
(
Fˆu+M
)
=
V0
nu+M
,
while
V ar
(
F˜u:u+M−1
)
=
V0(∑u+M−1
v=u nv
)2 u+M−1∑
v=u
nv =
V0∑u+M−1
v=u nv
.
The two are independent, and
F˜u:u+M = K
[(
u+M−1∑
v=u
nv
)
F˜u:u+M−1 + nu+M Fˆu+M
]
,
i.e., an average of the two with weights inversely proportional to variances. By the proof
above, this average is independent of the difference Y2 − Y1, which in our case denotes the
degree of last violation in the sequence. 
Lemma 3 Under the same assumptions, the weighted average F˜u:u+M is independent of
the event that the points indexed u . . . u+M are part of a violating sequence starting at u.
Proof By induction. Let the event in question be denoted v˜iolu:u+M . For M = 1, the
identity follows directly from Lemma 2.
ForM > 1, assume F˜u:u+M−1 ⊥ v˜iolu:u+M−1, and prove forM . Due to the independence
of the Fˆ -s, trivially F˜u:u+M ⊥ v˜iolu:u+M−1. Now the event v˜iolu:u+M = v˜iolu:u+M−1 ∩
{Fˆu+M < F˜u:u+M−1}. But by Lemma 2, F˜u:u+M ⊥ {Fˆu+M < F˜u:u+M−1}. Therefore it is
also independent of the intersection of these two events and the proof is complete. 
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These two lemmas show that weighted averages such as those produced by the PAV algo-
rithm, are invariant to monotonicity violations (under the specified distributional assump-
tions). This clears the way to a simple and useful fix to IR’s flat-interval problem.
Theorem 6 Under the same assumptions as above, for each violating interval from lu to
lu+M , PAVA produces an estimate which is biased upward at lu and downward at lu+M from
its unconditional expectations Fu, Fu+M , respectively.
Proof From Lemma 3,
E
[
F˜u:u+M | v˜iolu:u+M
]
= E
[
F˜u:u+M
]
= F u:u+M ,
the weighted average of F over the violating design points. By the strict monotonicity of
F , Fu < F u:u+M < Fu+M . 
So, for these particular distribution assumptions on point estimates, we have “nailed”
the IR estimate to be unbiased somewhere within the flat interval. It follows naturally, that
percentile (inverse) estimates around the interval must be biased away from the interval to
either direction.
Of course, in a treatment-response case the binomial estimates {Fˆm} are not normal.
However, the scenario covered by Theorem 6 approximates their asymptotic behavior as
n → ∞, especially if the binomial variance factor F (1 − F ) is changing slowly over the
violating interval.
Therefore, it may be useful to see where in the interval, according to that scenario, the
IR estimator is unbiased. The answer is quite simple:
Theorem 7 Under the same assumptions as above, and if F is twice continuously differ-
entiable in x, then F˜u:u+M – the PAVA estimate for a violating interval from lu to lu+M –
is unbiased to (Taylor) first order in segment length lu+M − lu, only at the weighted-average
point
lu:u+M ≡
u+M∑
v=u
ωvlv , where ωv ≡ nv∑u+M
j=u nj
. (3.19)
Proof First, from F ’s continuity, strict monotonicity and Theorem 6 we know that there is
exactly one point at which F˜u:u+M is the true value of F , and that this point is in (lu, lu+M ).
Now F˜u:u+M can be written as a first-order Taylor expansion from a single reference
point x∗ ∈ (lu, lu+M ):
F˜u:u+M = F (x∗) +
∑u+M
v=u ωvF
′(x∗)(lv − x∗) + 12
∑u+M
v=u ωvF
′′(ξv)(lv − x∗)2
= F (x∗) + F ′(x∗) (lu:u+M − x∗)+ 12∑u+Mv=u ωvF ′′(ξv)(lv − x∗)2, (3.20)
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where {ξv} are points between x∗ and lv, v = u . . . u +M . At x∗ = lu:u+M , the first-order
term vanishes, and therefore to first order,
E[F˜u:u+M ] ≈ F (xi:i+M).
Clearly, this is also the only location in the interval that removes the first-order term. 
This result will be used in the next section to improve upon IR.
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3.3 New Methodologies
3.3.1 Averaging Estimators
Overview
Averaging estimators are not just commonly used in U&D; surprisingly or not, their perfor-
mance is also pretty hard to beat under the popular SU&D and KR designs. The conver-
gence of Markov chains implies x¯n → µpi, the stationary mean, with asymptotically normal
behavior and without any further parametric assumptions on F . Averaging estimators
typically have the smallest variance, and more often than not it is the variance term that
dominates estimation performance. Averaging estimators’ major drawback, as the previous
section indicated, has to do with biases. Here is a summary of potential averaging estimators
biases:
1. Bias towards the starting point x1.
2. Bias away from the closest boundary.
3. Theoretical bias of µpi itself, as exposed in Section 2.2.
4. If a reversal-only average is used, an additional reversal-sampling bias.
Since there are so many biases in potentially different directions, sometimes they neu-
tralize each other to a certain extent. This is why the reversal-only average wˆ occasionally
outperforms the all-treatment average vˆ in numerical simulations. This phenomenon will
be observed numerically later on, in Section 3.4.
Items 2 and 3 on this list can be managed by choosing a sufficiently fine spacing (which
unfortunately increases the magnitude of item 1) – and by not imposing unnecessary bound-
aries. Additionally, for KR designs there is a potentially interesting fix to item 3 (stationary
bias). Recall from Section 2.2 that KR’s sub-chain of base states (i.e., picking only the first
trial of each visit to a treatment level) has an identical stationary distribution to that of
GU&D(k,0,1). This means that averaging only over the zero-state sub-chain may help us get
rid of KR’s first-order stationary bias.
for general designs, the first item on the list – the starting-point effect – has received
the most attention in devising new estimators.
Let wˆr be the average of all reversal points from reversal r onward; according to
Garc`ıa-Perez (1998), this is the most popular estimator in vision research for KR designs.
Our analysis up to now indicates that it should be outperformed by vˆr, the corresponding
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all-treatment average starting from the same reversal point. How should r be chosen? This
is a classic bias-variance dilemma: the farther out we push the cutoff point, the starting-
point bias w.r.t µpi decreases, but the variance increases.
Or perhaps there is another way out? Are reversals a good cutoff choice at all? The
previous section showed that under stationarity reversals have a larger variance than a
randomly-chosen treatment. This means their expected distance from µpi is larger. Since
stationarity is in fact a best-case assumption, it seems that reversals are not a very good
choice for cutoff.
A New Adaptive Estimator
Another approach seeks to adaptively identify the length of the initial transition phase. The
underlying assumption is that the latter phase of the chain resembles a sample from π. If
so, the average of the chain’s “tail end” is close to µpi. Meanwhile, the “head” or starting
point is arbitrarily fixed to x1.
7 The auto-detect estimator vˆAD chops off this biased
“head”, exactly at the first point in which the chain traverses to the other side of the “tail
end” average, compared with the starting point - and then proceeds to average the rest of
the chain. Symbolically this estimator can be described as
vˆAD ≡ x¯c(n):n ≡
∑n
i=c(n) xi
n− c(n) + 1 ,where c(n) = min1<i<n {i : sgn (xi − x¯i+1:n) 6= sgn (x1 − x¯2:n)}−1.
(3.21)
The location of the cutoff point is illustrated in Fig. 3.2
Sometimes, the “tail end” of the chain is an “unlucky draw” containing an excursion
far from target; sometimes the entire chain converges more slowly than expected by the
experiment’s designers. The auto-detect method would usually identify such cases by placing
the transition point relatively late. From an overall performance perspective, using a late
auto-detect point is not advisable; the probability that the auto-detect scheme has been
fooled by an excursion – conditional upon the value of c(n) – increases sharply as c(n)
approaches n. one should therefore set a maximum cutoff c(n)crit., so that if c(n) > c(n)crit.
we use c(n)crit. as our cutoff. This critical value should definitely be less than n/2. Since it
can be argued that the “tail end” needs to be sufficiently longer than the transition phase
in order to serve as a reference, c(n)crit. values around n/4 or n/3 seem reasonable. Thus,
the auto-detect estimator would be guaranteed to include at least the final two-thirds or
7A similar situation is encountered in MCMC simulations, where a variety of diagnostics have been
developed to determine stationarity. However, MCMC usually involves a very large sample and the ability
to run several parallel instances of the same run – privileges not available in the small-sample percentile-
finding application.
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three-quarters of the treatment chain.
If one wishes to be even more efficient, this critical value can be compared with the
number of trials required to reach the boundaries from x1 (if there are no physical bound-
aries, visualize “virtual boundaries” around the range in which you realistically expect Qp
to fall). Allow for one “switchback” of falling back one level towards x1 before resuming
progression. If such boundary-related predictions can be made, then resulting cutoff should
be compared with n/3 or n/4, and the smaller of the two chosen for c(n)crit. For example,
if the design is KR with k = 2 and the boundaries extend 5 levels in each direction, then
one needs 5 + (k + 1) = 8 trials to reach the bottom end including one “switchback”, but
5k + (k + 1) = 13 trials to reach the top end. Then, if n > 52, one can use c(n)crit. = 13
instead of n/3 or n/4, and improve precision.8
Conversely, if sample size is flexible, the auto-detect properties can be used to formulate
a stopping rule. The experiment should continue until c(n) ≤ n/3, or until n−c(n) passes a
certain value - in both cases promising a sufficient sample size of approximately stationary
sampling.
For KR designs, we may also wish to look at vˆAD,0 – the auto-detect estimator taken only
on the zero-state sub-chain. It promises to mitigate both the starting-point and stationary-
mean biases simultaneously. This idea has not been explored in detail in this thesis, and
may merit further examination.
A Geometrically Weighted Estimator
Instead of trying to locate a cutoff point, we can weight the chain according to convergence
theory. In Section 2.2, we saw that
|µn+1 − µpi| ∝ λn#, (3.22)
where µn+1 ≡ E [xn+1], and λ# is the second-largest eigenvalue of P . This justifies the
following weighted-average estimate:
QˆGW ≡
∑n
i=k+1wixi∑n
i=k+1wi
,where wi = g
(
λ−i#
)
. (3.23)
The weights should be a function that starts near zero, then increases until some transition
point where we suspect the bias term becomes small compared to the variance term. The
location of this point can be estimated by comparing the standard error of some raw form
8Clearly, this indicates that for below-median targets x1 should be positioned above the middle of the
“effective range”; see Section 3.6.
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Figure 3.2: Illustration of the auto-detect estimator. The chain first crosses the “tail-
average” line on trial 9, meaning that trial x9 is the first one smaller than the mean of
remaining trials (marked with a horizontal dashed line), while x1 . . . x8 were all larger than
the analogous tail means. The auto-detect estimate vˆAD is then the average of x8 . . . x41.
Trials 8 and 9 are circled. The chain used for illustration is the KR run from Fig. 2.1, but in
principle this method could be applied to any sequential experiment where a starting-point
effect is suspected, including non-U&D ones.
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of vˆ with some order-of-magnitude estimate for starting-point bias.
Of course, we do not know P and its eigenvalues; however, P can be nonparametrically
estimated from Fˆ . QˆGW provides a nice complement to vˆAD: the former uses responses to
evaluate convergence, while the latter tracks the treatment chain.
Two implementation notes:
• The Fˆ -derived Pˆ tends to produce optimistic rates, or even no rates (in case there is
only one point estimate of F falling in (0, 1)). It is therefore recommended to weight
F with a prior estimate, say uniform. A Bayesian saturated model, or any other
parametric model, are also an option (see Section 4.1). However, there is no reason
to ‘overkill’ this estimate of P with sophisticated procedures, as it is only used as an
aid to determine weights.
• Another implementation option is to multiply the decay factor by an ‘acceleration’
factor somewhat greater than 1. This ensures that the initial run’s weight is indeed
smaller than its impact on bias.
At bottom line, QˆGW has many more “moving parts” than other estimators. Since nu-
merical trials did not indicate an overall performance improvement over the simpler options
described above, it will not be discussed again below.
Mitigating the Boundary Effect?
If Qp is less than 2s away from a hard boundary, bias source 2 on the list at the beginning of
the section can overwhelm all the rest. The best fix is prevention: not to place a boundary,
unless it is physically impossible to continue moving up or down. If treatments are positive,
consider placing {lm} on a log-transformed scale (as is the default in sensory studies). If
they are proportions, consider a log-ratio transform. This is not as cumbersome as it sounds:
phrase the treatment levels as u parts component B to one part component A, etc. Yet
another alternative is to halve the spacing if a boundary seems to play a dominant role;
a trigger for halving could be the 2nd visit to the same boundary, or the first transition
decision violates the boundaries. Of course, this would have an impact only if the halving
occurs relatively early in the experiment.
Sometimes none of these fixes are available, and we are stuck with a real physical bound-
ary. One existing fix was described in Section 3.1 (Garc`ıa-Perez, 1998) - continue adminis-
tering treatments on the boundary, as a proxy for levels beyond it. This fix has the property
of over-assigning treatments on the boundary. An alternative, milder fix would be to impute
{xn} following the experiment by adding virtual treatments at lm+1 wherever a move ‘up’
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was mandated from lm, and at l0 wherever a move ‘down’ from l1 was mandated (these
virtual ‘treatments’ would of course never be administered, only added to the average).
the number of treatments added would follow the transition rule (e.g., for KR, k virtual
treatments would be added each visit to l0, but only 1 at lm). This imputation is equivalent
to assuming F = 0, 1 at the two boundaries. The imputation fix requires no change in
experiment planning.
It turns out, again, that neither of these fixes works as well as one might expect. This is
because both increase the averaging-estimator variance – an increase which is not necessarily
offset by a substantial bias reduction. It seems that, if the chain runs dangerously close to a
boundary, one should turn to response-based estimation – which, coincidentally, is our next
topic.
3.3.2 Centered Isotonic Regression
Due to the theoretical results on IR bias, culminating in Theorem 7, we may attempt
to modify isotonic regression by replacing each constant interval with a single point at
the location prescribed by (3.20). To be coherent, the new estimator would perform the
same action at intervals that were originally constant as well. Algorithm 2 describes this
estimator, dubbed “Centered Isotonic Regression” (CIR).
Algorithm 2 Centered Isotonic Regression (CIR) for Treatment-Response Designs
procedure CIR({lm}, {zm}, {nm})
while H ≡ {u : 1 ≤ u < m, zu > zu+1} 6= ∅ do
v ← min(H)
M ← 1
while zv > zv+M do
zv ← zv:v+M−1 ≡
∑v+M−1
u=v nuzu/
∑v+M−1
u=v nu
M ←M + 1
end while
lv ← lv:v+M−1 ≡
∑v+M−1
u=v nulu/
∑v+M−1
u=v nu
nv ←
∑v+M−1
u=v nu
Remove points {(lv+1, zv+1, nv+1) . . . (lv+M−1, zv+M−1, nv+M−1)
end while
Return {(lm, zm, nm)}.
end procedure
CIR’s point-estimate output is used to estimate F and its quantiles via linear interpo-
lation, including at original design points which have been removed. The following obser-
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vations may help clarify some more major similarities and differences between PAVA and
CIR.
1. CIR produces the same set of unique z values (point estimates) as PAVA, but under
CIR each value appears only once.
2. Unlike PAVA, CIR requires x values as inputs, and modifies them in the same manner
as the z values. As a result, each unique weighted-average z value is assigned to the
corresponding weighted-average x value.9
3. CIR identifies ties, too, as violations since they violate strict monotonicity.
4. In the absence of strict monotonicity violations, the two algorithms return the original
data.
5. In the presence of strict monotonicity violations, CIR returns a smaller number of
points than the input.
Due to the last property, sometimes a boundary point may be removed by CIR. Suppose
w.l.o.g. that the original l1 has been removed, and now some x
# > l1 is the smallest x value
for which a CIR estimate exists. Then complementing the CIR output with a constant
interval on [l1, x
#] is equivalent to the IR output on the same interval, and should be
regarded as the default. However, in case prior knowledge exists regarding F on or outside
the boundaries (e.g., F (0) = 0), then it should be incorporated either into CIR’s input
(when an appropriate weight can be assigned) or into its output.
Conceptually, the CIR process is analogous to saying: “We have this sequence of point
estimates, each perfectly valid on its own, but as a sequence they are suspect due to mono-
tonicity violations. We can pool them together to get a single, more believable estimate;
however, this is still a point estimate only, and deserves to be placed at a single point rather
than occupy a complete interval.”
Under the normal-error scenario described in Section 3.2 and some additional assump-
tions, it can be proven that CIR yields a smaller overall estimation MSE than IR, but the
calculation is rather cumbersome and uninteresting. In nearly all numerical U&D simu-
lations I have carried out, CIR clearly outperforms IR for quantile estimation (some data
will be presented below in Section 3.4). The only case when CIR is not recommended,
9The point placement prescribed by (3.20) is optimal for the normal-error scenario and seems to work
well for the treatment-response case as well. For other scenarios (e.g. a current-status dataset copmosed
of 1’s and 0’s only), the formula for the optimal point may be different.
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is when the researchers suspect F may resemble a staircase function. In that case, IR’s
piecewise-constant output is obviously more appropriate then CIR’s linear smoothing.
Table 3.2: Summary tables illustrating how CIR works in practice on treatment-response
data. Data are identical to that shown on Table 3.1.
Treatment Raw Input CIR Output Raw Input CIR Output
Yes No Fˆ Yes No x Fˆ YesNo Fˆ Yes No x Fˆ
0.17 0 4 0.00 0 4 0.17 0.00 1 7 0.13 1 7 0.17 0.13
0.33 3 9 0.25 3 9 0.33 0.25 4 8 0.33
6 14 0.40 0.30
0.50 3 7 0.30
4 10 0.55 0.28
2 6 0.25
0.67 1 3 0.25 4 0 1.00 4 0 0.67 1.00
0.83 1 1 0.50 1 1 0.83 0.50
(Simulation Run 14) (Simulation Run 9)
We now revisit the two data examples from Table 3.1 and Fig. 3.1. Table 3.2 and
Fig. 3.3 show the same data, estimated via CIR. Since CIR’s output is strictly monotone
(at least between its output point estimates), the quantile estimate for Run 9 (RHS) is now
unique. Note that CIR is not a risk-free fix. For example, in Run 9 the CIR estimate of
F at l3 is 0.56, while Fˆ3 was only 0.25. This is because the new estimate is a weighted
average of Fˆ2, Fˆ3 and Fˆ4 – the latter being equal to 1. From a least-squares perspective
(i.e., least-square distance from the original point estimates), CIR is clearly not better than
IR. However, with respect to the true F the pulling-in of neighboring Fˆ values to smooth
out the estimate in violating intervals (where point estimates are more suspect) seems to
pay off.
A Combined Estimator?
Averaging estimators and CIR appear to complement each other: the former typically have
smaller variance, and the latter smaller bias. This suggests the simple fix of using their
average as a combined estimator. Unfortunately this fix is not successful, because the two
estimator types are highly correlated (numerical ensemble correlations are typically around
0.8 or more). This means that a simple average of CIR and an averaging estimator is
likely to have higher variance than the averaging estimator alone. Since estimation error is
dominated by the variance term (often over 90% of the MSE is due to variance, see below
in Section 3.4), the improvement in bias may be insufficient to offset the variance hit.
Why are averaging estimators and CIR so correlated? Suppose w.l.o.g. that we observe
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Figure 3.3: Graphs illustrating how CIR works in practice on treatment-response data.
Data are the same shown on Table 3.2. Raw Fˆ values are in ‘X’ marks, and the CIR
output values are in circles connected by solid lines. The dashed red lines indicate the
inverse-interpolation process. Compare with Fig. 3.1.
a sequence of above-average thresholds. The response rate at most treatments will be below
the population expected values, pushing Fˆ downward and CIR inverse estimates upward.
At the same time, the negative responses will also push the treatment chain itself upward,
and with it the averaging estimators.
3.3.3 Interval Estimation
Confidence Intervals for Averaging Estimators
For averaging estimators, our rationale is that we sample from π and try to estimate the
standard error of the running sample mean. Trials before the cutoff point (be it a reversal
or the auto-detect point) are discarded. A simple estimate for the standard error could be
of the form
S.E.vˆ =
S√
nˆeff
, (3.24)
where S is the sample standard deviation of the sub-chain used for averaging, and nˆeff is
an estimate of the effective sample size – which should be smaller than the sub-chain length,
since the sampling is dependent. We can estimate neff using the approach offered by Choi
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(1990), again with some convenient simplifications. We assume an AR(1) structure. The
variance of an averaging estimator vˆ is then
n˜2V ar(vˆ)
σ2pi
=
n˜+ 2∑
i<j
ρj−i
 = [n˜+ 2ρ
1− ρ
n−1∑
i=1
1− ρi
]
= n˜
1 + ρ
1− ρ −
2ρ
1− ρ
[
1− ρn˜] (3.25)
n˜V ar(vˆ)
σ2pi
≈ 1 + ρ
1− ρ, (3.26)
where ρ is the first-order autocorrelation and n˜ is the chain length used for averaging. The
approximation in (3.26) is conservative. So our autocorrelation-based sample size estimate
is nˆeff = n˜(1 − ρˆ)/(1 + ρˆ). Since the variance is estimated from the data, we should use a
t-multiplier with nˆeff − 1 d.f. (or 1 d.f. if nˆeff < 2).
A rather different approach follows Tsutakawa (1967b)’s observation that intervals be-
tween hitting times are i.i.d. Tsutakawa (1967b) used the complicated formula (3.5) to
directly estimate the variance; however, as mentioned earlier this appears to be overly op-
timistic. Instead, we estimate vˆ’s variance from first principles. Let Nj be the length of
hitting-time interval j, and let Aj be the treatment mean over the interval (Ideally, we use
hitting times at the level closest to target, lu∗). Then each r.v. is i.i.d. across intervals.
10
Now, neglecting possible “leftovers” before the first interval and after the last, averaging
estimators can be expressed as
vˆ =
∑
j ajnj
n˜
,
where n˜, as before, is the sample size used for averaging (i.e., from the cutoff point onward).
Neglecting the randomness of n˜,11 we focus on the numerator. For a single interval,
V ar(AjNj) ≈ E [V ar(AjNj|Nj)] + V ar (E[AjNj |Nj ]) (3.27)
< E
[
N2j
(
σ2pi + (µpi − lu∗)2
)]
+ V ar(Nj)max(µpi, lu∗)
2,
where σ2pi is the stationary variance and lu∗ is the level used for determining the intervals.
Summing over all intervals, normalizing and replacing population parameters by estimates,
10We employ a convention that avoids gaps or overlaps, e.g. that each interval begins with the treatment
following the hitting time. Additionally, for KR each sub-state should be viewed as a separate state.
Hence, we look only at the first visit to each level (i.e., at visits to lu,0 only), since those are the most
numerous.
11For fixed-sample applications this is not a bad assumption. Of course, an approach using hitting-times
or reversals (which are related to them) as stopping rules will have to account for n˜’s variability.
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we obtain the estimate
S.E.vˆ =
h
{
n2h
(
S˜2 + (vˆ − lcu∗)2
)
+max(vˆ, lcu∗)
2S2h
}
n˜2
, (3.28)
where lcu∗ is the level closest to the point estimate, at which the hitting-times are counted;
h is the number of hitting-time intervals, S˜2 is the sample variance of the chain used for
averaging, and n2h and S
2
h are the sample mean-square and variance of interval lengths,
respectively. As above, we use a t-multiplier with h− 1 d.f. (or 1 d.f. if h < 2).
Based on bot h theoretical appeal and numerical trials, I chose the second, hitting-time-
based S.E. estimate (3.28). In general it is quite conservative. One reason for choosing
the more conservative option, is that vˆ estimates the stationary mean and not Qp, and
therefore the interval will inevitably be somewhat shifted. Sometimes, when the shift is too
large (i.e., one of the bias sources mentioned at the top of this section is too dominant), no
interval would do the job. This again points to the importance of averaging-estimator bias
reduction.
Confidence Intervals for CIR
CIR’s intervals (and also IR’s) can also be approximated using a simpler and more direct
approach than the bootstrap. Consider the CIR interpolated quantile estimate Q˜p. Sup-
pose w.l.o.g. that the it falls between the CIR-output treatment values l˜u and l˜u+1. The
estimation variance can be approximated by
V ar
(
Q˜(CIR)p
)
≈
[
l˜u+1 − l˜u
F˜u+1 − F˜u
]2
V ar
(
F˜ (Q˜p)
)
, (3.29)
Now, the forward estimate of F is simply a weighted average of binomial point estimates.
Obviously
V ar
(
F˜ (Q˜p)
)
< max
(
V ar(F˜u), V ar(F˜u+1)
)
.
Nearly always, the level with higher variance is the one with a smaller sample size, assume
w.l.o.g. it is l˜u. Recalling that the {nm} are random,
V ar(F˜u) ≈ E
[
V ar(F˜u|nu)
]
+ V ar
(
E[F˜u|nu]
)
(3.30)
= Fu(1− Fu)E
[
1
nu
]
.
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Note that the second term on the RHS is zero because E[F˜u] remains (at least to first order)
Fu regardless of sample size. Estimating the expectation of 1/nu is generally infeasible
without knowledge of F , but due to Jensen’s inequality we can see that the variance is
always larger than in the fixed-assignment case, as it should be. Note that this expression
still does not account for the total variance in the CIR inverse estimate, since different runs
may lead the estimate to fall in different intervals, i.e., different values of u.
In any case, a simple way to continue from here is by using binomial quantiles for F˜u.
We convert the standard piecewise-constant binomial quantile function, whose properties
are strongly dependent upon the specific (and random) value of nu, into a strictly increasing
q¯(nu, p), which is the linear interpolation between the exact-probability points {(pz, z)}, z =
0, . . . nu+ 1, where pz are defined via Pr(Z ≤ z) = pz. This piecewise-linear quantile curve
is then re-centered around the expectation n¯p for symmetry. One way to then account for
the inflated variance of (3.30), is to offset the curve by 1 to each direction away from nup.
Finally, divide by nu to normalize.
The resulting curve is always more conservative than standard binomial quantiles (see
Fig. 3.4); however, at extreme percentiles it still suffers from the limitations of the binomial
quantile function, and does not increase fast enough, considering that the experiment’s
sequential nature may generate heavy-tailed sampling distributions. Numerical trials show
that the linearized function q¯ does not provide enough differentiation between the 95th
percentile and 97.5th percentiles, and therefore 90% CI’s are overly conservative or 95%
CI’s lack in coverage (or both).
Recall that rare-event binomial probabilities can be approximated by Poisson proba-
bilities with rate nup, and note that the Poisson variance is always greater than the ap-
proximated binomial’s variance. Therefore, using Poisson for the binomial tail is generally
conservative for our purposes. We employ the same linearization method as above in order
to avoid step-function artifacts, and additionally symmetrize the quantile curve by using a
mirror image of the higher-probability tail in lieu of the less conservative lower-probability
tail.
The binomial-derived and Poisson-derived functions are compared on Fig. 3.4, for two
different small-sample scenarios. Even though the Poisson curve may be less conservative
than the standard binomial for some middle percentiles, and is generally less conservative
than the linearized binomial for all but the most extreme percentiles, it does provide a
better (and more realistic) distinction between percentiles on the tail. If negative values for
binomial or Poisson quantiles (as happens on the lower tail) seem counter-intuitive, recall
that we are not really sure between which two treatment levels the true quantile falls.
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Figure 3.4: Illustration of possible quantile functions used for CIR interval estimation.
Shown are scenarios with nu = 6, p = 0.5 (left) and nu = 9, p = 0.2 (right). Depicted
are standard binomial quantiles (black line), the linearized binomial (black ‘x’ marks) and
linearized symmetrized Poisson (red line). The latter two are described in the text.
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3.3.4 Down-Shift Schemes Revisited
In the previous chapter I mentioned the popularity of designs for which transition rules
change at some point, most commonly the first reversal. In particular, down-shift schemes
cut the spacing by half at the first reversal. The analysis presented since then indicate that
a reversal, and surely the first reversal, does not possess good properties for a transition
point. They are quite likely to be far removed from target. Numerical experimentation
confirms this: while under some conditions a reversal-based down-shift scheme provides
for estimation performance improvement, overall it is less robust. Using the third reversal
improves robustness, compared with the first reversal, though it does not solve the issue of
reversal variance under stationarity.
The hitting-time analysis performed earlier suggests another direction. Clearly, levels
near target are hit more frequently (in probability). Therefore, one can use trial xhj as a
transition point, where hj is the index where the most frequently-hit level is visited for the
j-th time. The natural choice for j appears to be j = 3: a smaller value does not preclude a
possible early excursion, and a larger value pushes the transition too far into the experiment.
Numerical runs indicate that this scheme is roughly equivalent to using the third reversal in
a reversal-based scheme; both provide overall performance (as measured via empirical MSE)
somewhere between that of the original and the halved spacing. Due to space limitations,
down-shift schemes are not part of the extensive numerical study presented in the next
section.
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3.4 Numerical Study
3.4.1 Simple Comparisons
IR and CIR
The theoretical results about IR and CIR in Section 3.2 were for a related limit case of
normal errors; however, the logic underlying them should hold for a wider array of scenarios
and hence we may expect CIR to perform better. Even though CIR is a bias-reducing
correction on an individual run basis, in ensemble-level simulation analysis the benefit should
manifest itself in estimation variance reduction. For different runs, IR’s flat intervals may
occur to the right or left of target, throwing the inverse estimate off either upward or
downward of target, respectively. Over a large ensemble, the individual-run offsets may
balance each other out – but would inflate ensemble variance instead.
This is indeed what Table 3.3 and Fig. 3.5 show. The empirical efficiency gains of CIR
over IR are quite substantial.12 In general, they increase as s increases (data not shown).
For exponential thresholds one can discern an average upward shift associated with CIR
(right-most frame in Fig. 3.5), and for logistic thresholds a downward shift (middle frame).
This is because, F being concave around target in the exponential case and convex in the
logistic case, the forward IR/CIR would under/over-estimate F , respectively – resulting in
an inverse (quantile-estimation) bias in the opposite direction. IR’s flat intervals mitigate
this bias, while CIR’s interpolation increases it. However, this bias increase is more than
compensated by the variance reduction.
Reversal-only and All-trial Averaging
For averaging estimators, we expect reversal-averages wˆ to be shifted upward and have
larger variance than otherwise-identical all-trial averages vˆ. This is indeed demonstrated
in Table 3.4 and Fig. 3.6. In one scenario, wˆ’s upward bias offsets some of the downward
starting-point bias, yielding roughly equal performance for the two estimators. An impor-
tant detail to note is that, in spite of averaging-estimators’ plethora of bias sources, it is
still the variance term that dominates performance.
BCD , KR, GU&D(k,0,1)
I end this simulation hors d’œuvre with some cursory method comparisons. From my
theoretical work, one would expect KR to show a clear advantage over BCD for averaging
12Keep in mind that the two estimate differ only over about half the runs; if one compares MSE only over
runs producing monotonicity-violations, the efficienty gain is about double that shown on the table.
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Table 3.3: Comparison of isotonic regression (IR) and centered isotonic regression (CIR),
from KR (k = 2) simulations over 3 distributional conditions and 2 sample sizes. The ‘Vio-
lation Frequency’ column indicates what proportion of runs (out of 2000) had monotonicity
violations in a region that affects estimation – meaning that for the remaining runs the IR
and CIR estimates were identical. E.E.R. is the ‘Empirical Efficiency Ratio’: the ensemble
MSE of IR estimates w.r.t the true Qp, divided by the MSE of CIR estimates. All statistics
were taken over the entire ensemble of 2000 runs. Bias and standard deviation are in the
same arbitrary normalized units of treatments. Spacing was 0.1, meaning that m = 10.
Distribution
Sample
Size
Violation
Frequency
Bias Std. Dev.
E.E.R.
IR CIR IR CIR
‘Nice’
Logistic
20 50.8% −0.003 0.008 0.091 0.081 1.24
40 50.6% −0.004 −0.001 0.071 0.062 1.30
‘Upward’
Logistic
20 59.0% −0.015 −0.035 0.110 0.097 1.15
40 59.8% −0.005 −0.011 0.086 0.076 1.25
Exponential
20 42.5% 0.039 0.045 0.152 0.132 1.28
40 46.3% 0.022 0.030 0.132 0.113 1.32
Table 3.4: Comparison of reversal-averaging from reversal 1 (wˆ1) and averages of all treat-
ment from reversal 1 (vˆ1), from KR (k = 2) simulations over 3 distributional conditions and
2 sample sizes. Details are as in Table 3.4.
Distribution
Sample
Size
Bias Std. Dev.
E.E.R.
wˆ1 vˆ1 wˆ1 vˆ1
‘Nice’
Logistic
20 0.036 0.022 0.068 0.066 1.24
40 0.019 0.009 0.052 0.049 1.20
‘Upward’
Logistic
20 −0.069 −0.071 0.099 0.093 1.06
40 −0.037 −0.044 0.070 0.068 0.96
Exponential
20 0.057 0.047 0.112 0.111 1.09
40 0.041 0.033 0.097 0.095 1.10
estimators, but also for CIR due to its sharper stationary distribution. As Table 3.5 shows,
the averaging-estimator gap is more pronounced (25% to 40% difference in MSE); the CIR
performance gap between designs is much less dramatic, but is still observed across the
board (including in many numerical runs not shown here).
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Figure 3.5: Comparison of isotonic regression (IR) and centered isotonic regression (CIR)
under the 3 scenarios summarized in Table 3.3 and a sample size of 40. Boxplots reflect
only those runs in which the two methods yielded different estimates. In all plots, IR is on
the left. Targets are marked by solid horizontal lines.
The GU&D(k,0,1) vs. KR comparison is less clear-cut (Table 3.6). KR does have an
edge with averaging estimators: in spite of GU&D’s smaller stationary bias, the GU&D
experiment is composed of a small number of same-treatment cohorts – causing a “grainy”
averaging estimator with increased variance. And again, it is variance that dominates
performance. Using CIR, the two designs run neck-and-neck with GU&D having a slight
edge in these particular scenarios.
The bottom line from these comparisons (and others, not shown here but reported in
earlier work: Oron (2005)), is that KR appears preferable over BCD – especially if we
can make averaging estimators work. Between GU&D(k,0,1) and KR, the decision would
probably depend upon whether a cohort design is required, desired or feasible – since the
performance differences are small. Also, clearly for BCD and GU&D, CIR appears to be
the preferred estimator.
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Figure 3.6: Comparison of reversal-averaging from reversal 1 (wˆ1) and averages of all treat-
ment from reversal 1 (vˆ1), from KR (k = 2) simulations over the 3 scenarios summarized in
Table 3.4 and a sample size of 40. In all plots, reversal-only averaging is on the left.
3.4.2 Detailed Estimator Study
We can be reasonably confident that CIR performs better than IR, that the KR design
has an edge over similarly-targeted BCD, and that reversal-averaging tends to shift the
estimate upward and has a larger variance than all-trial-averaging. This, however, leaves
many design decision questions unanswered.
Many factors affect estimation performance – spacing, the starting-point offset x1−Qp,
the distribution’s shape and scale, the location of boundaries, the sample size and so forth.
I have chosen to demonstrate the sensitivity of various estimators to the first two factors
(spacing and the starting-point effect), by neutralizing all others or holding them constant.
In order to make the results intuitively meaningful and more general, both s and x1 −
Qp, as well as estimation bias and standard deviation, were normalized by F ’s standard
deviation. The following series of figures shows 2-D contour maps of estimator performance.
The comparison is between vˆ1 (top left), wˆ1 (top right), vˆAD (bottom left) and CIR (bottom
right).
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Table 3.5: Comparison of estimator performance from BCD (Γ = 0.293) and KR (k = 2)
simulations. The two estimators compared are vˆ1 (top), and CIR (bottom). The E.E.R.
column quantifies KR’s performance edge over BCD. Details are as in Table 3.3.
Estimator Distribution
Sample
Size
Bias Std. Dev.
E.E.R.
BCD KR BCD KR
vˆ1
’Nice’
Logistic
20 0.031 0.022 0.074 0.066 1.34
40 0.011 0.009 0.056 0.049 1.30
’Upward’
Logistic
20 −0.084 −0.071 0.107 0.093 1.36
40 −0.055 −0.044 0.079 0.068 1.41
Exponential
20 0.058 0.047 0.123 0.111 1.27
40 0.041 0.033 0.107 0.095 1.31
CIR
’Nice’
Logistic
20 0.009 0.008 0.081 0.080 1.01
40 −0.003 −0.001 0.063 0.062 1.03
’Upward’
Logistic
20 −0.047 −0.035 0.098 0.097 1.11
40 −0.017 −0.011 0.077 0.076 1.05
Exponential
20 0.050 0.045 0.134 0.132 1.05
40 0.032 0.030 0.115 0.113 1.04
SU&D, Normal Thresholds
We begin from the most favorable U&D scenario, for which the method was originally
designed. The normal scenario is favorable for several reasons:
• f is symmetric, and hence for SU&D the stationary bias of µpi is negligible;
• The curvature of F around target is very mild, and therefore CIR is also expected to
have very little bias;
• f is thin-tailed, and therefore within-run excursions are less common.
These advantages are borne out in Fig. 3.7, mapping estimation bias for n = 30.13
Contours are color-coded to enhance interpretation: in general, “green is good” – i.e., a
small bias magnitude. Blue indicates negative bias and yellow positive bias.
13All scenarios illustrated in Figs. 3.7 through 3.15 were also mapped for half the sample size, but those
maps were omitted here for brevity.
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Table 3.6: Comparison of estimator performance from GU&D(2,0,1)) and KR (k = 2) sim-
ulations. The two estimators compared are vˆAD (top), and CIR (bottom). The E.E.R.
column quantifies KR’s performance edge over GU&D. Details are as in Table 3.3.
Estimator Distribution
Sample
Size
Bias Std. Dev.
E.E.R.
GU&D KR GU&D KR
vˆAD
Lognormal
18 −0.028 −0.045 0.132 0.124 1.05
32 0.007 −0.007 0.115 0.106 1.16
Normal
18 −0.006 −0.027 0.112 0.102 1.12
32 0.008 −0.013 0.094 0.085 1.20
Gamma
18 0.001 −0.023 0.103 0.099 1.03
32 0.013 −0.010 0.082 0.079 1.08
CIR
Lognormal
18 −0.011 −0.018 0.138 0.140 0.96
32 0.015 0.012 0.122 0.121 1.02
Normal
18 −0.006 −0.015 0.111 0.111 0.99
32 −0.001 −0.007 0.091 0.092 0.98
Gamma
18 0.001 −0.005 0.104 0.106 0.96
32 0.007 0.002 0.081 0.084 0.93
The dominant effect is starting-point bias, which gets worse with smaller s. The auto-
detect estimator (bottom left) mitigates the effect rather well. Note that the bias contours
of vˆ1 (top left) and wˆ1 (top right) are almost identical: as we found in Section 3.2, for
SU&D the only shift between these two estimators would be due to skew, and here there is
no skew.
The starting-point effect even spills over to CIR (bottom right): with small s and n
and large offset, most of the information about F is gathered somewhere between x1 and
Qp; since away from target F does have a substantial curvature, the resulting linear inverse
interpolation is therefore systematically biased towards x1.
If bias was the only “game in town” (and normal the only “distribution in town”), one
would be led to believe that coarse spacing and CIR are the way to go. Fig. 3.8 maps the
other component of estimation error - standard deviation - in the same units used for bias.
Note that here the y-axes show absolute offset w.r.t. x1, because of the symmetry of both
SU&D and F . Color-coding here still follows “green is good”, with the SD becoming yellow,
then brown as it increases. The same color-coding is used for MSE contours in subsequent
figures.
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The first observation is that for most design conditions, estimation SD dominates bias
– for normal thresholds, by a factor of about 10 (compare SD magnitudes with Fig. 3.7).
Next, we see that as s increases, so does the SD. Finally, note that the estimators have a
clear ranking w.r.t. SD - vˆ1 tightest, followed by vˆAD, wˆ1 and CIR, whose SD is larger than
vˆ1’s by about 10− 20%.
Next, we look at overall estimation MSE (Fig. 3.9). In the figure, the MSE is normalized
by the asymptotic, direct-sampling, threshold percentile estimation error (1.1), given in the
introduction. Note that when all stars are aligned correctly – no starting-point offset, fine
spacing, tight estimator – we can sometimes observe what seems like “superefficiency”: an
error smaller than the asymptotic direct-sampling expression. This happens especially with
averaging estimators, through which U&D converts percentile-finding into a potentially
more efficient averaging process.
Since the SD dominates estimation, the less variable vˆ1 or vˆAD provide better overall
performance. The former holds an edge for coarse spacing (s > σ), where starting-point
bias is small. On the other hand, the auto-detect estimator, since it mitigates starting-point
bias while retaining a relatively small SD, offers the best overall combination of performance
and robustness around s ≈ σ/2 – a factor of 2 smaller than the optimal spacing usually
quoted in literature. CIR’s large SD bars it from being competitive under this favorable
normal-thresholds scenario.
SU&D, Exponential Thresholds
What happens when the distribution is highly asymmetric? I chose the exponential with
location parameter ξ and scale parameter σ (equal to the threshold SD). The estimation
SD plot has been omitted, since the patterns observed in Fig. 3.8 are largely distribution-
independent. The bias magnitude is larger now (Fig. 3.10). Averaging-estimator bias is
positive almost across the board, since the second-order skew term is positive; it also in-
creases with increasing s. Starting-point bias still takes its toll on the finest-spacing designs,
but now also – albeit more mildly – on coarser designs.14 The auto-detect scheme can do
nothing about the stationary skew-related bias, and therefore vˆAD’s bias map shows vertical
iso-bias contours.
CIR, too, has a positive spacing-dependent bias – because F is concave (when F ’s linear
interpolation runs below the true curve, the bias is positive and vice versa). However, CIR’s
bias is certainly smaller in magnitude.
In spite of larger biases, the magnitude of estimation SD is still typically about twice
14The latter effect is due to the interaction between starting-point and f ’s skewness and restricted range.
Unlike the simpler starting-point bias, this one can only be positive under exponential thresholds.
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as large. The best combination of robustness and performance seems to be offered by vˆAD
(Fig. 3.11, lower left), in the s ≈ σ/4 to σ/2 range – closely followed by CIR. Note that
the “sweet spot” of quasi-superefficient estimation has moved to the lower left-hand corner,
where the negative starting-point bias nearly cancels out the positive stationary biases.
KR, Normal Thresholds
We move on to non-median targets. The data shown here are for KR, k = 3. We look at
bias and MSE w.r.t. to Q0.2 and not the exact formal target of Q0.2063, since there is little
applied interest in the latter (the difference is quite small in any case). CIR estimates were,
indeed, performed for Q0.2 – giving that estimator a slight a priori edge.
The starting-point biases make their appearances again, and are greater in magnitude
than for SU&D – which is expected since KR converges more slowly (Fig. 3.12). The other
dominant feature for vˆ1 or vˆAD are vertical iso-bias contours. This is the effect of µpi’s first-
order stationary bias. As found in Section 3.2, this bias is negative and linear in s. CIR
shows a negative spacing-dependent bias as well, because F is locally convex near Q0.2. The
reversal-average wˆ1 shows very little of this effect; it appears that with normal thresholds,
µpi’s bias is almost perfectly neutralized by reversal-averaging’s positive bias.
Looking at estimation performance, the picture is now more complex (Fig. 3.13). Be-
cause of the stationary bias, vˆAD is less attractive. Its performance deteriorates quickly as
s increases; around s ≈ σ/2 it is matched or beaten by CIR. Moreover, at somewhat larger
spacing, as the starting-point bias diminishes and stationary biases kick in, reversal-average
wˆ1 suddenly appears like a viable option.
However, while vˆAD’s and CIR’s advantages are grounded in their theoretical robustness,
the reversal-averaging surprise is more of a numerical coincidence related to a particular form
of F , as we shall soon see.
KR, Exponential Thresholds
Using exponential thresholds, the bias picture changes yet again (Fig. 3.14). Now, the first-
order spacing-dependent stationary bias has all but disappeared (it is still somewhat visible
in the auto-detect map for n = 40). This bias seems to be neutralized by f ’s upward skew,
which would of course affect the telescopic sum (3.7). This allows the starting-point bias to
dominate averaging estimation again.
As far as estimation goes, now wˆ1 is by far the worst among the four. vˆAD and CIR
are nearly equivalent with fine spacing (s ≈ σ/4 to σ/2). As s increases, there is a narrow
window in which vˆ1 appears to overtake them, before the first-order downward bias finally
kicks in and hurts all three averaging estimators.
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So for KR, normal and exponential thresholds produce almost the opposite outcomes,
with different bias sources neutralizing each other for different estimators, depending upon
the form of F . Note that overall, relative performance with KR is somewhat worse than
with SU&D (when normalized by the asymptotic direct-sampling efficiency) .
The same qualitative patterns were observed for k = 2 simulation results as well, but
have been omitted for brevity.
3.4.3 Interval Coverage
Table 3.7 compares the three interval-estimation options for CIR discussed earlier in the
chapter, using data from SU&D runs. Even though the bootstrap was never used for
inverse estimation in the U&D and IR context (at least not in published literature), it
has been recommended for forward estimation by Stylianou et al. (2003). They used the
bias-corrected bootstrap; here, after some experimentation with various bootstrap variants,
I opted for bootstrap-t, which is considered relatively robust and with a rate-n accuracy
(Davison and Hinkley, 1995, Ch. 5).
The bootstrap results are quite disappointing (the same level of coverage was observed
with other bootstrap variants, but not shown here). A possible explanation is that the
bootstrap process fails to reproduce the hierarchical nature of variability (in sampling, and
then in Fˆ values). On the other hand, the approach developed in Section 3.3 using linearized
quantile functions and allowing for the added variability in allocation, seems to be quite
conservative with satisfactory overall coverage. As explained earlier, the binomial option
fails to distinguish well between quantiles on the tail; the Poisson option does the job better
while sacrificing little in coverage. Therefore, subsequently I have used the linearized-Poisson
approach for CIR intervals.
Table 3.8 surveys coverage performance across a wider variety of designs, for both CIR
and the averaging estimator vˆAD. For the latter, the hitting-time approach outlined in
Section 3.3 was used (see equation (3.28)). Overall, coverage is good, tending to be on
the conservative side. Even in cases when the average coverage appears to dip below the
nominal level, it is usually due to a single difficult scenario out of 6−8 used for calculations;
for all other scenarios coverage was close to, or above, the nominal level.
The interval estimators have their vulnerabilities: CIR coverage suffers as F becomes
shallower, since then the Fˆ -s would show many monotonicity violations, resulting in fewer
points in CIR’s output, points whose location would vary from run to run.15 If F around
target is very shallow indeed, the coverage method would break down; this seems to occur
15Using IR would hardly alleviate this: with IR, the output would have wide flat intervals, with inverse
estimation highly variable as a result.
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somewhere below ∆F ≈ 0.05 between levels.
Averaging-estimator CI’s break down most conspicuously when the estimator’s bias
(whether due to starting-point or to boundary effects) is too large. Cases when target lies
on the boundary are not reflected in the averaging-estimator coverage statistics reported
here. On the other hand, CIR coverage is quite resistant to boundaries.
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Table 3.7: SU&D interval coverage for CIR estimates under four distribution scenarios, and
n = 15, 30. In all scenarios m = 10, with relatively fine spacing (s/σ < 0.5). Shown are
ensemble coverage percentages for 90% (top) and 95% (bottom) CI’s, based on ensembles of
2000 runs per scenario. The bootstrap simulations used 999 bootstrap repetitions per run.
Coverage of 90% Confidence Intervals: CIR for SU&D
Distribution Scenario Code
Interval Method “gam5090” “gam1090” “log0280” “norm3330”
Bootstrap-t
n = 15 70.6% 70.4% 71.2% 73.6%
n = 30 79.3% 78.7% 80.1% 78.9%
Linearized Binomial
Quantiles
n = 15 96.7% 92.1% 95.2% 94.8%
n = 30 97.2% 94.4% 95.5% 95.3%
Linearized Poisson
Quantiles
n = 15 92.1% 90.1% 92.1% 91.6%
n = 30 96.8% 93.9% 95.3% 95.1%
Coverage of 95% Confidence Intervals: CIR for SU&D
Distribution Scenario Code
Interval Method “gam5090” “gam1090” “log0280” “norm3330”
Bootstrap-t
n = 15 78.9% 77.7% 77.9% 79.4%
n = 30 85.5% 84.7% 85.8% 86.1%
Linearized Binomial
Quantiles
n = 15 96.9% 93.1% 96.2% 95.9%
n = 30 97.9% 95.4% 97.1% 96.6%
Linearized Poisson
Quantiles
n = 15 95.8% 93.4% 95.8% 95.3%
n = 30 98.4% 96.4% 97.5% 97.2%
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Table 3.8: Interval Coverage Summary for various designs and estimators. Shown are em-
pirical coverage statistics of 90% (top) and 95% (bottom) CI’s. For non-median designs, the
targets of Q0.2 and Q0.3 were used, rather than each design’s actual target. All summaries
are of 6 distribution scenarios each, with an ensemble size N = 2000 and a relatively fine
spacing (meff ≈ 10), except for the GU&D summary (second row in each table), which is
from 8 scenarios, N = 1000 and a fixed-boundary m = 6.
90% Confidence Intervals
Design and Estimator Mean S.D. Min. Max.
KR (k = 3) and CIR
n = 20 89.2% 2.6% 86.3% 93.1%
n = 40 92.1% 3.2% 86.5% 95.5%
GU&D(2,0,1) and CIR
n = 18 94.7% 3.3% 89.6% 99.5%
n = 32 95.7% 1.6% 93.8% 98.5%
KR (k = 3) and vˆAD
n = 20 94.8% 3.0% 89.2% 97.1%
n = 40 95.8% 2.7% 92.2% 99.6%
SU&D and vˆAD
n = 15 91.8% 4.1% 84.9% 97.1%
n = 30 96.6% 3.7% 90.0% 99.7%
95% Confidence Intervals
Design and Estimator Mean S.D. Min. Max.
KR (k = 3) and CIR
n = 20 93.3% 2.2% 90.4% 95.8%
n = 40 95.4% 2.4% 91.4% 97.8%
GU&D(2,0,1) and CIR
n = 18 97.1% 1.8% 94.8% 100.0%
n = 32 97.5% 1.3% 95.5% 99.4%
KR (k = 3) and vˆAD
n = 20 95.5% 2.6% 90.7% 97.9%
n = 40 97.9% 1.4% 96.4% 99.9%
SU&D and vˆAD
n = 15 94.7% 2.3% 90.6% 97.5%
n = 30 98.2% 2.0% 94.7% 99.9%
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SU&D, Normal Thresholds, Empirical Bias, n = 30
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Figure 3.7: Sensitivity of selected estimators to normalized spacing s/σ (horizontal axis)
and normalized starting-point offset (x1 − Qp)/σ (vertical axis). Contours are of SU&D
ensemble bias normalized by σ, for n = 30. Contours are color-coded: blue indicates
negative bias, yellow positive bias, and green indicates near-zero bias. In each page, four
estimators are shown: vˆ1 (top left), wˆ1 (top right), vˆAD (bottom left) and CIR (bottom
right). The threshold distribution is normal. Each contour plot uses 5 by 5 empirical bias
statistics, each of which was calculated from 2000 runs.
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SU&D, Normal Thresholds, Empirical SD, n = 30
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Figure 3.8: Sensitivity of selected estimators to normalized spacing s/σ (horizontal axis)
and to absolute offset |Qp−x1|/σ (vertical axis). Contours are of SU&D ensemble standard
deviation normalized by σ, for n = 30. Contours are color-coded: as the SD increases,
color changes from green through yellow to brown. All other details are as in Fig. 3.7.
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SU&D, Normal Thresholds, Empirical MSE, n = 30
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Figure 3.9: Sensitivity of selected estimators to normalized spacing s/σ (horizontal axis)
and to absolute offset |Qp − x1|/σ (vertical axis). Contours are of SU&D ensemble MSE,
normalized by the asymptotic percentile-estimation error (1.1), for n = 30. Color-coding is
as in Fig. 3.8. All other details are as in Fig. 3.7.
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SU&D, Exponential Thresholds, Empirical Bias, n = 30
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Figure 3.10: Sensitivity of selected estimators to normalized spacing s/σ (horizontal axis)
and to offset (x1−Qp)/σ (vertical axis). Contours are of SU&D ensemble bias, normalized
by the threshold SD, for n = 30. The threshold distribution is exponential. All other details
are as in Fig. 3.7, except that here 4 by 5 points underly the contours.
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SU&D, Exponential Thresholds, Empirical MSE, n = 30
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Figure 3.11: Sensitivity of selected estimators to normalized spacing s/σ (horizontal axis)
and to offset (x1−Qp)/σ (vertical axis). Contours are of SU&D ensembleMSE, normalized
by the asymptotic percentile-estimation error (1.1), for n = 30. The threshold distribution
is exponential. Color-coding is as in Fig. 3.8. All other details are as in Fig. 3.10.
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KR (k = 3), Normal Thresholds, Empirical Bias, n = 40
All Trials from Reversal 1
Spacing / SD
O
ffs
et
 / 
SD
0.2 0.4 0.6 0.8 1.0 1.2 1.4
−
1.
0
0.
0
0.
5
1.
0
1.
5
Auto−Detect Estimator
Spacing / SD
O
ffs
et
 / 
SD
0.2 0.4 0.6 0.8 1.0 1.2 1.4
−
1.
0
0.
0
0.
5
1.
0
1.
5
Reversals from Reversal 1
Spacing / SD
O
ffs
et
 / 
SD
0.2 0.4 0.6 0.8 1.0 1.2 1.4
−
1.
0
0.
0
0.
5
1.
0
1.
5
Centered Isotonic Regression
Spacing / SD
O
ffs
et
 / 
SD
0.2 0.4 0.6 0.8 1.0 1.2 1.4
−
1.
0
0.
0
0.
5
1.
0
1.
5
Figure 3.12: Sensitivity of selected estimators to normalized spacing s/σ (horizontal axis)
and to offset (x1 −Qp)/σ (vertical axis). Contours are of KR (k = 3) ensemble bias w.r.t.
Q0.2, normalized by the threshold SD, for n = 40. The threshold distribution is normal. All
other details are as in Fig. 3.7.
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KR (k = 3), Normal Thresholds, Empirical MSE, n = 40
All Trials from Reversal 1
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Figure 3.13: Sensitivity of selected estimators to normalized spacing s/σ (horizontal axis)
and to offset (x1 − Qp)/σ (vertical axis). Contours are of KR (k = 3) ensemble MSE
w.r.t. Q0.2,, normalized by the asymptotic percentile-estimation error (1.1), for n = 40.
The threshold distribution is normal. Color-coding is as in Fig. 3.8. All other details are as
in Fig. 3.7.
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KR (k = 3), Exponential Thresholds, Empirical Bias, n = 40
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Figure 3.14: Sensitivity of selected estimators to normalized spacing s/σ (horizontal axis)
and to offset (x1 −Qp)/σ (vertical axis). Contours are of KR (k = 3) ensemble bias w.r.t.
Q0.2, normalized by the threshold SD, for n = 40. The threshold distribution is exponential.
All other details are as in Fig. 3.7.
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KR (k = 3), Exponential Thresholds, Empirical MSE, n = 40
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Figure 3.15: Sensitivity of selected estimators to normalized spacing s/σ (horizontal axis)
and to offset (x1 − Qp)/σ (vertical axis). Contours are of KR (k = 3) ensemble MSE
w.r.t. Q0.2, normalized by the asymptotic percentile-estimation error (1.1), for n = 40.
The threshold distribution is exponential. Color-coding is as in Fig. 3.8. The green bands
showing on the top-left corners of the vˆ1 and wˆ1 maps are artifacts, as the MSE there is so
high that the contours need to cycle through the entire spectrum again (wˆ1’s normalized
MSE reaches as high as 13). All other details are as in Fig. 3.7.
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3.5 The Anesthesiology Experiment
As explained in the introduction, this study has been motivated by a consulting collabora-
tion on a real experiment plan (Oron, 2004). The experiment has eventually been carried
out from late 2004 to early 2007, and initial results are being presented (Bhananker et al.,
2007). Dr. M.J. Souter has kindly allowed me to present the data here as well. This will
help illustrate the theoretical features described so far, and to demonstrate the inevitable
gap between theory and practice.
3.5.1 Background
Propofol is the current anesthetic agent of choice for routine surgical procedures in the
industrialized world. It has replaced previous agents such as thiopental, because it has no
adverse effects on blood pressure like other agents, it enables faster patient recovery from
drowsiness after the procedure, and for other reasons. However, propofol has a very unpleas-
ant – and paradoxical – side effect: in the minutes before passing out, many patients feel
intense pain. Several studies and meta-analyses estimate the overall population frequency
of pain responses at 70% (Picard and Trame´r, 2000). Devising methods to alleviate this
side effect is an ongoing practical and academic endeavor.
One interesting approach has been to mix propofol with thiopental – an older agent
with less favorable overall outcomes, but without the pain side-effect. Several studies have
shown that the primary therapeutic (anesthesizing) effect for such mixtures is additive –
meaning that efficacy is not adversely affected (Vinik et al., 1999) – and that the prevalence
of pain responses is reduced (Pollard et al., 2002). However, to date no study had yielded a
clear, definitive recommendation for mixture proportions to the general patient population.
Being familiar with U&D, which is used extensively in anesthesiology for median-finding
(Capogna et al., 2001; Camorcia et al., 2004; Fisher, 2007), Dr. Souter approached our
Consulting Service to inquire whether U&D methodology can be used to find a propo-
fol/thiopental mix that reduces pain response frequency to under 20%.
3.5.2 Design Constraints and Initial Recommendations
Since propofol is used in routine surgery, and since the proposed treatment mixes it with
another FDA-approved agent, this experiment was relatively free of the typical ethical and
sample-size constraints encountered in medical research.16 In practice, any adult (within
certain health and age boundaries) assigned to surgery, who agreed to participate in the
16Of course, an appropriate IRB was submitted and approved.
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experiment could be recruited. On the other hand, this walk-in recruiting suggested that
indeed, a sequential design such as U&D would work better than a non-sequential one.
Our initial recommendations to Dr. Souter were based upon a literature search and
numerical simulations. The search has turned up both KR and BCD. KR exhibited superior
performance across the board in simulated runs, in line with the few numerical comparisons
appearing in literature. The runs also indicated that for an estimation with CI’s of about
±10%, sample size should be quite larger than those discussed in the papers presenting BCD
(Durham and Flournoy, 1995; Durham et al., 1995) - closer to 100 than to the samples of
15− 35 simulated there. Additionally, the convergence-stationarity tradeoff with respect to
spacing was identified. I recommended k = 4 (targeting Q0.159), narrowly over k = 3, both
because of somewhat better simulation results and to make sure the target is below Q0.2. I
also recommended a spacing of 10% and a starting point somewhere near the middle of the
range between 0 and 100% propofol.
3.5.3 Raw Results
The experiment went underway in fall 2004 at Harborview Hospital in Seattle, with a KR
(k = 4) design, starting point of 50 : 50, and 10% spacing. Treatment assignments were
double-blind, and there was a single designated observer to evaluate whether pain response
had occurred. The first stage was characterized by very low incidence of pain responses.
After 58 patients, and after several rounds of consultation, the pain evaluator has changed
and the design was switched to k = 3, continuing from the point at which the experiment
was at that time (80% propofol), until trial 90 when the experiment ended. Trials 59 − 90
will be referred to as Stage 2. Some sample demographics are summarized in Table 3.9. The
two stages’ chains are illustrated in Fig. 3.16, and the treatment-response summary tables
are shown in Table 3.10 .
3.5.4 Conceptual Interlude
The experiment’s rationale can be summarized as follows: we assume there is some gen-
eral population of potential patients, whose sensitivity to pain given a certain propo-
fol/thiopental mix can be modeled via an overall threshold subdistribution F , monotone in-
creasing with the proportion of propofol, and reaching F ≈ 0.7 at a propofol-only treatment.
We are looking for the 20th percentile of F , or more precisely, for an easy-to-administer
mix just below that percentile. Since the experiment was performed at a single convenience-
chosen hospital, the sampling population is not the general population. However, 70% pain
at propofol-only treatment is a rather universally well-established figure, and Dr. Souter’s
prior experience at that hospital had been compatible with this frequency as well. Hence,
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Table 3.9: Age and gender summary table for the propofol/thiopental experiment.
Stage 1 (trials 1-58) Stage 2 (trials 59-90)
Gender
Female 13 10
Male 45 22
Age
Minimum 20 19
First Quartile 28 25
Median 43 36
Mean 41.8 37.3
Third Quartile 51 47
Maximum 81 64
Table 3.10: Treatment-Response summary table for the propofol/thiopental experiment.
Propofol
Stage 1 (trials 1-58) Stage 2 (trials 59-90) Overall
Pain No Pain Fˆ Pain No Pain Fˆ Pain No Pain Fˆ
50% 0 4 0 0 4 0
60% 0 8 0 0 12 0 0 4 0
70% 1 16 0.06 4 11 0.27 5 27 0.16
80% 3 13 0.19 2 3 0.40 5 16 0.24
90% 2 6 0.25 2 6 0.25
100% 1 4 0.20 1 4 0.20
Total 7 51 0.12 6 26 0.19 13 77 0.14
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Figure 3.16: Chains of the propofol/thiopental experiment reported by (Bhananker et al.,
2007). Stage 1 (trials 1− 58) is on top and Stage 2 (trials 58 − 90) on bottom. Responses
are marked as in Fig. 2.1.
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we had no reason to expect sharp deviations from the general-population baseline.
Pain evaluation presents another difficulty. It is not measured via a standard instrument,
but evaluated by a subjective observer; thus F actually describes reported pain outcomes
from the population of potential patient-evaluator pairs. Therefore, from a statistical point
of view we should ideally sample (or randomize) several evaluators simultaneously with
the sampling of patients. However, the experiment design was constrained to a single,
specifically-trained evaluator, with a scheduled change of evaluators at a certain time point.
The two stages are in effect samples from two different threshold-evaluator sub-populations,
with subdistribution functions F (1) and F (2).
To sum it up, the experiment does not sample the general population of pain thresholds
and pain evaluators. Fortunately, the goal is not a purely academic exercise of studying F ,
but the practical determination of a mix that might reasonably work for general samples out
of F . Our hope is that the samples from F (1) and F (2) would show a behavior sufficiently
compatible with what we know about F , to make our percentile estimate practically useful
for the general population.
3.5.5 Analysis and Estimation
The results from Stage 1 (the first 58 trials) raise concerns regarding this compatibility.
In particular, beginning with subject 11 there were 20 consecutive trials with no pain re-
sponse, culminating in 4 no-pain trials at propofol-only treatment before finally observing
pain on the fifth. Given our knowledge of F we’d expect a pain probability of 0.7 for that
treatment. For a geometric r.v. with success probability 0.7, there is less than 0.01 chance
of observing 4 or more failures before the first success. A more comprehensive sensitiv-
ity analysis incorporating all 58 Stage 1 trials within a Bayesian framework was carried
out, using various functional forms for F (1), and a prior distribution calibrated to pre-
dict F (1)(100% propofol) ≈ 0.7. The results strongly suggest that Stage 1 data are not
compatible with the population baseline (Fig. 3.17, top). In fact, posterior medians for
F (1)(100% propofol) are around 0.3.
Later upon closer examination, it was found that Stage 1’s patients included subjects
aged 76 and 81, who should definitely have been excluded from the experiment due to old
age, and 3 more patients 65 years or older whose inclusion was marginal. None of them
exhibited pain.17 Since the design was sequential, this affected allocation to all subsequent
patients, hence distorting all averaging estimators. Since Stage 2 had no patients older than
17The common assumption is that the nervous system loses its sensitivity with age, and hence pain
incidence would decrease. The oldest patient out of all 90 trials to exhibit a pain response was 57 years
old.
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Figure 3.17: Histograms of posterior pain frequency at a propofol-only treatment, based
on Stage 1 (top) and Stage 2 (bottom) data, and using location-scale logistic (left), shape-
scale Weibull (center) and 3-parameter logistic (right) Bayesian models. The thick vertical
lines mark pain probabilities of 0.6 and 0.7. The posterior probabilities for pain frequency
exceeding 60% based on Stage 1 data were 0.008, 0.002 and 0.002 for the three models,
respectively. The analogous probabilities based on Stage 2 data were 0.36, 0.17 and 0.24.
Each posterior distribution was approximated via MCMC, using 400, 000 cycles thinned by
a factor of 40.
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64, this presents yet another difference between F (1) and F (2).
Stage 2 exhibited a rather different response pattern from Stage 1, a pattern reasonably
compatible with the population baseline – though still a bit on the low side (Fig. 3.17,
bottom).18 Therefore, we decided to estimate Q0.2 for the general population using only
Stage 2 data.
This estimation is quite straightforward: since Fˆ (2) is monotone, the IR and CIR es-
timates are identical - yielding a point estimate of 67.5% propofol for 20% pain response,
with a 95% CI of (55.9%, 79.1%). The auto-detect averaging estimator vˆAD identifies the
stage’s third trial as the averaging starting point, while the first and third reversals occur
on the second and fourth trial, respectively. vˆAD and the reversal-cutoff estimates vˆ1, vˆ3
are 67.33%, 67.42% and 67.24% propofol, respectively – very close to the IR/CIR estimate.
The 95% CI for vˆAD is (51.8%, 82.8%).
19 Considering convenience of application, my clinical
collaborators therefore decided to recommend a 2 parts (66.7%) propofol, 1 part thiopental
mix for reducing pain response frequency to around 20%.
18A label-permutation test showed some evidence for different evaluation sensitivities between the two
evaluators, even after removing the two oldest patients (p = 0.04). However, the evidence for this is
confounded by the differences in age and gender composition between the two stages (cf. Table 3.9).
19It seems that the IR/CIR interval estimate is a bit too optimistic, because of the steep slope of Fˆ between
60% and 70% propofol.
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3.6 Optimizing Up-and-Down: A Practical Summary
Chapters 2-3 have traversed a wide range of U&D topics. It is time to tie back the loose ends.
The optimization recommendations below are split into “Clearly Indicated” – meaning
that solid theory and/or across-the-board numerical results support the conclusion, and
“Recommended” – meaning that my work suggests this direction, but it is not as clear-
cut. Within each category, conclusions are arranged by subtopics.
3.6.1 Clearly Indicated
Method and Sample Size
1. Designs with super-small n < 10 should be avoided. Even though SU&D is fast-
converging, that convergence is probabilistic and does not apply deterministically to
each individual run. Under the recommended design decisions (see below), SU&D
convergence would typically take up (on the average) at least half a dozen trials, and
at least twice that for other U&D variants.
From the theoretical and numerical results presented here, a reasonably minimalist
sample-size range would be 16 − 32 for SU&D, and around 8 − 16 times (k + 1) for
KR designs.20
2. For non-median targets, KR is clearly recommended over BCD, unless the target
percentile cannot be approximated by a KR design.
Design: Spacing, Boundaries, Stages
1. Boundaries should be avoided. In case there is a real physical boundary (e.g., at zero),
a logarithmic (or log-ratio) treatment scale should be used if feasible. If boundaries
are unavoidable, then either use a scheme that halves the spacing given some trigger,
and/or estimate with the more robust CIR.
2. The recommendation, dominant since Dixon and Mood (1948), to set s ≈ σ, is wrong.
The indicated spacing magnitude is about half that, or even a bit smaller. Conceptu-
ally, this is because U&D’s stationary advantages do not kick in unless π has a clearly
defined, sharp peak. For SU&D with s ≈ σ, meff. – the number of levels where F is
substantially different from 0 or 1 – is about 4−6, too little to guarantee such a peak.
Technically, the spacing effect manifests itself in estimation variance and bias which
20The reason for the (k + 1) factor is that to move ’up’ and back ’down’ requires at least k + 1 trials.
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both increase with s. The main adverse effect of smaller s is larger starting-point
biases – but there are solutions that mitigate much of this effect.
Overall, with knowledge of σ one should set a spacing somewhat smaller than σ/2,
and yet a bit smaller for non-median targets. Without such knowledge, aim for meff.
to be somewhere between 8 and 12 (for non-median target, one should estimate meff.
as the number of levels where we expect F to be solidly within the interval (0, 2p)).
If one prefers the ∆F approach, that is, set s w.r.t to the expected increment of F
between levels around target, then the recommendations are equivalent to the range
∆F ≈ 0.1 to 0.15 (the currently recommended spacing translates to ∆F ≈ 0.3).
3. The optimal starting point minimizes the expected number of trials to target. Whether
design boundaries exist or not, visualize a “realistic range”: the range in which you
realistically expect the target might be. The starting point should then be the treat-
ment from which the chain would take the same number of steps to either end. For
example, with k = 2, x1 should be 2/3 of the way up that range (see Section 3.5 for
my mistaken placement of x1 in the anesthesiology experiment, which cost about a
dozen trials).
Estimation
1. Centered Isotonic Regression (CIR) is clearly preferred over IR, unless one knows
that F resembles a stair-step function. Even though the bias reduction was proven
only for an approximate limit case, the logic underlying the correction is generic, and
numerical results point to a 20− 30% or even greater improvement in efficiency under
most scenarios.
2. BCD and GU&D should be used with the CIR estimator and not with averaging
estimators – the former because of its slow convergence, and the latter because of the
graininess of cohort-based chains.
3. For SU&D and KR, the reversal-average wˆ should be abandoned in favor of vˆ-type
estimators averaging all treatments from a cutoff point. They have smaller variance,
and one bias source less to worry about.
4. The first reversal is too early for such a cutoff point, as it is far from guarantee-
ing removal of the starting-point effect. Alternatives will be discussed below under
“Recommended”.
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3.6.2 Recommended
Method and Sample Size
• Regarding cohort-based group U&D (GU&D) designs: designs with ru = 0 (ru being
the “remain at the same level” probability) at all levels should inherently converge
faster. Conversely, the stationary profile becomes steeper (more “peaked”) as ru in-
creases. The GU&D(k,0,1) design, examined here numerically, seems to be a reasonable
candidate for Phase I trials (with k = 2 or 3). Note the comment above regarding
GU&D estimation.
• The question of whether better U&D methods can be found or whether an optimal
one can be formulated – briefly treated by Bortot and Giovagnoli (2005) for second-
order methods using a BCD-type randomization scheme – remains open. However,
it appears that the combination of simplicity, performance and usage track record
offered by SU&D and KR, would be hard to beat.
Design: Spacing, Boundaries, Stages
• The “layover” boundary conditions suggested by Garc`ıa-Perez (1998) to mitigate the
boundary effect, do not appear to be advantageous on the whole. Whatever bias
reduction they offer in some scenarios, is offset by opposite bias in scenarios where
the underlying assumption (that F remains constant beyond the boundary) does not
hold – and by increased variance. The milder “imputation” fix suggested here suffers
from the same problems. Again, the best way to deal with a boundary is to avoid
having it, to half the spacing upon brushing up against it, and to estimate using a
boundary-resistant estimator such as CIR.
Estimation, Stopping Rules, Multistage Schemes
• Instead of the first reversal, one should set the cutoff point for averaging estimators
either at the auto-detect point developed here, or possibly at the third reversal. The
AD point has the advantage of being adaptive: in case the starting-point effect is small,
the AD point will happen early – while the other alternatives would lose efficiency.
However, AD should be used with care: the AD point is not to be allowed to be
greater than n/3, or than the number of trials required to reach each end of the
“realistic range” (described above) – leaving room for one “switchback” along the
way. For example, for SU&D if that range is 5 levels from x1, then the AD point
should not be later than 5 + 2 steps later, i.e, no later than x8. Clearly, if n is too
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small to allow for meeting the latter criterion, then it should probably increased (or
the spacing made coarser).
• For KR designs, one may wish to explore incorporating the AD estimator over the zero-
state sub-chain only – an estimator which gets rid of the first-order stationary bias,
and introduces a second-order bias in the opposite direction (perhaps some average of
vˆAD and vˆAD,0 can be used).
• The AD point could also be used for a stopping rule, by mandating that the experiment
continue until AD analysis yields n˜ trials used for averaging.
• For interval estimation, the bootstrap based on point estimates of Fˆ does not appear
to capture the magnitude of U&D’s inverse-estimation variability. The more direct
methods developed here are suggested instead.
• Regarding multistage schemes: here, too, using the first reversal as a transition point
seems too risky. Either the third reversal, or the third or fourth hitting-time at the
most frequently visited level are more robust alternatives. Since these events typically
occur only a dozen or more trials into the experiment, one should probably refrain
from multistage schemes unless n is large enough to a allow for a substantial part of
the experiment to take place after the transition point.
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Additional Glossary for Chapter 3
Note: some terms appearing only in the sequence of proofs leading up to Theorem 6 are
omitted here. They are of no interest beyond that particular result, where they are ex-
plained.
CIR: Centered Isotonic Regression.
IR: Isotonic Regression.
NPMLE: The nonparametric MLE.
PAVA: Pooled Adjacent Violators Algorithm. The algorithm used to produce IR esti-
mates.
Bc:d: An average of “B” values, from Bc to Bd. “B” here is a dummy stand-in for any
value which is indexed over levels, trials, etc., such as Fˆ , x, and so on. Also, the
average may be weighted if applicable.
c(n): The location (as index in the treatment chain) of the averaging cutoff point iden-
tified by the auto-detect estimation method.
Fˆu: The binomial point estimate of F at lu, obtained simply by calculating the pro-
portion of positive responses at lu accumulated until the point in time at which the
estimate is taken.
F¯ : The linear interpolation of F between design points.
F : The general meta-population (or hyper-population) of potential reported pain out-
comes, out of the overall population of patients and pain evaluators. A concept used
to interpret the meaning of the anesthesiology experiment in Section 3.5
L: The likelihood.
M : The length of a monotonicity-violating interval identified by the PAVA or CIR
algorithms.
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neff : The effective sample size: the number of hypothetical i.i.d. observations needed
to achieve the same rate of variance reduction for the sample mean as that observed.
vˆAD: Arithmetic average of all treatments, beginning with the “auto-detect” point; a
suggested estimator of Qp.
vˆj : Arithmetic average of all treatments, beginning with the j-th reversal; a possible
estimator of Qp.
wˆj: Arithmetic average of treatments at reversal points only, beginning with the j-th
reversal; a popular estimator of Qp.
w¯j: Similar to wˆj, except that the average is somewhat modified. This was Wetherill et al.
(1966)’s original reversal estimator (now less commonly used than wˆj).
zu: A value used to denote the running estimate of Fu during the PAVA and CIR
algorithms. Its initial value is equal to Fˆu.
µpi: The mean of the stationary distribution.
νj : The length (in trials) of the interval between the j-th and j + 1-th hitting times
at a certain Markov-chain state.
ρj : The treatment chain’s j-th order autocorrelation coefficient. If j is omitted, ρ
refers to the first-order coefficient (note the difference from the use of ρ in Chapter 2).
σ: The standard deviation of thresholds.
σpi: The standard deviation of π.
ωu: The weight given to a point estimate at lu (usually proportional to nu in the
context of PAVA/CIR).
103
Chapter 4
BAYESIAN PERCENTILE-FINDING DESIGNS
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4.1 Overview
4.1.1 History
There is evidence for earlier sources, but credit for the first massive and practical introduc-
tion of Bayesian designs to percentile-finding goes to Watson and Pelli in psychophysics,
circa 1980 (Watson and Pelli, 1979, 1983). Their algorithm, nicknamed QUEST, is widely
used (though perhaps not as widely as U&D-descended designs) and even implemented
into automated experiment control software. However, the current statistical debate is
dominated by QUEST’s younger relative CRM (Continual Reassessment Method) – a de-
sign using the same principles, developed independently vis-a-vis the Phase I application
(O’Quigley et al., 1990).1 In that latter paper, the motivation and principles were clearly
described, and CRM’s advantage over both the ‘3+3’ Phase I design and U&D was forcefully
argued. The main argument is that using only the outcomes of a single cohort to determine
allocation is inherently inferior to model-based allocation using information from all trials.
CRM’s essential features have not changed much since 1990. However, some modifica-
tions have been suggested to cope with what appears to be CRM’s greatest obstacle: its
perception as risky by the medical community (see, e.g., Palmer (2002)). This is not only a
perception problem: in statistical literature, as well, researchers showed that CRMmay esca-
late doses too quickly (Korn et al., 1994). The simplest fix - limiting transitions to ±1 level
(Goodman et al., 1995) - has been widely accepted, but unconstrained CRM is still practiced
by some leading biostatisticians (Mathew et al., 2004; Pisters et al., 2004). Similar concerns
have surfaced with respect to QUEST in psychophysics (Alcala`-Quintana and Garc`ıa-Perez,
2004; Garc`ıa-Perez and Alcala`-Quintana, 2005). Recent CRM designs seem to focus on more
sophisticated solutions to this problem. One of them, Escalation with Overdose Control
(EWOC, Babb et al., 1998) will be discussed in the next subsection. Both CRM and EWOC
are available online as software packages (Xu et al., 2007). An article titled “CRM tutorial”
for general audiences, including discussion of its modifications, has been recently published
(Garrett-Mayer, 2006). Two nonparametric or “model-free” approaches to CRM have also
been suggested – one of them still using the Bayesian framework with prior and posterior
distributions, but with a saturated model (Gasparini and Eisele, 2000), and one where allo-
cation decisions are based solely on a nonparametric local estimate of Fˆ (Leung and Wang,
2001; Yuan and Chappell, 2004; Ivanova et al., 2007, see below in Section 4.1.3).
The current popularity of Bayesian approaches in the statistical community notwith-
standing, the relative merit of Bayesian percentile-finding designs is hard to assess, espe-
cially for Phase I trials. Phase I clinical trials is not an application that easily accommo-
1Interestingly, O’Quigley et al. did not cite QUEST, and were probably not aware of its existence.
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dates repeated or large-scale comparative experiments. To date, the only clear theoretical
result regarding CRM properties, is that one-parameter models converge to optimal allo-
cation (to be defined later) under rather restrictive conditions on F (Shen and O’Quigley,
1996; Cheung and Chappel, 2002). In most other CRM publications, claims for a given de-
sign’s advantage are usually supported by logical arguments or by simulation comparisons
with competing methods. A recent mini-review co-authored by one of CRM’s developers
(O’Quigley and Zohar, 2006) even claims that numerical simulations are the recommended
approach to compare percentile-finding designs.
Unfortunately, simulations are prone to ‘rigging’, whether intentional or unintentional.
The most common ‘rigging’ in favor of parametric designs is to choose scenarios in which
F is correctly specified (or very closely approximated) by the author’s parametric model
(Babb et al., 1998). Another fallacy is using the wrong estimator for the ‘competitor’ meth-
ods. This is almost always the case whenever U&D appears in CRM publications - not
intentionally, but out of ignorance among statisticians regarding common U&D usage. For
example, the paper introducing EWOC (Babb et al., 1998) claims its advantage over a host
of competitors, including stochastic approximation, CRM, the ‘3+3’ protocol, GU&D(3,0,2)
and KR with k = 2. However, all simulation scenarios were generated via the location-scale
logistic model used by the authors’ EWOC, and U&D ‘estimation’ was defined as the dose
allocation following the last trial. By contrast, a recent comparative simulation study in
psychophysics, performed by researchers who contributed to both U&D and Bayesian de-
signs and who are acquainted with ‘best practices’ in both, has yielded the conclusion that
QUEST is the worst of the five designs tested, especially as far as robustness (or in their
terminology, ‘usability’) is concerned (Garc`ıa-Perez and Alcala`-Quintana, 2005).
In general, the safe assumption (lacking a clear and verified scientific model for F ) is
that any parametric model used is misspecified. Therefore, when examining the properties
of CRM or other parametric designs, our attention will focus on what happens when the
model is misspecified.
4.1.2 Description of Common Bayesian Designs
Definition and Terminology
Definition 5 Let a CRM scheme be a generic Up-and-Down design (see 1 (i)), also
having:
1. A response model G(x, θ), which is a (sub)distribution function on x for any θ ∈ Θ,
and a strictly monotone2 continuous algebraic function of θ, with continuous first and
2Shorthand for: strictly monotone in each θj holding x and the other parameters constant.
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second partial derivatives everywhere in Θ (hereafter: the CRM model). The family
of possible curves for a given model will be referred to as G.
2. A prior distribution Π(θ|φ) for the model’s parameters.3
3. A two-stage decision rule for allocating the next treatment xi+1, using the posterior
distribution of θ, Π(Qp|x1, . . . xi, y1, . . . yi, φ)).
4. A stopping rule.
The monotonicity in each parameter is needed for model identifiability. The allocation
rule will be further defined and refined in the next section. There has been some work
regarding CRM stopping rules (e.g. Zohar and Chevret, 2003); however, here I assume for
simplicity that the stopping rule is “stop after the fixed-size allocated sample is exhausted”
– which is still the most commonly used rule.
Unlike U&D, Bayesian designs almost always assume a finite set of treatment levels.
Allocation rules
QUEST’s original rule is
xi+1 = luˆ, uˆ ≡ argmax (Π (Qp|x1, . . . xi, y1, . . . yi, φ))) , (4.1)
with the maximum taken over design points only. That is, allocation goes to the (discrete)
posterior mode over design points.4 The original CRM rule is
xi+1 = luˆ, uˆ ≡ argmin |lv − E [Qp|x1, . . . xi, y1, . . . yi,Π(θ)]| , (4.2)
or in words: allocate the next treatment to the level ‘closest’ to Qp’s posterior mean
(O’Quigley et al., 1990). ‘Closest’ may be measured either on the treatment scale or on
the response scale. Technically, the estimate is calculated either by viewing Qp as an al-
gebraic function of θ and estimating θ, by calculating at G’s posterior estimates at design
points, or directly by looking at Qp’s posterior distribution.
3The lower-case pi, usually used to denote prior and posterior in Bayesian literature, has already been
taken in this text for denoting stationary distributions.
4Doubtlessly, this rule was chosen for computation reasons. It allowed calculation to proceed as a simple
updating of the previous posterior, instead of tedious integrals (MCMC in its current form did not exist
at the time). So this was probably the only option enabling individual researchers to use QUEST for their
experiments.
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Following concerns regarding potential jumps by CRM to high-toxicity territory (Korn et al.,
1994), Goodman et al. (1995) suggested modifying this rule to: move one level in direction
of Qp’s posterior mean (or no move, if the current level is the closest). EWOC’s rule is even
more conservative: after setting an acceptable risk level α, allocation is
xi+1 = max {lv : Pr (G(x = lv, θ) ≥ Qp|x1, . . . xi, y1, . . . yi) ≤ α} , (4.3)
or in words: allocate the next treatment to the largest level whose posterior probability of
exceeding Qp is not greater than the predetermined risk level (Babb et al., 1998).
5. This
allocation rule can be traced to the asymmetric loss function
lα(x,Qp) =
{
α(Qp − x) x ≤ Qp
(1− α)(x−Qp) x > Qp
(4.4)
EWOC’s originators used a risk level of α = 0.25. Note that since G is monotone in x, the
EWOC estimator allocates to the level just below the 100α% percentile of Qp’s posterior
distribution. Therefore, using median instead of mean with the ‘plain’ CRM approach is
basically equivalent to using EWOC with α = 0.5, showing that these two CRM variants
are very closely related.
Models and estimation
QUEST was introduced with a 4-parameter Weibull model.6 By contrast, the original
model used by O’Quigley et al. was a one-parameter “hyperbolic tangent” or “power”
model, which is essentially a 3-parameter logistic model with location and scale fixed and
a free shape parameter. Since then, O’Quigley and others have repeatedly argued in favor
of a one-parameter CRM and against using more parameters. The reasoning is that since
Qp is a single parameter, using more than 1 parameter in the model that tracks it down
is dangerously redundant and less robust. A currently popular one-parameter CRM model
is G(lu) =
(
G(0)(lu)
)θ
, where the G(0) values at design points are determined according to
prior knowledge, and θ is a single parameter (Mathew et al., 2004). Clearly, the original
“power” model is a special case of this family. Another variation is one-parameter scale
logistic, with fixed location (Garrett-Mayer, 2006). However, many other CRM researchers
use the 2-parameter, location-scale logistic model, perhaps simply because it is the most
5EWOC’s originators actually assume a continuous treatment range, in which case the next dose can be
allocated so that the risk is exactly α.
6Two of these parameters are the ‘false positive’ and ‘false negative’ rates used in psychophysics, and two
are the familiar shape and scale Weibull parameters.
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commonly used model in medical dose-response applications, and can be generalized to
logistic regression. EWOC developers recommend this model as well.
Following the CRM experiment, estimation is a straightforward: most often, CRM
estimation is simply the next allocation. This is in stark contrast to U&D, where
allocation and estimation are quite separate. Sometime minor variations appear, such as
using the MLE for estimation (which is equivalent to a uniform prior), but the principle
remains the same. The practice of using allocation for estimation may seem self-evident,
but it may also raise questions, especially with regards to CRM. CRM’s developers still
claim that a one-parameter model should be used, regardless of researchers’ beliefs about
the properties of the true F . This is understandable for allocation, but once the experiment
is over one would think that the final estimate should be generated using the most realistic
model, not the one deemed most effective for mid-experiment allocation. However, that
point is not often debated nowadays.
4.1.3 Nonparametric CRM
A radically different modeling approach was recently suggested: here the main argument is
that misspecified models impose too many constraints, preventing the CRM scheme from
adapting to the data (Gasparini and Eisele, 2000). The proposed solution is to use a sat-
urated model: a model with m parameters, that can exactly match F on {lm}. This
model has not been generally accepted in CRM circles, and its performance is not quite
spectacular, even in the simulations presented by its originators. One counter-argument to
saturated CRM was that saturated models, too, imposed constraints via the model’s prior
- as claimed by O’Quigley (2002) in a direct rejoinder to Gasparini and Eisele (2000) – but
that unlike parametric models, these constraints are less easily tractable.
A truly nonparametric approach was suggested by Leung and Wang (2001). Here, in-
stead of a Bayesian posterior estimate, the point estimates to be used at each stage are
derived from isotonic regression. At each step, the next level is chosen from the current
level and its two immediate neighbors, according to whose IR estimate is closest to p. This
design can also be seen as a constrained CRM with a saturated model and no prior (i.e., a
constrained MLE-based allocation).
Two modifications to this design have since appeared, both of them relaxing the con-
ditions somewhat to include an interval of Fˆ values that allows remaining at the same
level. Yuan and Chappell (2004) suggest the interval [p, 2p], tailored to very low targets.
Ivanova et al. (2007) suggest a more generic window: [p−∆1(p), p +∆2(p)]. For conve-
nience, the authors preferred to use ∆1(p) = ∆2(p) = ∆(p). Recommended values for ∆(p)
were determined by intense numerical scenario searches run on the tpm’s of GU&D designs
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with increasing cohort size (the authors view a decision at lu as a GU&D decision with a
cohort size equal to nu). For 0.1 ≤ p ≤ 0.25, ∆(p) = 0.09; ∆(0.3) = 0.10 and ∆(0.5) = 0.13.
This design has been dubbed Cumulative Cohort Design (CCD), and will be discussed
later on.
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4.2 Theoretical Study: Convergence
As CRM researchers admit, since the application is a small-sample one good asymptotic
properties are no guarantee for actual performance. On the other hand, convergence proper-
ties may help us understand important aspects of small-sample behavior. The main existing
result regarding CRM convergence, from Shen and O’Quigley (1996), deals with misspeci-
fied one-parameter models. These models can guarantee to match the true F at one point;7
the hope is that the CRM scheme ensures this point will be the design point closest to
(Qp, p). Shen and O’Quigley (1996) were able to prove convergence to this point almost
surely as n → ∞, only by assuming that the family of G curves be “close” enough to F ,
so that no matter which value of F is matched by G, the optimal level is still allocated.
Cheung and Chappel (2002) illustrate this restriction, noting that it is quite unrealistic for
one-parameter models; essentially, it means that the model is only “mildly misspecified.”
They conjecture that the condition may be relaxed, but do not present a proof. As far as I
know, no convergence result exists for multi-parameter models.
During my work I have attempted to find more general CRM convergence proofs, as a
tool to better understand the properties of this design approach. Following is a summary of
my main results, beginning with one-parameter models. For the remainder of this section, I
assume that in all cases, regardless of the allocation method, there is only a single optimal
level (i.e., we rule out ties). Additionally, I assume that the design is constrained CRM (i.e.,
CRM limited to transitions of ±1 level), rather than the original unconstrained design.8
4.2.1 Preamble
First, I find that CRM’s input data are better described by running proportions and point
estimates than by the treatment and response chains.
Lemma 4 The statistics
(
{pˆm}, {Fˆm}
)
, with {pˆm} defined via
pˆu =
nu
n
, (4.5)
and {Fˆm} defined in eq. (3.2) in Chapter 3, are sufficient for θ in the CRM likelihood.
The proof follows easily from the factorization theorem.
Next, we look more closely at the CRM allocation rule.
7It is possible that more points would match, but this would be a lucky coincidence, not a matching
guaranteed by the model.
8It can be proven that the two become equivalent as n increases, and therefore the proofs hold for both;
but this thesis has enough text in it already, and unconstrained CRM is not recommended in any case.
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Definition 6 The CRM allocation rule is composed of two stages:
1. A point estimate θˆ, generically defined as
θˆ = A1
(
{pˆm}, {Fˆm}|G,φ
)
. (4.6)
θˆ must be a continuous function of {pˆm}, {Fˆm}, with continuous first-order
partial derivatives.
This estimate is then used to generate Gˆ = G(θˆ) and Qˆp = Gˆ
−1(p). Or, these statistics
can be estimated directly from their posterior distributions, in such a way that they
obey the same smoothness requirements w.r.t. {pˆm}, {Fˆm}.
2. A distance-based allocation xn+1 = A2(Gˆ). Common options include
(a) “Closest treatment”: argminu
∣∣∣lu − Qˆp∣∣∣;
(b) “Closest response”: argminu
∣∣∣Gˆu − p∣∣∣;
(c) “Just under”: max
{
lu : lu ≤ Qˆp
}
.
Part 1 of this definition ensures that the CRM estimate is a smooth function of the
sufficient statistics. If one takes the posterior mean, median or (continuous) mode of
Π
(
θ|{pˆm}, {Fˆm}, φ
)
to estimate θ, this smoothness condition should hold.9
Finally, let us define a key property of parametric models in general and of CRM in
particular.
Definition 7 • A CRM model G(x, θ) will be said to have d degrees of freedom
(d.f.), if for any ǫ > 0, any set of d indices (u1 < . . . < ud) ∈ {1 . . . m} and any set
of corresponding real numbers 0 < a1 < . . . < ad < 1, there exists a domain D ∈ Θ,
containing a d-dimensional open rectangle, such that
∣∣Guj − aj∣∣ < ǫ ∀θ ∈ D, j ∈
1 . . . d. Also, Π(θ) > 0 ∀θ ∈ Θ.
• A CRM model will be called economical if d is equal to the number of parameters.
• A CRM model will be called misspecified if there exists ǫ > 0, such that there is no
θ ∈ Θ for which |Gu − Fu| < ǫ ∀u ∈ 1 . . . m, where F is the true response-threshold
CDF. Otherwise, the model will be called correctly-specified.
9If for some reason it does not, then probably that specific CRM scheme is inadequate for use.
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In words, a model with d d.f. can always fit up to d values of F arbitrarily closely at
any given time. All CRM models discussed here are assumed to be economical, i.e. that
d equals the number of parameters. Typical standard parametric models usually answer
this requirement. For example, the 1-parameter shape logistic model known as “power”
(O’Quigley et al., 1990) has d = 1, a standard location-scale logistic or normal model has
d = 2, and a shape-scale Weibull model has d = 2 if responses are known to be positive.10
Clearly, a CRM model with d = m d.f. cannot be misspecified. The case d = m is of course
a saturated model.
4.2.2 Convergence Proofs for Misspecified One-Parameter Models
Note that the posterior distribution
Π
(
θ|n, {pˆm}, {Fˆm}, φ
)
∝ f (x1, . . . xn, y1, . . . yn | θ)Π(θ | φ) (4.7)
can be written as
Π
(
θ|n, {pˆm}, {Fˆm}, φ
)
=
1
C
L (x1, . . . xn, y1, . . . yn; θ)Π(θ | φ), (4.8)
where C, a shorthand for the marginal distribution of the data, is not a function of θ.
As n → ∞, the prior’s relative weight diminishes, and the posterior’s form converges to
that of the likelihood for all parameters about which our information continues to increase.
Therefore, Bayesian estimators – whether the mean, mode or a given posterior percentile
– will converge to the MLE. Moreover, this means that asymptotically it does not matter
whether the statistics Gˆ, Qˆp are estimated directly or via θˆ. With one parameter this
assumption always holds, and it has been used by Shen and O’Quigley (1996) in their
proof.11 Similarly, my inspection of CRM asymptotics will be likelihood-based.
Shen and O’Quigley (1996) have shown that correctly specified and “mildly misspeci-
fied” CRM schemes with d = 1 converge almost surely to the optimal allocation. Instead of
constraining F , I now constrain the treatment chain.
Lemma 5 Suppose that a CRM experiment has a limiting distribution π = (π1 . . . πm)
′ (in
the sense that as n → ∞, pˆu → πu ∀u ∈ {1 . . . m} in probability; of course,
∑
u πu = 1).
Then at most 2 elements of π are nonzero, and the corresponding levels must be adjacent to
each other.
10Note that in literature one may encounter non-economical model choices - for example, the 1-parameter
scale logistic (O’Quigley and Chevret, 1991), for which a careless choice of µ0, the fixed location parameter,
can prevent the model from fitting all design levels as Qp. Such a model will have d = 0 d.f.
11I will discuss the multi-parameter case more carefully later on.
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Proof Let us first assume allocation according to the “Closest treatment” or “Just under”
rules. We use the properties of Gˆ, Qˆp outlined in Definitions 5,6. Since both are continuously
(partially) differentiable in {pˆm}, {Fˆm}, as the former tend to a limit so will they: Gˆ→ G˜,
and in particular Qˆp → Q˜p, in probability. Therefore, for every ǫ > 0 there is an n0(ǫ)
such that for all n > n0, Pr
(
Qˆp ∈ [Q˜p − s/3, Q˜p + s/3]
)
> 1 − ǫ. But all points in this
interval imply an assignment by stage A2 in Definition 6 either a single level or to one of two
adjacent levels. Thus, at most 2 levels have a nonvanishing probability of being assigned.
As to the “Closest response” rule, the conditions on Gˆ imply that Gˆ → G˜ as well, and
therefore allocation would behave in a similar manner. 
The proof’s rationale is illustrated in Fig. 4.1. Note that the lemma says nothing about
whether the method converges correctly.
0
0.5
0 0.2 0.4 0.6 0.8
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(Q p , p )
Figure 4.1: Illustration of the proof in Lemma 5. From the lemma’s conditions and from
generic CRM model smoothness properties, the model curve Gˆ converges to a limit curve G˜,
with a limit target-estimate Q˜p (which is generally not the true target). This estimate must
lie between two design points, depicted here as lu, lu+1. Due to the curve’s convergence,
the probability of Qˆp straying far enough from Q˜p to allocate other levels beside these two
(the distance s/3 for “Closest treatment” allocation is used in the proof and shown here),
is diminishing.
Lemma 5’s proof emphasizes the importance of checking the model G’s properties. If we
are not assured that outputs (estimates) are smooth in the inputs (raw data), as specified
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in Definition 6, we cannot guarantee convergence. This is because the maximal-likelihood
set may include a positive-measure region in Θ. If the allocation’s first step hops arbitrarily
within that region, the allocation itself may end up spread out across several levels. For-
tunately, a posterior-based decision process (posterior mean, percentile or mode) should
usually fulfill the necessary requirements.
Another consequence of Lemma 5 is that for every ǫ > 0 there is a sufficiently large n,
such that the score equations can be rewritten as∣∣∣∣∣∣ ∂ln∂θj −
∂G(lv , θ)
∂θj
pˆv
(
Fˆv −Gv
)
Gv(1−Gv) +
∂G(lv+1, θ)
∂θj
pˆv+1
(
Fˆv+1 −Gv+1
)
Gv+1(1−Gv+1)
∣∣∣∣∣∣ < ǫ, j = 1 . . . d,
(4.9)
assuming of course that the two nonzero elements are πv, πv+1.
Now, recall that for a given d = 1 curve family G, only a single curve can (via the
likelihood equation) be guaranteed to pass through a specified point (x, F (x)). Let this
curve be called the CRM curve that matches F at x.
Theorem 8 For a CRM scheme with d = 1, assume a limiting distribution π exists. Then:
(i) If π has exactly two nonzero elements indexed u, u + 1, and if all CRM curves G
matching F in [lu, lu+1] obey Gu+1 −Gu ≤ Fu+1−Fu (i.e., the model is “shallower” than
the true curve in the vicinity of [lu, lu+1]), then lu, lu+1 must be the two levels around target.
(ii) Under the “Closest response” or “Just under” allocation rules, if π has a single
nonzero element indexed u, and if the model is “shallower” than the true curve in the
vicinities of [lu−1, lu] and [lu, lu+1], (assuming w.l.o.g. 1 < u < m), then the scheme
converges in probability to optimal allocation, i.e. allocation only to the closest level
to target.
Proof (i) Since there are two elements, the solution to the score equations (4.9) tends to a
limit curve G˜ obeying
G˜u+1 − Fu+1 = −K
(
G˜u − Fu
)
for some positive constant K. Clearly, G˜ must match F somewhere in (lu, lu+1). Since all
G curves answering this criterion are “shallower” than F in the vicinity of this segment, we
have G˜u ≥ Fu and G˜u+1 ≤ Fu+1. Now assume by contradiction and w.l.o.g. that Fu > p and
u > 1, so that lu, lu+1 are not the design points around target. Then, obviously, p < Fu ≤
G˜u < G˜u+1. The probability of assigning lu+1 diminishes, reaching a contradiction. 
(ii) The proof here is for the “Closest response” rule, but it can be easily tailored for
the “Just under” rule as well. Since πu is the dominant element, G˜ will match F exactly
at lu. Now, assume by contradiction that this is not the optimal level, and further assume
115
w.l.o.g. that lu−1 is closer to target. This means that p < G˜u. Since G˜u−1 ∈
[
Fu−1, G˜u
)
,
G˜u−1 is closer to target than G˜u. lu−1 becomes a superior assignment under G˜, reaching a
contradiction. 
The proof’s rationale for part (i) is illustrated on Fig. 4.2.
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Figure 4.2: Illustration of the proof in Theorem 8, part (i). We assume by contradiction
that levels lu, lu+1 each receive an non-diminishing fraction of the allocations, and that both
are on the same side of target. Since d = 1, the model’s limit curve G˜ cannot match the
true curve F at both design points, and instead matches it somewhere between them. Since
G˜ is “shallower” than F in this region, both G˜ values are on the same side of target as well,
ensuring the gradual elimination of allocations to lu+1 - yielding a contradiction.
4.2.3 Convergence Proofs for Multi-Parameter Models
First, we must note that the likelihood-based approach to analyze CRM convergence is not
automatically correct with d > 1. We also need that G(x) will be a nontrivial function of
all parameters at all design points. I will assume this is the case (though it may not be true
for some saturated model forms), and continue using the likelihood-based approach. Then
Lemma 5’s result can be further strengthened with 2 or more d.f.
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Lemma 6 Suppose that a CRM experiment has a limiting distribution π = (π1 . . . πm)
′.
Then for d ≥ 2 d.f., only a single element of π is positive (i.e., it is equal to 1 and the rest
are zero).
Proof Following Lemma 5, let us assume that the only nonzero elements are πv, πv+1. For
every ǫ > 0 and sufficiently large n, the score equations can be approximated by (4.9). The
MLE is found by setting the score to zero. Since there are d ≥ 2 such equations, the MLE
converges to the degenerate solution Gˆv = Fˆv, Gˆv+1 = Fˆv+1. This means that as n → ∞,
Gˆv → Fv, Gˆv+1 → Fv+1. Since we have ruled out ties in the introduction to this section,
one of these level is closer to the true target Qp. Therefore, for sufficiently large n, this level
would dominate. 
The proof’s rationale is illustrated in Fig. 4.3. Note that here, too, the lemma says
nothing about whether the method converges correctly.
We are now ready to prove convergence for misspecified-model CRM using the limiting-
distribution approach, under certain conditions – regardless of how misspecified the model
is.
Theorem 9 Suppose that a CRM experiment has
1. A limiting distribution π = (π1 . . . πm)
′;
2. d ≥ 2 degrees of freedom;
3. The “Closest response” or “Just under” allocation rule; and
4. If πu > 0, then lu−1 and lu+1 (when applicable) also belong to S, defined as
S ≡ {lu : nu →∞ as n→∞} . (4.10)
Then πu∗ = 1, with u
∗ being the index of the level closest to target. In other words, the
CRM scheme converges to optimal allocation.
Proof Again by contradiction.
First, note that a level belonging to S does not automatically have a positive stationary
frequency; all we know is that it is allocated infinitely often. In fact, due to Lemma 6, we
know that only a single level, say lv, has πv > 0 (in fact, πv = 1).
Now assume w.l.o.g. that v > u∗, meaning that Fv > p. Since
nv ≫ max (nv−1, nv+1)
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(the relation a ≫ b is introduced here as a shorthand for b/a → 0 as a → ∞), we can
show using similar reasonings to that used above in Lemma 6, that Gˆv → Fv. Therefore,
Pr(Gˆv < p)→ 0 and Pr(Gˆv > p)→ 1. Now, lv+1 can only be allocated if Gˆv < p, and lv−1
can only be allocated if Gˆv > p. Hence, not only nv ≫ nv−1 (given), but also nv−1 ≫ nv+1.
So if any contradiction can arise, it can do so only from allocations to lv−1. We focus our
attention there.
Since d ≥ 2, Gˆ can match Fˆ in at least two points – the first being of course lv.
Since nv−1 ≫ nv+1, matching at lv−1 (rather than at lv+1) will yield higher likelihood.
At the same time, since nv−1 → ∞ (given), Fˆv−1 → Fv−1. Since it is given that lv−1 is
closer to target, then (again similarly to Lemma 6’s proof) Pr
(∣∣∣Gˆv−1 − p∣∣∣ < ∣∣∣Gˆv − p∣∣∣)→ 1,
meaning that CRM allocations to lv−1 will eventually dominate allocations to lv – producing
a contradiction. 
The rationale for this proof, as well, can be understood via Fig. 4.3.
Why does Theorem 9 not apply to the “Closest treatment” allocation rule? Because
then the allocation is based on modeling F between design points, where we have no direct
information. A misspecified model would in general model the curve incorrectly. Even when
Gˆ = F at the two design points around Qp, the misspecification error between them can be
large enough to perceive the second-closest level as closest. However, it can be shown that
under the “Closest treatment” rule and assuming all other conditions hold, we can do no
worse than second-closest.
Lemma 6 and Theorem 9 hold regardless of whether the model is correctly specified.
Can we do better assuming the model is correctly specified - as is the case with d = 1?
In this problem, the difference between misspecified and correctly-specified models boils
down to the number of F values that can be simultaneously fitted – up to d for misspecified
models, and up to m for correctly-specified models. For the latter, one would expect that
the MLE’s consistency – a standard textbook result – would guarantee CRM’s optimal
allocation convergence. However, the textbook result refers to i.i.d. sampling. Consistency
under U&D sampling was proven by Tsutakawa (1967a); the key to the proof was the fact
that allocation proportions converge to π, similarly to the condition used in the misspecified-
model proofs above.
Our case is yet a bit more different. For U&D, every treatment level for which 0 < Fu < 1
has a positive πu. For CRM, we have just proven that if π exists then it has only 1 nonzero
element if d > 1. This means that for d > 1 we cannot rely on the likelihood equations to
provide a consistent MLE for θ, because there is no identifiability. With over one d.f. you
can run an infinite number of curves through a single point. So at present, Theorem 9 is
the most I can offer using the limiting-distribution approach, regardless of whether or not
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Figure 4.3: Illustration of the proof in Lemma 6. Assuming by contradiction that levels
lu, lu+1 each receive an non-diminishing fraction of the allocations, and since d ≥ 2, the
model’s limit curve G˜ will match the true curve F at both design points. But then, since
we have ruled out ties, one level will clearly emerge as closer to target (according to the
allocation definition of “closer”), and from a certain point onward would dominate the
allocations. Note that this would happen whether lu, lu+1 are the two levels around target
(as in the illustration) or not.
This figure can also be used to understand Theorem 9’s proof. Say that lu+1 is CRM’s limit
level, but lu is closer to target. If nu, nu+2 are also unbounded, then nu ≫ nu+2. Gˆ will
tend to match F at lu+1 and lu, and ultimately lu (being closer to target) will supplant lu+1
as the most frequently allocated level.
the model is correctly specified.
4.2.4 Nonparametric CRM-type Models
Finally, we turn to the nonparametric CRM-style designs mentioned earlier. Leung and Wang
(2001)’s “isotonic regression” design can be seen as a special (prior-less) case of a d = m
CRM scheme. Since there is no prior, the likelihood-based anlysis used here is applicable.
However, as discussed above, the addition of more degrees of freedom beyond the second one
does not appear to help guarantee convergence; in fact, it may hinder it due to premature
over-fitting (see further below). Regarding the more sophisticated CCD scheme and similar
designs (Ivanova et al., 2007; Yuan and Chappell, 2004), I have the following result.
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Theorem 10 Schemes that repeatedly allocate level lu as long as Fˆu ∈ [p−∆1(p), p +∆2(p)],
and move “up” or “down” if Fˆu is below or above this interval, respectively, will converge
optimally if lu∗ is the only level whose true F value is in the said interval.
Proof Assume the condition specified in the theorem holds. Then, any level lu that is
allocated infinitely often will ultimately see Fˆu → Fu. If Fu lies outside the interval,
allocation will eventually move away from lu – upward if Fu is below the interval, and
vice versa. As n→∞, this will happen for all levels except lu∗ . 
4.2.5 Conceptual Interpretation of the Results
The various proofs may leave worrying about conditions like “having an asymptotically
dominant level, whose neighbors still receive allocations infinitely often” being too vague,
not directly observable from the design or perhaps even circular.
First, let us frame this in context. As far as I know, to date, a full generation since
Bayesian percentile-finding schemes were first implemented, there has been one (1) conver-
gence proof published (Shen and O’Quigley, 1996), with much narrower applicability and
under conditions more restrictive than those postulated here (Cheung and Chappel, 2002).
Moreover, this proof – and the subject of CRM proofs in general – has not played a central
role in the CRM debate.12 The absence of theoretical results may indicate that they are
not easy to come by, or that they require inconvenient conditions such as those I used.
For example, the existence of π was specified as a condition, though it perhaps can
be proven in some cases. At face value, it may be hard to envision a treatment chain for
this application that does not converge to some π; however, quasi-periodical chains that
gravitate between levels without stabilizing may be possible. In general the existence of
π is a random condition. The same goes for specifying that certain levels are allocated
infinitely often. Whether or not a random condition holds, may depend upon an individual
run’s trajectory.
In spite of using various approaches, I could not bring about a hermetic convergence
proof for general CRM designs, regardless of the form of F , without resorting to random
conditions. Without these conditions, a CRM experiment may find itself dug in a “hole”
with very misguided point estimates surrounding the optimal level – point estimates which
cannot be corrected over time with more information, since they themselves prevent the
12According to an August 14, 2007, ISI Web of Science search, 151 articles have cited O’Quigley et al.
(1990), CRM’s “founding manifesto”, since 2000. Over the same time period, only 23 articles cited
Shen and O’Quigley (1996), the paper presenting the above-mentioned proof – and 9 of these were co-
authored by O’Quigley. This compares, e.g., with 85 articles citing Goodman et al. (1995) and 49 citing
Babb et al. (1998) – two other key CRM articles published around the same time frame.
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allocation of any trials to these levels. This means, that for many designs and distribution
scenarios, some runs may converge and some not, depending upon their particular history.
This is an important point, whose significance will be more fully understood in the next
section.
Meanwhile, one thing that can be learned from the proofs is CRM’s operating principle.
CRM takes advantage of two salient features of percentile-finding experiments:
1. The pointwise convergence of {Fˆm}, as mandated by the laws of large numbers.
2. The problem’s basic geometry in 2 dimensions, i.e. a continuous increasing F , a
horizontal line corresponding to F = p which it must cross at some point, and the
discrete grid – on which both decisions and observations must take place (cf. Fig. 4.1).
As seen above, CRM designs take advantage of the second (geometric) feature only if
they have 2 or more d.f. This point has not been noticed so far by CRM theorists.
Inverting the conditions spelled out in the definitions and the theorems, can help provide
more details about what might stop CRM from converging:
1. An allocation scheme whose posterior Qˆp is not smooth in the sufficient-statistic inputs
(see Definition 6), or is not monotone in all parameters (see Definition 5) cannot be
guaranteed to converge.
2. Non-economical models (see Definition 7) should be avoided.
3. One-parameter models seem better off with a “shallow” curve family. “Shallowness”
improves the chain’s mobility: the experiment is less likely to lock into a single level
based on flimsy evidence. On the other hand, “shallow” models are more likely to
end up oscillating between 2 levels rather than converging to a single level. The
model’s slope around target can be easily checked via sensitivity analysis before the
experiment.
4. Schemes are more likely to converge correctly when using the “Closest response” rule
than when using the “Closest treatment” rule. This is because the former does not
require correct specification between design points. To my knowledge, this has not
been explicitly mentioned in CRM literature, though “Closest response” does appear
to be more widely used.
5. If the experiment locks into a single level early on and appears to never leave it, there
is no guarantee that this is indeed the optimal level. This point can be inferred from
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the conditions to most theorems and lemmas in the previous section, and will be
discussed in more detail in the next section.
It seems that for CRM convergence, misspecification and over-fitting are two sides of
the same coin. With misguided point estimates, both a “steep” one-parameter model and
a saturated model are prone to lock onto the wrong level, perhaps indefinitely.
At bottom line, from a convergence point of view and with no knowledge of F ’s true
form, a flexible-shape 2− 3 parameter model appears to be most suitable. However, there
is no guarantee that this model type has an advantage for small n – where quick response
may be more crucial than long-term fit, and therefore a one-parameter model may be more
suitable.
The nonparametric “isotonic regression” design is essentially a saturated CRM scheme,
so it is prone to over-fitting and therefore not recommended. The modified CCD method
of Ivanova et al. (2007), which allows a tolerance window, avoids some of the convergence
pitfalls of saturated models because it forces transitions once the local point estimate is
outside the window – regardless of the estimates at neighboring levels. However, it too is
not guaranteed to converge optimally, unless level spacing is very coarse.
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4.3 Theoretical Study: Small-Sample Behavior
4.3.1 Conceptual Interlude
Looking back at the two core features driving CRM’s convergence (mentioned at the previous
section’s close), they seem simple and reliable enough. However, while feature 2 (geometry)
always holds, feature 1 (point estimate precision) kicks in only when n becomes quite large.
Before this happens, things can go wrong – most often via the “locking” phenomenon.
More broadly, CRM is an estimation-based allocation scheme. At each point in
the experiment, we choose to observe thresholds at the level most likely to be closest to
target according to our model. This is in sharp contrast with U&D, where allocation is
sampling-oriented: there, we quickly converge to random-walk sampling from π, without
insisting that each single trial be performed at the best level. Sampling proceeds regardless
of where we believe the exact target lies. Through this sampling, U&D provides us with
gradually better information about the location of π’s mean, and also about F values in the
3− 4 levels closest to it – enabling response-based estimation as well.
CRM does not consider any given observation’s value for estimation further down the
road, but focuses on the here and now. This should be seen as a vulnerability, and is
of course related to the “locking” phenomenon. From a common-sense perspective, we
certainly should not presume that our model is good enough for meaningful estimation at,
say, n = 5 – especially if we acknowledge that the model is misspecified. However, CRM
is based precisely upon this presumption. Nonparametric CRM approaches, including
CCD, share this basic presumption, and therefore also display CRM’s core vulnerability.
4.3.2 ”Locking”, “Gambling” and “Unlucky Batches”
I introduce the notion of “lucky” and “unlucky batches” of thresholds. We can quan-
tify these terms: a “lucky batch” is a sequentially-sampled group of, say, 5− 10 thresholds,
whose sample moments (most importantly the first two: mean and variance) are “close” to
the population moments. Again, the meaning of “close” can be quantified: close enough so
that, with a given spacing, the level closest to the batch’s 100p-th percentile is indeed the
optimal level.13 An “unlucky batch” is the opposite - a similarly sized sample whose mo-
ments are far enough from population moments, to throw {Fˆm} off in a manner that causes
CRM to allocate to the wrong level. “Unlucky batches” are to binary-response sampling
what outliers are to ordinary direct sampling.
Whether a batch is deemed “unlucky” in a particular experiment depends on the inter-
13Keep in mind, though, that thresholds are not directly observed.
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play between the threshold variance V ar(T ), the level spacing s, the CRM model (including
its prior specification) and also the “luck of the draw” – the particular sequence in which
the batch is observed, and the treatment levels at which it is observed. The first two fac-
tors can be summarized via ∆F , the difference in F values between adjacent levels around
target. Once ∆F is fixed, some notion of how likely “unlucky batches” are can be gained
by looking at Pr
(
|Fˆu − F | ≤ ∆F
)
at a single level lu, for various values of p and ∆F , as a
function of nu: The higher the probability, the smaller the chance of an “unlucky batch”.
This is a simple, straightforward calculation of binomial probabilities. Fig. 4.4 shows this
for ∆F = 0.2 (top) and 0.1 (bottom), and true values p = 0.2, 0.3 and 0.5.
If ∆F is large – 0.2 or greater – the probability that a given batch would be “unlucky”
decreases to about 20% by the time nu ≈ 5 for p = 0.2 (Fig. 4.4, top). If the target is closer
to the median, it takes more trials – around nu ≈ 10 – to reach the same risk level. What if
the design spacing is finer, so that ∆F = 0.1? The risk of “unlucky batches” dramatically
increases: it hovers around 50% for nu ≈ 5−15, regardless of target. A risk of less than 20%
is not attained until well after the typical sample size for CRM experiments is exhausted
(Fig. 4.4, bottom). All in all, it is reasonable to expect that in an experiment of size
20− 40, at least one “unlucky batch” of 5− 10 observations will occur.
”Unlucky batches” can throw any design off. An U&D chain, too, will trend up when
encountering a sequence of uncharacteristically high thresholds, and vice versa. However,
its Markov-chain short memory becomes an asset: by the next hitting time at a level close
to target, the probabilistic effect of previous excursions upon future allocations becomes
zero (Tsutakawa, 1967b).14
On the other hand, CRM is a long-memory method – a property that its developers are
all too happy to point out as an advantage (O’Quigley and Zohar, 2006). The long memory
itself is not necessarily detrimental, but combined with CRM’s estimation-oriented alloca-
tion scheme, CRM turns into a something of a gambling endeavor. The effect of outliers on
estimation can be devastating for small n, but diminishes as n increases. Similarly, the ef-
fect of an “unlucky batch” on CRM’s estimation-allocation depends mostly upon when
it occurs in the experiment. If the “unlucky batch” happens late enough, after point
estimates have stabilized reasonably close to their true values, especially around target –
the CRM chain will be quite resistant to subsequent “unlucky batches”. On the other hand,
an early “unlucky batch” can create a “perfect storm”. CRM would trend away from tar-
get and lock onto the wrong levels, collecting subsequent information at the wrong place –
thereby slowing down the self-correction process. Moreover, since the estimation-allocation
uses all previous data, it will resist the correcting influence of more well-behaved batches
14The effect on estimation is still retained, whether averaging or IR/CIR estimation is used.
124
5 10 15 20 25 30
0.
0
0.
2
0.
4
0.
6
0.
8
1.
0
Precision of Small−Sample Binomial Estimates
Number of Trials at Level of Interest
Pr
 (F
−h
at 
wi
thi
n 0
.2 
of 
Tr
ue
  F
)
F=0.2
F=0.3
F=0.5
5 10 15 20 25 30
0.
0
0.
2
0.
4
0.
6
0.
8
1.
0
Precision of Small−Sample Binomial Estimates
Number of Trials at Level of Interest
Pr
 (F
−h
at 
wi
thi
n 0
.1 
of 
Tr
ue
  F
)
F=0.2
F=0.3
F=0.5
Figure 4.4: Graphs of Probabilities of Pr
(
|Fˆu − p| ≤ ∆F
)
as a function of nu, for ∆F = 0.2
(top) and 0.1 (bottom), and true F values of 0.2 (blue), 0.3 (red) and 0.5 (black).
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following the “unlucky” one.
To sum it up: CRM, with its long memory and estimation-based allocation, gambles
that “unlucky batches” would occur late in the experiment – or not at all. If the gamble
succeeds, we are quite likely to have a successful experiment. If it fails, we are almost
assured of the opposite.
This gambling property of CRM is demonstrated in Figs. 4.5 through 4.7. In in Fig. 4.5
we see the proportion of runs for which, out of the first 20 trials, at least 12 were allocated
to the same single level (in symbols: the proportion of runs for which, at n = 20, pˆu ≥ 0.6
for some u). This is the proportion of runs for which CRM was quite “sure”, during the
early phase, that it “knew” where the target is. This proportion varies with target location
(relative to the prior’s weighting), and with distribution, but for one-parameter CRM (top)
it remains at or above 60% of the runs. However, in about half of the cases, the gamble fails:
the bulk of the first 20 trials were allocated to the wrong level (in all scenarios depicted, there
is only a single optimal level). Also shown are data from a CCD experiment (Ivanova et al.,
2007), simulated over the same thresholds (Fig. 4.5, bottom). The “gambling” tendency is
somewhat subdued, but around 50% of runs, on average, are still dominated early on by a
single level. The success rate is, if anything, even worse than CRM’s. Note that for U&D
designs, such an exclusive allocation pattern is all but impossible.
In Fig. 4.6, we can see that the effect of early “gambling” lingers on. Shown are his-
tograms of pˆu∗ after 40 trials. That is: after 40 trials, the cumulative proportion allocated
to the correct optimal level is calculated separately for each run; the proportion from all
runs are then tallied into a histogram. These histograms can be interpreted as descriptive
measures of convergence uniformity. This is done for U&D and for 3 different CRM
models. If the design converges uniformly, we expect the distribution of pˆu∗ to be tight.
This indeed occurs for U&D designs (top left-hand corner of each group of 4 histograms).
The peak is rather modest in its location: pˆu∗ < 0.4 in most runs – but on the other hand,
pˆu∗ rarely falls below 0.2. CRM designs over the same thresholds (regardless of specific
model) show a much large variability. With an “easy” distribution (normal, top), the en-
semble mean of pˆu∗ for all 3 models is larger than U&D’s. However, a sizable proportion of
runs have little or no allocation at lu∗ after 40 trials. With a less convenient distribution
(gamma with shape parameter 1.2, bottom), the ensemble mean is approximately the same
for U&D and CRM, but the proportion of poorly-allocated CRM runs shoots up, especially
with the one-parameter model.
It should be noted, that while the ensemble mean of pˆu∗ is often reported in CRM
simulation studies as a measure of the design’s success, to my knowledge no study has
looked at pˆu∗ ’s variability between runs.
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Figure 4.7 shows a similar analysis comparing GU&D2,0,1 and the nonparametric CCD
with cohort the same cohort size and target. The patterns are similar, with CCD having
much larger variability. I used the same cohort size to make comparisons easier. Similar
analysis with CCD and cohort size 3 (the size recommended by its developers) showed the
same pattern. This indicates, that CRM’s allocation robustness problem is not primarily
caused by the use of a model, but rather by the reliance upon blunt point estimates to drive
allocations early in the experiment.
4.3.3 Effect of Prior
In the previous section discussing convergence, the prior was almost always neglected. How-
ever, for small samples it plays a decisive role. The first few allocations are not only driven
by point estimates, but also by the prior. From numerical studies, it is clear that CRM
performs much better when the true target corresponds to a high-density region of the
prior, and vice versa. Naturally, the more parameters to the model, the “heavier” the prior
becomes and the more time it takes for its effect to wear off. Since ultimately we’d like the
data to play the leading role, this is one place where one-parameter models have a distinct
advantage. In this work I have not attempted to tinker with priors too much, but usually
optimized them so that Qˆp has a broad unimodal distribution centered around the middle of
the design range, and so that the boundary levels have a smallest prior probability, but not
a negligible one. The existence of a peak in Qˆp’s prior, even a broad one, was sufficient to
show a clear performance gap between scenarios in which in coincided with the true targets,
and scenarios in which it did not.
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Additional Glossary for Chapters 4-5
BUD: Bayesian Up-and-Down: a family of methods combining U&D and CRM alloca-
tion principles.
CCD: Cumulative Cohort Design, a method recently developed by Ivanova et al. (2007).
I characterize it here as a nonparametric Bayesian design.
CRM: Continual Reassessment Method, the Bayesian design developed by O’Quigley et al.
(1990). Due to its prominence in statistical circles, it is also used here as shorthand
for any Bayesian percentile-finding design.
EWOC: Escalation With Overdose Control, the Bayesian design developed by Babb et al.
(1998). Essentially it is a CRM variant that aims to reduce the incidence of visits to
treatments above target.
QUEST: The Bayesian design developed by Watson and Pelli (1979, 1983). Very sim-
ilar to CRM, but predates it by a decade and is almost unknown outside of psy-
chophysics.
d: The number of degrees of freedom in the model (see Definition 7).
G: The Bayesian model curve for F .
G˜: The limit curve of G as n→∞ (in case it has a limit curve).
G: The space of possible model curves under a given specification.
pˆu: The empirical cumulative proportion of allocations to lu for a given sample size.
q: The cardinality of the set S (see below).
S: The set of all levels receiving an unbounded number of allocation in a given ex-
periment. In general this set is random.
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u∗: The index of the level closest to target according to the metric used (a.k.a. the
optimal level).
α: A key parameter in EWOC: allocation is to the α posterior quantile of Qp.
β: A key parameter in BUD: if the U&D allocation falls outside the (quantile-based)
100(1− 2β)% posterior credible interval for Qp, it can be overridden by the Bayesian
allocation.
∆1(p),∆2(p): Parameters used in nonparametric Bayesian designs
θ: The parameter vector used to construct the model G, to create a tolerance window
of Fˆ values, for which the current allocation is retained.
Θ: The parameter space of θ.
Π: Prior and posterior distributions of θ.
φ: The parameter vector in θ’s prior distribution.
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Early Gambling: CRM 1-Parameter 'Power' Model 
Snapshot after 20 Trials (6 treatment levels, cohort size 2)
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Early Gambling: CCD (nonparameteric CRM)
Snapshot after 20 Trials (6 treatment levels, cohort size 2)
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Figure 4.5: Charts depicting the proportion of CRM-type runs, in which at least 12 of the
first 20 trials were allocated to the same level. This proportion is then split cases when
this level was correct (optimal, light blue) and wrong (maroon). The experiment simulated
was a cohort design with cohort size 2, p = 0.3, m = 6 and seven different distributions
arranged according to target location. Shown are the one-parameter “power” (logistic with
free shape) model of O’Quigley et al. (1990), optimized with “shallow” slope (top); and
the CCD method of Ivanova et al. (2007), with their recommended window width ∆ = 0.1
(bottom) – over the same simulated thresholds.
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U&D Uniformity, 40 Trials (N=500)
Cumulative Within−Run Proportion on Optimal Level
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CRM 2−Par Logistic Model Uniformity, 40 Trials
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CRM 2−Par Weibull Model Uniformity, 40 Trials
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CRM 2−Par Logistic Model Uniformity, 40 Trials
Cumulative Within−Run Proportion on Optimal Level
N
um
be
r o
f R
un
s
0.0 0.2 0.4 0.6 0.8 1.0
0
20
40
60
80
12
0
CRM 2−Par Weibull Model Uniformity, 40 Trials
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Figure 4.6: Uniformity of U&D and CRM allocations, shown via histograms of pˆu∗ from 500
runs, after 40 trials. Simulations were non-cohort (or cohort size 1), with normal (top) and
gamma, shape 1.2 (bottom) thresholds. In both cases m = 8. Each frame shows histograms
of U&D runs (top left-hand corner), vs. CRM with the one-parameter “power” model
(bottom left-hand corner), two-parameter logistic (top right-hand corner) and shape-scale
Weibull (bottom right-hand corner).
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CCD Uniformity, Uniform Thresholds
Cumulative Proportion Allocated to Optimal Level
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CCD Uniformity, Gamma Thresholds
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CCD Uniformity, Normal Thresholds
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CCD Uniformity, Lognormal Thresholds
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GU&D Uniformity, Uniform Thresholds
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Figure 4.7: Uniformity of CCD (top) and GU&D (bottom) allocations, shown via histograms
of pˆu∗ from 1000 runs, after 32 trials. Cohort size is 2 in designs targeting Q0.3, with uniform
(top-left frames), and gamma, shape 0.8 (bottom-left), normal (top-right) and lognormal
(bottom-left) thresholds. In all cases m = 6 and x1 = l2. The location of lu∗ in the frames
was l1, l2, l3 and l4, respectively.
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Chapter 5
COMBINED DESIGN APPROACHES
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5.1 Existing Designs and Current Knowledge
Designs combining U&D with Bayesian or other long-memory methods are a recent and
increasingly popular area of research. These designs focus mostly on the Phase I appli-
cation. They are fueled by the dissatisfaction with traditional ’3+3’ type designs among
statisticians, and by the failure of purely Bayesian designs to win over many practitioners
due to their perceived risk. Since the Phase I field is rife with creative statisticians, I am
sure that newer designs will continue to be published as this thesis goes to print.
A few researchers (Storer, 2001; Potter, 2002) have suggested the simple “two-stage”
template familiar from U&D designs: start the experiment as U&D, then after the first re-
versal change to a CRM or other model-based design. The two cited studies suggest starting
with a median-targeting SU&D, then switch to a design that targets a lower percentile.
An interesting combination has originated from one of the few statistical groups studying
U&D (Ivanova et al., 2003). They suggested a novel U&D variant that uses information
from all previous trials in transition decisions. Attributed to an idea from an unpublished
1950’s thesis by Narayana, this method (dubbed here NM for “Narayana Method”) requires
the experiment to fulfill two conditions in order to move ’up’ or ’down’ at trial i: 1. Some
U&D transition rule (e.g., BCD, KR, etc.), and 2. Fˆ (xi) ≤ p for ’up’ transitions, and vice
versa for ’down’ transitions. If only one condition is fulfilled, the experiment remains at the
same level, i.e. xi+1 = xi. NM’s condition 2 is essentially nonparametric CRM, as discussed
in Chapter 4. Asymptotically, NM was proven to converge to a 2 − 3 level Markov chain
around target (3 levels corresponds to the case when Qp is very close to a design level).
NM appears to have been abandoned, but may have helped inspire the ideas of Ivanova et al.
(2007). Even though the latters’ recent CCD method is presented as a fusion of U&D and
CRM principles, it is in fact a nonparametric CRM, with U&D affecting it only indirectly
in the determination of the window width ∆(p) (see Section 4.1.3).
5.2 Theoretical Discussion
At this point in the dissertation, the problems with the two-stage approach cited above
are apparent. The first reversal happens too early in the experiment to guarantee reliable
model-based estimation-allocation. Moreover, both authors chose to use median-targeting
SU&D for the first stage, even though the experiment’s ultimate target is lower. Even
though this may seem like a clever way to offset the first reversal’s typical downward bias
(assuming the experiment starts low as is customary in Phase I), it means that a sizable
proportion of these two-stage experiments would end up with a transition point close to the
median. This is highly undesirable, especially for the toxicity-averse Phase I application. A
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safer two-stage hybrid scheme would begin with an U&D whose target is closer to Qp, and
then transition at reversal 3 or 5, or at a hitting time (see Section 3.6).
Similarly, by now we may suspect what could go wrong with NM. First, being a CRM
rule it suffers from the “locking” and “gambling” tendencies described in Section 4.3.1.
Moreover, even among CRM variants the saturated nonparametric model seems to have
inferior convergence properties (see Section 4.2.5), since it shares little information between
point estimates. Finally, the use of two criteria, both of which must be satisfied for a
transition to occur, further amplifies the CRM-related “locking” tendency. Therefore, even
though the asymptotic proof in Ivanova et al. (2003) is valid once the chain actually reaches
the vicinity of target, it does not preclude the experiment being held up away from target
for an indefinite amount of time. These problems have emerged in some numerical trials I
performed (data not shown; see more discussion in Oron (2005)).
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5.3 New Methodologies and Optimization
5.3.1 Conceptual Overview
Before proceeding to new combined Markovian-Bayesian designs, it may be helpful to list
each approach’s pros and cons. Using the insight gained by prior researchers and the added
results reported in this thesis, the picture is clearer now. The table below compares the
properties of ”best in class” implementations of each approach.
The main conclusion from Table 5.1 is that there is probably no magic solution to the
small-sample percentile-finding problem. In particular, the Achilles heel of both approaches
is allocation. Even though U&D is listed as superior to CRM on most line items under “al-
location”, it is only a relative advantage. Run-to-run variability cannot be eliminated given
the problem’s nature. On the other hand, post-experiment estimation is not as problematic
as it may appear. For U&D, the pros and cons of averaging estimators vs. CIR were clearly
outlined in Chapter 3, and both are satisfactory if used “as directed”. Moreover, there is
nothing preventing us from choosing model-based estimation after an U&D experiment, if
we trust the model. Similarly, while CRM’s “natural” estimator is the next allocation, we
may supersede it with a more sophisticated model if warranted – or with CIR if we trust
no model.
Returning to allocation, both approaches are vulnerable to outlying “unlucky batches”
and to variations in the form of F (though U&D is in general less sensitive). Fortunately, to
a large degree the two approaches are complementary. U&D is relatively more robust early
on, and converges faster to its stationary behavior. As to CRM, its allocation performance
improves with time. As n increases, it actually becomes more robust than U&D.
As discussed in the previous section, current proposals to combine U&D and Bayesian
designs fail to alleviate the worst small-sample risks. Instead of these ideas, I propose a
gradual transition scheme, which is applicable regardless of sample size. Two options are
described below.
5.3.2 Randomized Transition
Since CRM relies upon point estimates, its model’s performance is indexed to n. The
following randomization scheme utilizes this property:
Randomized Bayesian Up-and-Down (R-BUD):
• Start with a 5− 10 trial U&D ’burn-in’;
• For each subsequent trial, apply CRM allocation with probability n/(n+n0); otherwise
apply U&D allocation.
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Table 5.1: Side-by-side comparison of Markovian and Bayesian design properties.
Category U&D Bayesian Advantage
Allocation
Convergence
Rate
Geometric
√
n U&D
Guaranteed? By Markov Proper-
ties
Generally, No U&D
Sharpness Only as good as π Asymptotically
maximal sharpness
Bayesian
Robustness to
Misspecification
Sensitive to slope of
F around target
Sensitive to slope,
to shape deviations
from model family
and to bad prior
U&D
Robustness
to “unlucky
batches”
Short memory; re-
set at next hitting
time
Depends on when
they occur
U&D
Estimation
Method Method choice a
’free-for-all’
’Natural’ Esti-
mation as next
allocation, but
misspecified
None
Efficiency Approximately
√
n Approximately
√
n None
Robustness Averaging sensitive
to boundaries, CIR
robust but less effi-
cient
Sensitive (see allo-
cation above)
U&D
Interval Estima-
tion
Complicated but
feasible
’Naturally’ avail-
able
Bayesian
Implementation
Aspects
Intuitive Sim-
plicity
Simple; no counter-
intuitive transitions
Sophisticated;
Counter-intuitive
transitions possible
at start
U&D
Step-by-Step Practitioners can
be self-sufficient
Requires con-
stant statisti-
cian/software
support
U&D
Flexibility Cohort designs and
best-in-class single-
trial designs lim-
ited;
Flexible Bayesian
Sensitivity to
Spacing and
Boundaries
Optimal around
∆F ≈ 0.1 − 0.15,
sensitive to bound-
aries
Needs ∆F ≈ 0.2 or
more, no problem
with boundaries
None
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The factor n can be replaced by
√
n, or any other increasing function (preferably one
that has theoretical justification). Another optional safety precaution is to mandate that
the first several allocations at each level will be U&D.
Even though individual allocations are random, the R-BUD design actually guarantees
transition to CRM-dominated allocations at a predetermined pace. This pace is controlled
by the tuning parameter n0. In view of results presented earlier in the thesis, good values
for n0 are in the range 10− 30.
5.3.3 Inference-Based Transition
Description
R-BUD provides a reasonable combination template. However, it does not adapt to the data.
In some cases, a “lucky” early run or a successful CRM model may provide opportunity for
earlier transition; in other cases the opposite happens.
At least to some extent, CRM itself can provide testimony about how well it is doing.
This is sketched in Algorithm 3 below.
Algorithm 3 Credible Bayesian Up-and-Down (C-BUD)
procedure C-BUD(x1, {lm},cutoff,n)
i← 1
while i ≤ cutoff do
xi+1 ← x(U&D)i+1
i← i+ 1
end while
while i ≤ n do
if x
(U&D)
i+1 6= x(CRM)i+1 then
Calculate Qˆp,β, Qˆp,1−β : the CRM β and 1− β posterior quantiles of Qp
if x
(U&D)
i+1 ∈
[
Qˆp,β − s/2, Qˆp,1−β + s/2
]
then
xi+1 ← x(U&D)i+1
else xi+1 ← x(CRM)i+1
end if
end if
i← i+ 1
end while
end procedure
Notes:
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1. The C-BUD scheme allows CRM to override U&D, only when a quantile-based 100(1−
2β)% credible interval around the former is narrow enough to exclude a CRM alloca-
tion identical to the U&D one.1 As β increases, a CRM override becomes easier.
2. This allows the following easy interpretation: for β ≥ 0.5, C-BUD becomes CRM. For
β = 0, C-BUD becomes U&D. Hence, it would seem that β = 0.25 is a roughly equal
mix of the two designs. However, if the two allocations differ, then due to the discrete
design CRM automatically begins with some positive baseline credibility level (on
the order of 1/m). This is conceptually balanced by demanding the exclusion buffer
around the 100(1 − 2β)% credible interval. In practice, the range 0.15 − 0.25 for β
seems to reflect a relatively balanced combination. With these β values we may expect
around 10− 15 trials to pass before observing the first Bayesian allocation override.
3. An equivalent definition of the C-BUD rule is: take the tail closest to the U&D alloca-
tion (including the U&D-allocated level itself), and calculate the posterior probability
of Qp falling within that tail. If it is less than 100β%, override the U&D allocation.
4. Posterior-median CRM allocation fits naturally within this scheme and is strongly
recommended over posterior mean or mode - though, of course, the method could be
implemented with any CRM allocation rule.
5. Usually, if the two allocations differ then x
(U&D)
i+1 = x
(CRM)
i+1 ±s. However, occasionally
the U&D and CRM allocations point in different directions (i.e., x
(U&D)
i+1 = xi +
s, x
(CRM)
i+1 = xi − s or vice versa). In that case we have two options:
(a) Proceed as in the usual case, i.e. use the CRM allocation whenever the U&D
one is outside the calculated credible interval;
(b) If the U&D allocation is “rejected”, use the CRM allocation only if
xi 6∈
[
Qˆp,β − s/2, Qˆp,1−β + s/2
]
as well. Otherwise xi+1 = xi.
6. For toxicity-averse applications such as Phase I, the design can be modified to have
two different β values on the two tails. If we desire to minimize upward excursions,
then the right-hand β should be larger.
1This exclusion is ensured by adding the s/2 buffers on each side of the Cr.I.; the method could be
implemented without them, though this is not advisable; see note 2.
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Lifelong (or converted) Bayesians would now ask, “what is the loss function?” First
we should note that in spite of the use of Bayesian calculations, our framework is hybrid:
one which evaluates a non-Bayesian procedure using Bayesian methods, but which gives the
non-Bayesian decision a “home-court advantage”. Therefore, it is not clear that formulating
a loss function provides added value, being mostly an exercise in reverse engineering. At
this moment, I have no satisfactory formulation for the loss function.
Because of C-BUD’s greater theoretical appeal and flexibility, from this point on we
limit discussion of BUD to this variant and leave the randomized R-BUD behind. From
now on, referring to BUD will imply C-BUD, unless otherwise noted.
5.3.4 Estimation and Stopping Rules
In view of CRM’s coherence advantage, one is tempted to use the n+1-th CRM allocation
as the BUD estimate. However, this is somewhat self-contradictory. After all, the BUD
framework is about not accepting the CRM decision at face value; why, then use it as
the final estimate? Moreover, the CRM allocation model is knowingly misspecified. If we
use a model-based estimation, it better be the most realistic model we can suggest for the
problem, rather than the CRM model. An alternative option is to use U&D estimators –
either vˆAD, which can be applied to any chain (not necessarily a purely U&D one), or CIR.
The BUD framework suggests some interesting stopping rule options. The most straight-
forward one would be to stop after a specified number of successful CRM overrides (defined
as allocation that exceeds the required credibility threshold, whether or not it coincides with
the U&D allocation), indicating that the model is fitting reasonably well around target. This
subject is left for subsequent research.
5.3.5 CCD-BUD Combination
The frequentist interpretation suggests a way to combine CCD (Ivanova et al., 2007) with
U&D. We recall that CCD forces a transition whenever Fˆ (xi) is outside a pre-specified
tolerance window around p. This is still CRM-style estimation-driven allocation, but it is
somewhat less prone to “locking” than CRM (see Fig. 4.5). Additionally, since it has no
prior and no curve assumptions, it is more robust to misspecification and to boundaries.
In order to combine it with U&D, we use frequentist binomial confidence intervals for Qp,
instead of the credible intervals.
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5.3.6 Numerical Examples
As a demonstration of the pros and cons of CRM and BUD, I present graphically some
summaries from numerical simulations. The first (Figs. 5.1, 5.2) is of a one-trial-at-a-time
experiment with m = 8; the second (Figs. 5.3, 5.4) is of a cohort (k = 2) experiment with
m = 6 and a low starting point, a la` Phase I. Shown are estimation “success” probabilities,
with “success” declared whenever the level closest to Qˆp is also the level closest to Qp (a
rather standard measure of success in Phase I literature). The most salient observation is
that success is very far from being assured; indeed, even after 30− 40 trials, expecting 60%
success is a bit optimistic under both frameworks.
In the first example, the focus was on inspecting both BUD (color-coded to blue hues,
β = 0.15 in all cases) and various CRM models (shades of red and pink). Here I refrained
from simulating conditions with target on the boundary, which is equivalent to assuming
that the design did not really have a physical boundary (i.e., treatments could in principle be
increased or decreased beyond the nominal boundaries). The three CRMmodels differ wildly
from each other in their performance pattern: one-parameter “power” tends to strongly
over- or under-perform, while the two-parameter logistic seems most robust, but overall
its success rate is relatively low, and seems to improve more slowly than others over time
(compare the top figure for n = 20 with the bottom, n = 40). The BUD models track
pretty closely to U&D at n = 20, but post visible gains over it at n = 40. Interestingly, the
one-parameter BUD combination appears to be most robust.
From the same simulations, Fig. 5.2 demonstrates convergence uniformity or robustness
to “unlucky batches”, as in Fig. 4.6. For BUD runs, pˆu∗ is almost as tightly distributed
around its mean as for U&D runs – but the peak shifts (sometimes almost imperceptibly)
to the right. The better the model fit, the more substantial the rightward shift. The risk of
very bad runs (very low pˆu∗) only slightly increases compared to U&D.
In the second numerical example I retained only the “power” model, since the focus was
on Phase I style constraints, with smaller m (6) and a low starting level (l2). Here (Fig. 5.3)
GU&D was color-coded blue, CRM red, and BUD in shades of purple and pink, according
to the value of β (0.15 to 0.35). Additionally, the x− axis was arranged so that the true
targets are in increasing order. ’Hard’, reflecting physical boundaries were assumed, as is
the case in these applications. This immediately suggests using the boundary-resistant CIR
for U&D and BUD estimation.
A clear pattern emerges, with CRM holding the edge when targets are at or above the
center of the treatment range, and U&D better for targets lower than center or on the
boundaries. The explanation is quite mundane: CRM’s prior has a (broad, but distinct)
peak on levels 3 − 4. Hence, it has a forfeit advantage if these are indeed the targets, and
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BUD Performance Across Distributions, 20 trials
beta=0.15 for all models; 8 levels in all runs
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BUD Performance Across Distributions, 40 trials
beta=0.15 for all models; 8 levels in all runs
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Figure 5.1: Comparison of U&D (KR, k = 2), CRM and BUD (β = 0.15) estimation on a
variety of simulated distributions, and n = 20 (top) and 40 (bottom). “Correct level” was
defined as the level whose F value is closest to 0.3. The design had 8 levels, with all runs
starting at level 4. The ’power’ model is logistic with shape parameter and fixed location
and scale (d = 1), introduced by O’Quigley et al. (1990). The other two models have d = 2:
’Logistic’ is location-scale, and ’Weibull’ is shape-scale. The auto-detect averaging estimator
vˆAD was used for U&D and BUD estimation.
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BUD, Logistic Model, alpha=0.15, 40 Trials (N=500)
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BUD, Weibull Model, alpha=0.15, 40 Trials (N=500)
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BUD, Logistic Model, alpha=0.15, 40 Trials (N=500)
Cumulative Within−Run Proportion on Optimal Level
N
um
be
r o
f R
un
s
0.0 0.2 0.4 0.6 0.8 1.0
0
50
10
0
15
0
BUD, Weibull Model, alpha=0.15, 40 Trials (N=500)
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Figure 5.2: Uniformity of U&D and BUD (β = 0.15) allocations, shown via histograms
of pˆu∗ from 500 runs, after 40 trials. Simulations were non-cohort (or cohort size 1), with
normal (top) and gamma, shape 1.2 (bottom) thresholds. In both cases m = 8. These
are the same scenarios depicted in Fig. 4.6. Each frame shows histograms of U&D runs
(top left-hand corner), vs. BUD combined with the one-parameter “power” model (bottom
left-hand corner), two-parameter logistic (top right-hand corner) and shape-scale Weibull
(bottom right-hand corner).
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also to level 5 (which U&D has to climb 3 levels in order to reach). On the boundaries, CRM
suffers from having a low prior weight placed there (which is intuitively natural; otherwise,
the boundaries would be wider).
How does BUD fare in these simulations? It seems that the design most exposed to CRM
override (β = 0.35) is not as robust as smaller exposures, without gaining the advantages of
full CRM. Smaller values of β seem to remain well within the performance envelope created
by U&D and CRM, regardless of who’s on top. Overall, they track closer to U&D which is
understandable given the small n, and perform better on the average than either U&D or
CRM.
Fig. 5.4 summarizes simulation results under the same conditions, but comparing U&D
to CCD and CCD-BUD with β = 0.25. Note that the vertical scale is smaller here, because
all designs are substantially more robust than CRM in terms of estimation success. CCD
(k = 2), in particular, is the most robust design I’ve observed from that respect.2 At n = 18,
there are very few overrides with β = 0.25, and as a result CCD-BUD tracks very closely
to U&D. Later on some differences emerge, and again CCD-BUD seems to perform, on the
average, better than either U&D or CCD.
2This does not indicate all-around robustness; in terms of run-to-run variability discussed on Section
4.3.1, CCD is almost as variable as CRM and much less robust than U&D or BUD. See Fig. 4.7.
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Performance Across Distributions, 32 trials
Cohort Design (size 2), 6 Levels, Isotonic Regression Estimates
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Figure 5.3: Comparison of U&D (GU&D(2,0,1)), CRM (with cohorts of size 2) and BUD
(β = 0.15, 0.25, 0.35) designs on a variety of simulated distributions, and n = 18 (top) and
32 (bottom). ’Correct level’ was defined as the level whose F value is closest to 0.3. The
design had 6 levels, with all runs starting at level 2. Only the ’power’ model (d = 1) was
used for CRM and BUD. The CIR estimator was used for U&D and BUD. Distributions
are arranged by target location, so that the leftmost distribution has level 1 as the optimal
level, and the rightmost distribution has level 6.
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Performance Across Distributions, 18 trials
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Performance Across Distributions, 32 trials
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Figure 5.4: Comparison of U&D (GU&D(2,0,1)), CCD (with cohorts of size 2) and CCD-BUD
(β = 0.25) designs on the same thresholds and under the same conditions as in Fig. 5.3.
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Percentile-Finding: Limitations and Potential
Revisiting the framework outlined in the introduction, we now have a better grasp of the
problem’s limitations and of the way they play out in practice. As the anesthesiology
experiment demonstrated (Section 3.4), the variability encountered with live subjects is
usually much greater and less tractable than when using a simplistic functional form for F ,
and experimental runs are never as smooth as computer simulation output.
Considering the two main solution paths currently available (U&D and Bayesian), the
choice is between quick convergence, albeit to a random walk that is by definition prone
to excursions; and a design that locks onto a single level, without guarantee that it is in
fact the best one. In the longer run, as far as estimation precision is concerned the two
approaches would usually agree; however, the sequence of treatment allocations during the
early phase is almost as different as it gets.
Since the settings are those of an experiment, even if toxicity to live subjects is involved
the decision whether to take a risk over the allotted sample has already been taken. Hence,
placing “allocation purity” above all other considerations appears to be detrimental to the
goal of controlling toxicity over a larger population (thanks to Barry Storer for emphasizing
this point). Moreover, as Section 4.3 demonstrated, CRM’s attempt to identify the best
level early on may actually result in increased risk compared with U&D.
On the other hand, the list of “best in class” U&D designs is short and imposes prac-
tical constraints. For example, the fastest-converging cohort design targeting Q0.3 has
a cohort size of 2; the next fast-converging option is with cohort size 5 (GU&D(5,1,2);
Gezmu and Flournoy (2006)). Designs with k = 3, the most popular cohort size for Phase
I studies, are much slower. similarly, for single-trial experiments the best design (KR) can
approximate Q0.3, Q0.2 or smaller percentiles (somewhat underestimating the former and
overestimating the latter) – but cannot work for other below-median targets such as Q0.4.
Another constraint has to do with boundaries, whose effect must be avoided or mitigated
in one of the ways outlined on Chapter 3.
CRM and its nonparametric offshoots (CCD, etc.) are much less constrained in this
respect. They perform best (besides the more detailed conditions outlined in Chapter 4)
when the spacing is coarse so that ∆F between levels is around 0.2 or more. Still, given
their large small-sample variability, I would not recommend using an exclusive CRM-type
design.
If one plans a highly constrained experiment (i.e., with constraints that hamper U&D
performance), a BUD-type hybrid design offers less risk than CRM/CCD alone. Without
these constraints, “best in class” U&D should suffice, possibly with a down-shift scheme
to smaller spacing midway through the experiment. The finer points of further optimizing
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U&D remain to be explored.
Centered Isotonic Regression
Rather early in my work I accidentally discovered the fix described here as centered isotonic
regression (CIR). It immediately showed a clear performance improvement; however, its
theoretical justification and properties were not as clear. The theoretical treatment pre-
sented in Sections 3.2 and 3.3 has been developed gradually since then (aided in part by
Marloes Maathuis). Many other ideas and directions related to CIR were not discussed here.
This estimator may have applicability beyond U&D, perhaps as yet another modified-MLE
estimator, to be almost automatically preferred over the MLE in ordinary settings due to its
practical advantage (such as using S2 rather than σˆ2 for normal sample variance estimates).
Tailoring CIR to other applications may mandate different solutions for finding the
optimal x-coordinate of pooled estimates. This is probably true with binary current-status
data. Another interesting perspective is viewing CIR as a form of monotone linear splines,
for which the node location is determined automatically. The latter idea may be extended
to higher-order splines.
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Appendix A: Proof of KR Unimodality
In principle this appendix is redundant, but for some reason the question of KR’s mode
has become controversial and resulted in at least two article rejections - one by Gezmu and
Flournoy and one by yours truly. Therefore, a detailed derivation proving that KR has a
single stationary mode follows.
As indicated in Theorem 1, the proof looks at the stationary profile γ as a continuous
function of F . Since F is a continuous strictly increasing function of x, it suffices to show
that γ(F ) is monotone decreasing. We simplify equation (2.9) to the form
γ(F ) =
F (1 − F )k
F+ {1− (1− F )]k} , (1)
where F+ = F (x+ s). The derivative γ
′
(F ) has the same sign as
F+
{
(1− F )k + kF (1 − F )2k−1}+ F ′+F (1− F )2k
−F+
{
(1− F )2k + kF [(1− F )k−1 + (1− F )2k−1]}− F ′+F (1− F )k. (2)
Canceling terms and dividing through by F+(1− F )k−1 we get
1− F + F
′
+
F+
F (1− F )k+1 − (1− F )k+1 − kF − F
′
+
F+
F (1− F ).
< 1− F − (1− F )k+1 − kF.
(3)
This expression is zero at F = 0, and has derivative (k + 1)
[
(1− F )k − 1] < 0 for F > 0.
Therefore it is negative for F > 0, and by extension γ(x) is decreasing. Therefore, by
Lemma 1, KR has a single stationary mode as claimed in Theorem 1.
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Appendix B: Code for The New Estimators
Code for Auto-Detect Estimator
Note that the AD estimator can be used not only for U&D chains, but for any vector
that has a starting-point effect and eventually converges to some stationary behavior. In
that latter case, however, care must be taken in interval estimation. One should use the
autocorrelation-based estimate of neff (se1 in the code) and not the “hitting time” estimate
which is based on U&D theory.
ADmean<-function (x,before=T,safe=length(x)/4,full=T) {
#### REMOVING ’FRONT TAIL’ AND RETURNING MEAN OF REMAINING VALUES
# Assaf Oron, 10/2007
# ARGUMENT LIST
# x: The vector to be averaged
# before: if true (default), averaging begins from one position before the
# identified transition point
# safe: a position beyond which the algorithm stops looking. This means that
# at least length(x)-safe+1 elements will be included in averaging. Defaults
# to length(x)/4.
# full: if true, output includes information needed for for interval estimation.
# Otherwise, only point estimate is returned.
cutoff=round(safe)+1
n=length(x)
base=sign(x[1]-mean(x[2:n]))
a=2
while (a<cutoff & sign(x[a]-mean(x[(a+1):n]))!= -(base)) a=a+1
if (before) a=a-1
if (!full) return(outmean) ### POINT ESTIMATE ONLY
#### NOW THE TOUGH PART - VARIANCE ESTIMATION
#### WE BASE IT ON THE SD AND TWO ESTIMATES OF EFFECTIVE SAMPLE SIZE
#### IN ANY CASE, WE USE ONLY THE AVERAGED PART OF x
### THE FIRST IS AUTOCORRELATION BASED; WE LOOK AT 1ST AND 2ND DEGREE
xx=x[a:n]
nn=length(xx)
cor1=max(cor(xx[1:(nn-1)],xx[2:nn]),0)
cor2=max(cor(xx[1:(nn-2)],xx[3:nn]),0)
corfac=max(cor1,sqrt(cor2))
### THE FOLLOWING SAMPLE SIZE ESTIMATE IS BASED ON DERIVATION IN THESIS
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eff_n1=max(nn*(1-corfac)/(1+corfac),1)
sig2=var(xx)
se1=sqrt(sig2/eff_n1)
############
### NOW, CALCULATING S.E. VIA INTERVALS BETWEEN HITTING TIMES
### AT A GIVEN LEVEL (MARKOV CHAIN THEORY)
firsts=c(ifelse(a==1,1,ifelse(x[a]==x[a-1],0,1)),diff(xx))
tmp=table(xx[firsts!=0])
unq=sort(unique(xx[firsts!=0]))
dists=sort(abs(unq-mean(xx)),index.return=T)
### The effective i.i.d. sample size is the mean number of
### hitting intervals for the two levels closest to our estimate
eff_n2=tmp[dists$ix[1]]-1
closest=unq[dists$ix[1]]
piececut=ifelse(firsts!=0 & xx==closest,1,0)
#cat(xx,’\n’)
#cat(piececut,’\n’)
pieceid=cumsum(piececut)
piecelens=sapply(split(xx,pieceid),length)
#### THIS, TOO, IS BASED ON A DERIVATION FOUND IN THE THESIS
se2=sqrt(eff_n2*(mean(piecelens^2)*(sig2+(outmean-closest)^2)
+max(outmean,closest)^2*var(piecelens))/nn^2)
####### NOW WE TAKE THE MORE CONSERVATIVE S.E. ESTIMATE; BOTH WILL BE RETURNED ANYWAY
se=max(se1,se2)
#### THE D.F. ESTIMATE FOR T-STAT IS TAKEN FROM THE HITTING TIME APPROACH
df=max(eff_n2-1,1)
return(c(outmean,se,df,a,se1,se2,eff_n1,eff_n2))
}
Code for CIR Estimator
First, a generic code for forward estimation (point estimate only). This code is completely
analogous to the well-known PAVA code; in fact, parts of the R pava() code are copied and
pasted here.
cir.pava <- function (y,x, wt=rep(1,length(x)),boundary=2,full=FALSE) {
# Returns centered-isotonic-regression y values at original x points #
# Assaf Oron, 10/2007
#
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### ARGUMENTS:
# y: y values (raw point estimates). Must match the x values.
# They are given as first argument, both for compatibility with ’pava’
# and to enable parallel running via ’apply’ type routines
# x: treatments. Need to be pre-sorted in increasing order
# wt: weights.
# boundary: action on boundaries. Defaults to 2,
# which is analogous to ’rule=2’ on function ’approx’, i.e.
# returned y values are constant outside the boundaries.
# boundary=1 does linear extrapolation.
# In addition, one can impose boundaries as inputs or
# augment the output with boundaries, as discussed in
# the dissertation text.
# full: if FALSE, only point estimates at x values are returned
### Validation stuff
n <- length(x)
if (n <= 1) {
if (!full) return (y)
else return(list(x=x,y=y,z=x))
}
if (any(is.na(x)) || any(is.na(y))) {
stop ("Missing values in ’x’ or ’y’ not allowed") }
if (any(diff(x)<=0)) {stop ("x must be strictly increasing")}
z<-x # Keeping a ’clean’ copy of x for final stage
lvlsets <- (1:n)
repeat {
viol <- (as.vector(diff(y)) <= 0) # Find adjacent violators
if (!(any(viol))) break
i <- min( (1:(n-1))[viol]) # Pool first pair of violators
y[i] <- (y[i]*wt[i]+y[i+1]*wt[i+1]) / (wt[i]+wt[i+1])
x[i] <- (x[i]*wt[i]+x[i+1]*wt[i+1]) / (wt[i]+wt[i+1]) # new x is calculated
wt[i]<-wt[i]+wt[i+1] # weights are combined
# Deleting the i-1-th element
y<-y[-(i+1)]
x<-x[-(i+1)]
wt<-wt[-(i+1)]
n <- length(y)
if (n <= 1) break
}
if (boundary==1) {
### Utilize this option if you wish to use linear extrapolation
### outside the boundary
### (the ’approx’ function does not have this option)
### In general, this is *not* recommended;
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### rather, impose boundary conditions whenever possible
### (as inputs or after output of this function)
### or use the default, constant boundary conditions
if (x[n]<max(z)) {
x<-c(x,max(z))
y<-c(y,y[n]+(y[n]-y[n-1])*(x[n+1]-x[n])/(x[n]-x[n-1])) }
if (x[1]>min(z)) {
x<-c(min(z),x)
y<-c(y[1]-(y[2]-y[1])*(x[2]-x[1])/(x[3]-x[2]),y) }
}
# Now we re-interpolate to original x values, stored in z
# If we didn’t set boundary=1, then this will give constant
# y values for x values falling outside new range of x
if (!full) return(approx(x,y,z,rule=2)$y)
else return(list(x=x,y=y,z=z,wt=wt))
}
Now, inverse estimation specifically tailored for the U&D application. The input here is
as a yes-no summary table of the binary responses. The output is a vector, with the first
element an inverse point estimate of Qp, and the other elements percentile estimates of Qp
for percentiles given by the user (for interval estimation).
This code includes interval estimation as discussed in the text - again, tailored for U&D
in which treatment allocation is random. The same principles can be applied to generate
interval estimates for non-random allocations.
The code uses some small utilities that follow below.
cir.upndown<-function(yesno,xseq,target,xbounds=c(0,1),ybounds=c(0,1),
full=F,cioption="poisson",plist=c(.025,.975)) {
# Centered-isotonic-regression for Up-and-Down
# Assaf Oron, 10/2007
# Returns Point & Interval Estimates of Target percentile
### ARGUMENTS:
# yesno: Yes-no table of binary responses. Can contain rows of zeros
# xseq: Treatment values matched to the responses
# target: The target response rate (between 0 and 1)
# xbounds,ybounds: used for interpolation in case (estimated)
# target falls outside CIR output boundaries.
# full: complete output or estimates only
# cioption: which method to use for interval estimation
# can choose from ’poisson’, ’t’ or binomial (any other string)
# plist: percentile list for interval estimation. Is a vector
# of any length
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n_m<-yesno[,1]+yesno[,2]
x<-xseq[n_m>0]
y<-yesno[n_m>0,1]/n_m[n_m>0]
xbounds[1]<-min(xbounds[1],min(x))
xbounds[2]<-max(xbounds[2],max(x))
### Point Estimate ###########################
# We start via forward estimation, just calling ’cir.pava’
pavout<-cir.pava(y,x,wt=n_m[n_m>0],full=TRUE)
newx<-pavout$x
newy<-pavout$y
newn=pavout$wt
### Error control if the interpolation target is outside boundary
if (min(newy)>target) {
newx<-c(xbounds[1],pavout$x)
newy=c(ybounds[1],pavout$y)
newy=c(ybounds[1],pavout$y)
newn<-c(1,pavout$wt)
}
mm=length(newy)
if (max(newy)<target) {
newx<-c(newx,xbounds[2])
newy=c(newy,ybounds[2])
newn=c(newn,1)
}
### The estimate is generated by using ’approx’ with x and y interchanged
out=ifelse(length(newy)==1,newx,approx(x=newy,y=newx,
xout=target,ties="ordered",rule=2)$y)
### Now to Interval Estimate ###########################
# We find the point estimate’s location w.r.t. our grid
yplace=min(max(rank(c(target,newy),ties.method="max")[1]-1,1),length(newy)-1)
minn=min(newn[yplace],newn[yplace+1],na.rm=T)
if (length(newy)==1 || newy[yplace+1]==newy[yplace]) {
### degenerate cases (error control)
cigaps=ifelse(plist<0.5,xbounds[1]-xbounds[2],xbounds[2]-xbounds[1])
# }
} else {
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yplratio=(target-newy[yplace])/(newy[yplace+1]-newy[yplace])
if(cioption==’t’) {
width=smoothqt(plist,minn,target)/minn
} else if (cioption==’poisson’) {
width=smoothqpois(plist,minn,target)/minn-target
} else width=smoothqbinom(plist,minn,target)/minn-target
### Inverting the forward interval estimates
cigaps=width*(newx[yplace+1]-newx[yplace])/(newy[yplace+1]-newy[yplace])
}
#### Output
if (!full) { return(c(out,out+cigaps))
} else return (list(raw=yesno,paved=pavout,out=out,ci=out+cigaps))
}
Finally, the utilities used for interval estimation.
smoothqbinom=function(p,size,prob,add=T,half=F) {
q1=qbinom(p,size,prob)
p1=pbinom(q1,size,prob)
### We smooth out the binomial quantile function, because n is random
p2=pbinom(q1-1,size,prob)
out=q1-(p1-p)/(p1-p2)
if(add==T) {
out[p>0.5]=out[p>0.5]+2
out[p<0.5]=out[p<0.5]-1
}
if (half==T) out=out-0.5
#### This part to ensure we are still conservative compared with
#### the traditional quantile function
out[p<0.5]=ifelse(out[p<0.5]<q1[p<0.5],out[p<0.5],q1[p<0.5])
out[p>0.5]=ifelse(out[p>0.5]>q1[p>0.5],out[p>0.5],q1[p>0.5])
out
}
####
smoothqt=function(p,size,prob) { qt(p,df=size-1)*sqrt(size*prob*(1-prob)) }
####
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smoothqpois=function(p,size,prob,add=F) {
refp=c(0.5,ifelse(p<0.5,1-p,p))
q1=qpois(refp,lambda=size*prob)
p1=ppois(q1,lambda=size*prob)
p2=ppois(q1-1,lambda=size*prob)
### We smooth out the Poisson quantile function, because n is random
out=q1-(p1-refp)/(p1-p2)
extra=ifelse(add==T,1,0)
ifelse(p>0.5,out[2:length(out)]+extra,2*out[1]-out[2:length(out)]-extra)+
size*prob-out[1]
}
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Appendix C: Some Technical Details of CRM and BUD simulations
A wider range of CRM models than that which appears in Chapter 4 figures was simulated
and contemplated during my work. In the end, I presented results from only three models
– O’Quigley et al. (1990)’s original one-parameter model, location-scale logistic and shape-
scale Weibull – for the following reasons:
• Only these three have been used in practice a reasonable number of times (the Weibull
model is popular in sensory studies’ QUEST);1
• Chapter 4’s theoretical results indicate little benefit from models with more than 2-3
parameters;
• Simulation running times increase exponentially with the number of parameters, as
will be detailed below.
The implementation involves calculation of posterior statistics. In terms of both com-
puting time and precision, the worst-case default is MCMC. This is reasonably feasible
option for a single actual experiment. However, in simulation (or sensitivity analysis) the
calculation time could be prohibitive: for each single run, one has to simulate quite a few
MCMC cycles (it seemed that no fewer than 20, 000 cycles are usually needed), for each
single trial. Moreover, as stated we are only interested in a handful of statistics at most
– so having the complete posterior on our hands (as MCMC provides) is quite an overkill.
Therefore, researchers in this field naturally look for shortcuts. Computationally the easi-
est solution is to find a closed-form expression. For example, Gasparini and Eisele (2000)
simulated a saturated model using a ”product of betas” prior that enabled them to find a
closed-form expression for the posterior mean.
The next-fastest solution is numerical integration. The posterior mean, either of θ, of
{Gm} or of Qp, can be easily calculated using a ratio of two integrals. Posterior percentiles
of Qp can also be found this way – by converting the likelihood equation so that Qp is one
of the parameters, and integrating it over intervals (or parameter-space slices) of the form
[lu − s/2, lu + s/2]. Numerical integration is typically more accurate than MCMC (tested
over known prior distributions). The computing time increases exponentially with d, the
number of parameters. For d = 1, a calculation that would take days using MCMC takes
only minutes via R’s integrate() function. For d = 2, it takes hours using adapt() –
which is still a factor of 5 − 10 shorter than MCMC. For d ≥ 3 the integration approach
1Here I implicitly count the ”power” model used nowadays as a generalization of O’Quigley et al. (1990)’s
one-parameter model.
167
becomes more cumbersome symbolically, less stable numerically, and may in fact take more
time than MCMC.
In implementing BUD, I cut a few corners – while the CRM allocation was usually
calculated using the “closest response” criterion mandated by theory, I calculated posterior
percentiles (to determine override) using the “closest treatment” criterion, because this
could be done via numerical integration rather than MCMC. Sensitivity analysis showed
that the difference from doing a “closest response” calculation are quite small, and since
the focus was on a proof of concept the extra computing expense was not worthwhile.
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